Document:

Form of License Agreement

 Exhibit 10(n) 
  
 CERTAIN INFORMATION IN THIS EXHIBIT IS SUBJECT TO A REQUEST FOR CONFIDENTIAL TREATMENT. IN ACCORDANCE WITH RULE 24B-2 UNDER THE SECURITIES
EXCHANGE ACT OF 1934, AS AMENDED, SUCH INFORMATION HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. THE LOCATION OF SUCH OMITTED INFORMATION HAS BEEN INDICATED WITH ASTERISKS (*****). 
  
 EXCLUSIVE LICENSE AND SUPPLY AGREEMENT 
  
 THIS EXCLUSIVE LICENSE
AGREEMENT (the “Agreement”) is entered into as of September 28, 2004 (the “Effective Date”) by and between OXIS INTERNATIONAL, a Delaware
corporation (“OXIS”), located at 6040 N. Cutter Circle, Suite 317, Portland OR 97217 and HAPTOGUARD, INC., a Delaware corporation (“HaptoGuard”), located at 10 Rockefeller Plaza,
Suite 1001, New York, New York 10020. 
  
 RECITALS 
  
 WHEREAS, OXIS is the owner of certain Licensed Patents, Licensed Compounds, Licensed Know-How, Licensed Process, and Licensed Product (each as defined below), as described below; 
  
 WHEREAS, OXIS has conducted and successfully completed non-clinical
studies for the Licensed Product for oral administration, a Phase-I and a Phase-IIA Clinical Trial of the Product in the United States and United Kingdom. 
  
 WHEREAS, HaptoGuard is a biopharmaceutical company that is interested in developing and commercializing the Licensed Product; and

  
 WHEREAS, OXIS wishes to grant HaptoGuard
and HaptoGuard desires to obtain an exclusive, worldwide license under the Licensed Patents, Licensed Compounds, Licensed Know-How, Licensed Process, and Licensed Product on the terms set forth herein. 
  
 NOW THEREFORE, in consideration of the
foregoing and the covenants and premises contained in this Agreement, the parties agree as follows: 
  

	1.	DEFINITIONS 

  
 The following capitalized terms shall have the meanings indicated for purposes of this Agreement. 
  
 1.1 “Affiliate” shall mean, as to any person or
entity, which, directly or indirectly, controls, is controlled by, or is under common control with such person or entity. For purposes of this definition, “control” shall mean the ownership of more than 50% of the shares of stock entitled
to vote for the election of directors in the case of a corporation, and more than 50% of the voting power in the case of a business entity other than a corporation. 
  

 1 

 1.2 “ANDA” shall mean an Abbreviated New Drug Application filed pursuant to the
requirements of the FDA, or the equivalent application in any other country or jurisdiction, required before Commercial Sale of a drug product. 
  
 1.3 “Cardiovascular Indications” shall include three groups of disease and/or conditions as follows: Group A — *****
(hereinafter “Group A Cardiovascular Indications”); Group B – ***** (hereinafter “Group B Cardiovascular Indications”); and Group C — ***** (hereinafter “Group C Cardiovascular Indications”).

  
 1.4 “Combination Product” any product that
combines Licensed Product with any HaptoGuard product or technology. 
  
 1.5 “Confidential Information” shall have the meaning in Section 7. 
  
 1.6 “Disclosing Party” shall have the meaning provided in Section 7.1. 
  
 1.7 “Disputes” shall have the meaning provided in
Section 10.4. 
  
 1.8 “FDA” shall mean the
United States Food and Drug Administration or any successor agency. 
  
 1.9 “Field” shall mean any and all uses including but not limited to the therapeutic, diagnostic, preventative, amerliorative, and/or prognostic in Cardiovascular Indications, except for all drug eluting implanted
devices. 
  
 1.10 “First Commercial Sale”
shall mean, with respect to any Licensed Product, the first sale on a commercial basis in an arm’s length transaction for end use of such Licensed Product in a country after the governing health regulatory authority of such country has granted
regulatory approval of such Licensed Product, to the extent such regulatory approval is required in such country. Licensed Product distributed or used for clinical trial purposes shall not be considered sold, marketed or made publicly available for
sale and shall not constitute first commercial sale. 
  
 1.11
“HaptoGuard Indemnitee” shall have the meaning provided in Section 10.1(b). 
  
 1.12 “Generic Competition” shall mean on a country by country basis the commercial sale of a generic product containing the same
compound as Licensed Product as an active ingredient. 
  
 1.13
“Indemnifying Party” shall have the meaning provided in Section 10.1(c). 
  
 1.14 “Parenteral Formulation” shall mean Licensed Product formulated sterilely for administration through a needle or indwelling catheter to a human subject. 
  
 1.15 “Licensed Know-How” shall mean, with respect to
the Field, all information, data, compositions, materials, method, processes, protocols, reports, techniques relating to ***** 
  
 1.16 “Licensed Compound” shall mean a set of compounds having a ***** 
  

 2 

 1.17 “Licensed Patents” shall mean any and all i) Patents covering the Licensed
Compounds, Licensed Process, Licensed Know-How which have a Valid Claim; and ii) the Patents set forth on Appendix A which have a Valid Claim; 
  
 1.18 “Licensed Process” shall mean synthetic routes, materials, conditions, and/or processes relating to and for the manufacture
of the Licensed Compounds and/or Licensed Product relating to the Field. 
  
 1.19 “Licensed Product” shall mean any products prepared, created, generated or synthesized by use of the ***** 
  
 1.20 “Losses” shall have the meaning provided in Section 10.1(a). 
  
 1.21 “NDA” shall mean a New Drug Application filed
pursuant to the requirements of the FDA, or the equivalent application in any other country or jurisdiction. 
  
 1.22 “Net Sales” shall mean the amount actually received by HaptoGuard and its Affiliates or, if HaptoGuard or its Affiliate
sublicenses its rights with respect to Licensed Product in a given jurisdiction, by the Sublicensee in such jurisdiction for sales of Licensed Product for use in the Field to independent purchasers in arm’s length transactions, less the
following customary and reasonable items, actually allowed or granted for such Licensed Product (if not previously deducted from the amount invoiced): 
  
 (a) discounts, credits, retroactive price reductions, rebates, refunds, charge backs, allowances and adjustments, including
Medicaid, managed care and similar types of rebates, rejections, market withdrawals, recalls and returns, and administrative fees charged by hospital buying groups and managed care organizations; 
  
 (b) trade, quantity and cash discounts and rebates
actually allowed or given; 
  
 (c) sales,
excise, turnover, value-added, and similar taxes assessed on the sale of the Product, and import and customs duties; 
  
 (d) shipping and insurance charges, postage, and freight out; and 
  
 (e) government imposed rebates or discounts. 
  
 1.23 Sales of Licensed Product by and between HaptoGuard and its
Affiliates and sublicensees are not sales to Third Parties and shall be excluded from Net Sales calculations for all purposes. Sales of Product for use in conducting clinical trials of Licensed Product in a country in order to obtain the regulatory
approval of Licensed Compounds and/or Product in such country shall be excluded from Net Sales calculations for all purposes. Net Sales shall be determined in a manner consistent for all products sold by or on behalf of HaptoGuard and in accordance
with applicable U.S. generally accepted accounting principles. 
  
 1.24 “Non-Parenteral Intravenous Formulation” shall mean Licensed Product formulated ***** 
  

 3 

 1.25 “OXIS Indemnitee” shall have the meaning provided in Section 10.1(a).

  
 1.26 “OXIS Improvements” shall mean
any new invention related to active pharmaceutical ingredient production, formulation or chemical structure of the Licensed Processes and/or Licensed Compounds developed by OXIS whereby such improvements are covered under and/or disclosed by the
Patents. 
  
 1.27 “Patents” shall
mean, with respect to the Field, (a) patents and patent applications, existing as of the Effective Date or filed during the Term in accordance with Section 4.1, (b) any and all corresponding foreign patents and patent applications, whether now
existing or hereafter filed, (c) provisionals, substitutions, divisionals, reexaminations, reissues, renewals, extensions, term restorations, continuations, continuations-in-part, substitute applications and inventors’ certificates, arising
from, or based upon, any of such patents or patent applications, and (d) patents issuing from any such patent applications. 
  
 1.28 “Phase I Clinical Trial” shall mean a human clinical trial in any country conducted by HaptoGuard or its Affiliate to
initially evaluate the safety of Licensed Product in human subjects or that would otherwise satisfy the requirements of 21 CFR 312.21(a) or the equivalent laws, rules or regulations in a regulatory jurisdiction outside the United States. 

 
 1.29 “Phase II Clinical Trial” shall mean a human
clinical trial in any country conducted by HaptoGuard or its Affiliate to initially evaluate the effectiveness of Licensed Product in human subjects with the disease or indication under study or that would otherwise satisfy the requirements of 21
CFR 312.21(b) or the equivalent laws, rules or regulations in a regulatory jurisdiction outside the United States. 
  
 1.30 “Phase III Clinical Trial” shall mean a pivotal human clinical trial in any country conducted by HaptoGuard or its Affiliate
the results of which could be used to establish safety and efficacy of the Licensed Product as a basis for approval of an NDA for such Licensed Product or Additional Product or that would otherwise satisfy the requirements of 21 CFR 312.21(c) or the
equivalent laws, rules or regulations in a regulatory jurisdiction outside the United States. 
  
 1.31 “Receiving Party” shall have the meaning provided in Section 7.1. 
  
 1.32 “Regulatory Approval” shall mean approval of an NDA and satisfaction of any related applicable regulatory registration and
notification requirements (if any). 
  
 1.33
“Royalty Term” shall mean, with respect to each country in which Licensed Product is sold, on a product-by-product basis, that time period beginning on the First Commercial Sale of such Licensed Product covered by a Valid Claim
in such country and expiring, on a country-by-country basis, the expiration in such country of the last-to-expire Licensed Patent with a Valid Claim. 
  
 1.34 “Sublicense Fee”*****  
  

 4 

 1.35 “Sublicensee” shall mean any Third Party to which HaptoGuard or its
Affiliate has granted rights in the to the Licensed Patents covering the Licensed Product pursuant to the terms of this Agreement. 
  
 1.36 “Term” shall have the meaning provided in Section 9.1. 
  
 1.37 “Third Party” shall mean any entity other than OXIS or HaptoGuard or an Affiliate of OXIS or
HaptoGuard. 
  
 1.38 “U.S.” shall mean the
United States. 
  
 1.39 “Valid Claim”
shall mean a claim of an issued patent included within the Licensed Patents in the Field, which claim has not lapsed, been cancelled or become abandoned irrevocably and has not been declared invalid or unenforceable by an unreversed and unappealable
decision or judgment of a court or other appropriate body of competent jurisdiction, and which has not been admitted to be invalid or unenforceable through reissue, disclaimer or otherwise. 
  

	2.	LICENSE; 

  
 2.1 License Grant. Subject to the terms and conditions of this Agreement, OXIS hereby grants to HaptoGuard and its Affiliates during the
Term, with respect to the Field only, an exclusive, worldwide, royalty bearing license, with the right to grant sublicenses through multiple tiers of sublicenses, in, to, and under the Licensed Patents, Licensed Compounds, Licensed Know-How,
Licensed Process, and Licensed Product to develop, distribute, market, make, have made, use, have used, sell, have sold, offer for sale, and import Licensed Compounds, Licensed Processes, and Licensed Products. The parties hereto acknowledge that
such license as described in the preceding sentence is not intended to apply to Licensed Patents, Licensed Compounds, Licensed Know-How, Licensed Process, and Licensed Product which is not related to the Field. 
  
 2.2 Sublicenses. In the event that HaptoGuard sublicenses any
of its rights hereunder to a Sublicensee pursuant to Section 2.1, such sublicense shall include terms and conditions consistent with the terms and conditions of the license granted under this Agreement. Sublicenses, if any, granted hereunder, will
be to Third Parties in an arm’s length transaction under written agreements (each, a “Sublicense Agreement”), copies of which will be provided to OXIS, and conditioned on such Sublicensees’ agreement to accept and abide with the
terms and obligations of this Agreement. 
  
 2.3
Disclosure of Licensed Know-How. OXIS will supply HaptoGuard, as promptly as practicable after the Effective Date, and in any event within sixty (60) days of the Effective Date, with all Licensed Know-How available to or possessed by OXIS
that will enable HaptoGuard to independently manufacture the Licensed Products and obtain subsequent Regulatory Approvals. The parties agree to work in good faith and to use best efforts to complete the disclosure of Licensed Know-How to HaptoGuard
within the time period set forth above. 
  

 5 

 2.4 OXIS agrees to provide HaptoGuard within twenty (20) days of a written request from HaptoGuard
with a cross-reference letter to any OXIS regulatory applications and approvals relating to the Licensed Compounds. The cross-reference letter shall be without limitation to clinical phase of the ongoing study. Any such cross-reference letter shall
remain in effect and may not be revoked by OXIS unless this Agreement is terminated. 
  

	3.	CONSIDERATION 

  
 3.1 Upfront Payment. HaptoGuard will pay OXIS a lump sum non-refundable payment in the amount of Three Hundred Thousand US Dollars
($300,000) on the Effective Date of this Agreement and an additional lump sum non-refundable payment in the amount of One Hundred Fifty Thousand US Dollars ($150,000) within sixty (60) days of the Effective Date of this Agreement. In the event that,
for any reason whatsoever, the second payment above of $150,000 is not paid on time, HaptoGuard will be extended one grace period of thirty (30) days to pay such amount, provided that it pays OXIS an additional payment of One Hundred Thousand
Dollars ($100,000) at the same time. If for any reason, any of the above payments are not transacted within the required time periods all HaptoGuard rights as defined by this agreement shall become null and void and OXIS shall have the right to
terminate this Agreement.  
  
 3.2 Milestone
Payments. HaptoGuard will pay OXIS the amounts set forth below upon the first occurrence of each of the milestone events set forth below, each such payment to be made within thirty (30) days after achievement of such milestone event. It is
understood that the payment amounts listed below are set for a ***** and would be increased by the number of ***** for which milestone events are achieved. ***** 
  

			
	 (1) Initiation of the Phase III Clinical Trials of the Licensed Product *****
  
 HaptoGuard shall not pay any additional fees other than the ***** for initiation of any additional Phase III Clinical Trials of the Product
*****.
	 	 *****

		
	 (2) Grant by FDA of marketing approval of the Licensed Product in the US for *****
  
 HaptoGuard shall not pay any additional fees other than the *****
	 	 *****

		
	 (3) Grant of a marketing approval of the Licensed Product by the EMEA for *****
  
 HaptoGuard shall not pay any additional fees other than the ***** for initiation of any additional marketing approval in Europe of the
Licensed Product for *****
	 	 *****

		
	 (4) Grant of marketing approval of the Licensed Product in each of any additional regulatory territory for *****
  
 HaptoGuard shall not pay any additional fees other than the ***** per each additional
regulatory territory marketing approval *****
	 	 *****

  

 6 

 3.3 Royalties. Upon the First Commercial Sale of Licensed Product, HaptoGuard shall pay to
OXIS a royalty of: 
  
 ***** 
  
 3.4 Sublicense Fee. HaptoGuard or its Affiliates shall pay to
OXIS an amount equal to ***** of the Sublicense Fee received from any Sublicensee pursuant to the Sublicense Agreement. ***** 
  
 3.5 ***** 
  
 3.6 Calculation and Payment of Royalties and Percentage of Sublicense Fees. 
  
 (a) Notwithstanding anything in this Agreement to the contrary, during the Royalty Term for a given
country, the applicable royalty payable on Net Sales of Licensed Products in such country shall be ***** of the royalty rate payable under Section 3.2 for so long as there is a ***** covering such Licensed Product in such country. ***** 

 
 (b) Payments pursuant to Sections 3.2, 3.3 and 3.4
and reports for the sale of Licensed Product shall be calculated and reported for each calendar quarter. All payments due to OXIS pursuant to Sections 3.2, 3.3 and 3.4 shall be paid within ***** of the end of each calendar quarter, unless otherwise
specifically provided herein. Each such payment shall be accompanied by a report ***** U.S. dollars, the method used to calculate such royalty and the exchange rates used, as applicable. All payments to OXIS including those with respect to the
Sublicense Fee will be paid within thirty (30) days of receipt of payments from Sublicensee. 
  
 3.7 Tax Withholding. Any tax required to be withheld by HaptoGuard or any Affiliate or Sublicensee under the laws of any foreign country for the account of OXIS under this Article 3 shall be deducted
from the applicable payment to OXIS and promptly paid by HaptoGuard or said Affiliate or Sublicensee for and on behalf of OXIS to the appropriate governmental authority (provided that, if HaptoGuard assigns its obligations under this Agreement to a
non-U.S. Affiliate, the amount of any withholding taxes deducted from payments by such Affiliate to OXIS shall not exceed the amount of any withholding taxes that would have been deducted by HaptoGuard had HaptoGuard made such payment to OXIS), and
HaptoGuard or the Affiliate shall furnish OXIS with proof of payment of such tax together with official or other appropriate evidence issued by the appropriate governmental authority sufficient to enable OXIS to support a claim for income tax credit
in respect of any sum so withheld. 
  
 3.8 Exchange
Rate; Manner and Place of Payment. All payments hereunder shall be payable in U.S. dollars. For payments made on sales of Licensed Product, with respect to each quarter, for countries other than the U.S., whenever conversion of payments from any
foreign currency shall be required, such conversion shall be made at a rate of exchange equal to the rate of exchange for the currency of the country from which payments are payable as published in The Wall Street Journal, Western Edition, on
the last business day of the calendar 

  

 7 

 
quarter for which a payment is due. All payments owed under this Agreement shall be made by wire transfer to a bank and account designated in writing by
OXIS, unless otherwise specified in writing by OXIS. 
  
 3.9
Prohibited Payments. Notwithstanding any other provision of this Agreement, if HaptoGuard is prevented from making any such payment by virtue of the statutes, laws, codes or governmental regulations of the country from which the payment
is to be made, then such royalty may be paid by depositing funds in the currency in which accrued to OXIS’s account in a bank acceptable to OXIS in the country whose currency is involved. 
  
 3.10 Records; Audits. HaptoGuard shall, and shall cause its
Affiliates and Sublicensees to, keep complete and accurate records pertaining to the sale of Licensed Product and payment of Sublicense Fees in sufficient detail to permit OXIS to confirm the accuracy of payments due hereunder. Upon written request
to HaptoGuard by OXIS, ***** and no more than once in a calendar year, OXIS shall have the right to cause an independent, certified public accountant reasonably acceptable to HaptoGuard to audit such records to confirm Net Sales and royalty payments
and payments with respect to Sublicense Fees for any calendar year ending not more than three (3) years prior to the date OXIS requests such audit. OXIS agrees to treat, and to cause such accountant to treat, all such information as confidential and
not to use or disclose any such information for any purpose except to determine compliance with this Agreement. For the avoidance of doubt, HaptoGuard, its Affiliates and Sublicensees shall not be obligated to provide OXIS or such accountant with
access to any records or information other than that which is necessary to confirm Net Sales, royalty payments or payments with respect to Sublicense Fees payable under this Agreement. Such audits may be exercised during normal business hours upon
reasonable prior written notice to HaptoGuard. If any audit or examination shall reveal a deficiency of any payment due, HaptoGuard shall make payment to OXIS of such deficiency. Payment shall be made within ten (10) days following announcement of
the results of the audit to HaptoGuard and OXIS. The parties shall promptly make any adjustments necessary to reflect the results of such audit. OXIS shall bear the full cost of such audit unless such audit discloses a shortfall by more than *****
from the actual amount of any payment due under this Agreement, in which case, HaptoGuard shall bear the full cost of such audit. 
  

	4.	INTELLECTUAL PROPERTY 

  
 4.1 Prosecution and Maintenance of Licensed Patents. HaptoGuard shall control, prosecute and maintain all Patents included in the Licensed
Patents. HaptoGuard shall provide OXIS with an opportunity to review and discuss with HaptoGuard prosecution strategy and to consult with HaptoGuard on the content of patent filings with respect to Licensed Patents. HaptoGuard shall be responsible
for all costs, fees and expenses incurred from and after the Effective Date in connection with the filing, prosecution and maintenance of such Licensed Patents. HaptoGuard undertakes to notify OXIS in writing in a timely manner if it does not desire
to support the continued prosecution, appeals, or maintenance of any of the Patents included in the Licensed Patents. In the event HaptoGuard declines to maintain any of the Patents included in the Licensed Patents, OXIS may, at its own expense,
continue to prosecute or maintain such Licensed Patent, in which case all rights with respect to such Patents shall be transferred to OXIS. 
  

 8 

 4.2 Enforcement of Licensed Patents. Each party shall promptly notify the other in writing
of any alleged or threatened infringement of any Patent included in the Licensed Patents of which such party becomes aware. 
  
 (a) With respect to any infringement in the United States, Europe or any other territory of any Patent included in the Licensed
Patents, HaptoGuard shall have the first right, but not the obligation, to direct, bring and control any action or proceeding in its own name, with respect to such infringement at its own expense and by counsel of its own choice, and OXIS shall have
the right, at its own expense, to be represented in any such action by counsel of its own choice. If HaptoGuard fails to bring such an action or proceeding, OXIS may commence such a proceeding and the fees and expenses associated with such
proceeding shall be borne equally by OXIS and HaptoGuard. 
  
 (b) In the event HaptoGuard brings an infringement action in accordance with this Section 4.2, OXIS shall cooperate fully, including if required to bring such action, the furnishing of a power of attorney.
***** 
  
 4.3 Third Party Infringement Claims. Each
party shall promptly notify the other in writing of any allegation by a Third Party that the activity of either of the parties pursuant to this Agreement infringes or may infringe the intellectual property rights of such Third Party. HaptoGuard
shall have the sole right to control, direct or defend in its own name any defense, action, appeal of any such claim, action, proceeding at its own expense and by counsel of its own choice. If HaptoGuard fails to defend any such claim against OXIS,
and the failure to so defend would have an adverse effect on any Patent within the Licensed Patents, then OXIS shall have the right to assume the defense against such claim at its own expense and by counsel of its own choice. Neither party shall
have the right to settle any patent infringement litigation under this Section 4.4 relating to the Patents in a manner that diminishes the rights or interests of the other party without the consent of such other party (which shall not be
unreasonably withheld). During the pendency of any such proceeding or any appeal thereof, any payment hereunder to OXIS shall be paid by HaptoGuard into an interest-bearing escrow account pending the outcome of such proceeding. Upon a favorable
final resolution of such proceeding or any appeal thereof retaining the full rights, HaptoGuard shall resume paying OXIS the full royalties, and all funds in such escrow account shall be paid to OXIS. Upon an unfavorable final resolution of such
proceeding or any appeal thereof, the funds in such escrow account shall be applied toward the damage award in such action, if any, and the balance, if any, paid to OXIS. 
  
 4.4 Cooperation of the Parties. Each party agrees to cooperate fully in the preparation, filing, and
prosecution of any Licensed Patents under this Agreement and in the obtaining and maintenance of any patent extensions, supplementary protection certificates and the like with respect to any Patent claiming a Licensed Product being developed or
commercialized by HaptoGuard or Sublicensees. Such cooperation includes, but is not limited to, promptly informing the other party of any matters coming to such party’s attention that may affect the preparation, filing, prosecution or
maintenance of any Patents. 
  

	5.	DUE DILIGENCE 

  
 ***** 
  

 9 

 HaptoGuard shall report to OXIS no less than quarterly on the development and commercialization
activities performed hereunder. 
  
 ***** 
  

	6.	SUPPLY AGREEMENT 

  
 6.1. OXIS Supply Obligations 
  
 (a) Licensed Product Supply - During the Term OXIS shall be ***** of the Product to HAPTOGUARD and HAPTOGUARD Affiliates, of all
the requirements of Licensed Product for distribution, marketing and selling anywhere in world. OXIS shall supply the Licensed Product in FDA approved primary packaging as requested by HAPTOGUARD.  
  
 (b) Licensed Product Delivery - OXIS shall supply
Licensed Product to HAPTOGUARD only against receipt of HAPTOGUARD’s written purchase orders. Except as otherwise provided herein or as otherwise expressly agreed in writing by the Parties, delivery shall be within ninety (90) days from receipt
and confirmation by OXIS of HAPTOGUARD’s purchase order. OXIS shall confirm the delivery dates within ten (10) business days after receipt of HAPTOGUARD’s purchase orders, OXIS shall use its best reasonable efforts to fill such orders on
the requested delivery dates, but shall in any event fill such orders within ninety (90) days from receipt and confirmation of HAPTOGUARD’s purchase order. OXIS shall deliver Licensed Product F.O.B. as designated by HAPTOGUARD. HAPTOGUARD shall
assume title to and risk of loss for Licensed Product purchased hereunder upon receipt of delivery. 
  
 (c) Licensed Product Shipping Instructions - HAPTOGUARD shall provide OXIS with appropriate instructions for each shipment of
Licensed Product hereunder designating the desired carrier, destination and method of transport. If OXIS becomes aware that the designated carrier is unable to accept the desired shipment within the requested delivery period, OXIS shall promptly
notify HAPTOGUARD and HAPTOGUARD shall promptly designate another carrier or carriers. 
  
 6.2. Manufacturing Subcontractor 
  
 OXIS shall remain the sole supplier of Licensed Product to HAPTOGUARD. In order to seek the lowest manufacturing cost of Licensed Product for supply to HAPTOGUARD by OXIS, HAPTOGUARD may identify select, and engage an
alternate manufacturer in order to obtain for OXIS the lowest manufacturing cost of Licensed Product for supply to HAPTOGUARD by OXIS 
  
 6.3. Prices and Payment 
  
 (a) Pricing Formula - OXIS’s annual price of Licensed Product to HAPTOGUARD, shall be ***** 
  

 10 

 (b) Invoicing and Payment - OXIS shall invoice HAPTOGUARD for orders of Licensed
Product shipped, and HAPTOGUARD shall pay such invoice within thirty (30) days of receipt. 
  
 6.4. Licensed Product Warranties and Limitations 
  
 OXIS warrants and represents that the Licensed Product manufactured by OXIS, its Affiliates and delivered to HAPTOGUARD or its Affiliates hereunder for clinical use and/or for sale shall (i) from the date of shipment
until the end of the specified shelf-life conform to the specifications as requested by HAPTOGUARD and as reasonable agreed to by OXIS. and shall be manufactured in accordance with U.S. FDA Good Manufacturing Practices and (ii) be transferred free
and clear of any security interests, liens and encumbrances. 
  
 6.5. Certificate of Analysis 
  
 OXIS shall
furnish HAPTOGUARD with one or more certificates of analysis, in the form required by law where the Licensed Product is marketed, for each batch of Licensed Product supplied hereunder with shipment of each such batch. 
  
 6.6. Licensed Product Inspections 
  
 (a) HAPTOGUARD Inspection and Analysis - HAPTOGUARD
shall inspect and analyze a representative sample of Licensed Product from batches supplied by OXIS within Thirty days (30) after receipt. If, after inspection, HAPTOGUARD reasonably believes the shipment does not meet the specifications as
requested, HAPTOGUARD shall notify OXIS in writing within forty five (45) days after HAPTOGUARD’s receipt of any such goods. If HAPTOGUARD does not so notify OXIS, HAPTOGUARD shall be deemed to have waived all claims against OXIS for said
quantity delivered, except for any latent defects that could not have been reasonably discovered upon such inspection, which defects shall be notified by HAPTOGUARD to OXIS within fourteen (14) days from discovery of same. Any claims by HAPTOGUARD
regarding goods delivered shall specify in reasonable detail the nature and basis for the claim and cite relevant OXIS lot numbers or other information to enable specific identification of the goods involved. HAPTOGUARD shall not be required to
accept Licensed Product having a shelf-life of less than ninety percent (90%) of the stated expiration dating on the date of shipment by OXIS. 
  
 (b) OXIS Response - OXIS shall respond to all claims made by HAPTOGUARD on a case-by-case basis and OXIS shall have the right to
first inspect any goods involved before being required to take any action with respect thereto. OXIS shall review any such claim of non-conformity made by HAPTOGUARD within thirty (30) business days of receipt and conduct any required testing of the
goods involved as soon as possible, but in no event later than forty-five (45) days after receipt thereof. If such review and testing by OXIS (or testing by an independent laboratory as set forth below) confirms that a claimed quantity does not meet
the specifications, then, at OXIS’s expense, HAPTOGUARD shall dispose of or return such quantity involved as OXIS shall direct in writing and OXIS shall replace such quantity with conforming goods as soon as possible, but in no event later than
sixty (60) days after testing is 

  

 11 

 
completed. If the Parties fail to agree as to whether a delivered quantity meets the specifications, then the Parties shall have the batch in dispute
analysed by a mutually agreed upon independent testing laboratory in the country in which Licensed Product to which goods relate is intended for clinical use and/or sale. Such laboratory’s determination shall be deemed final as to any dispute
over the specifications and the non-prevailing Party shall bear the costs of such independent laboratory’s testing. 
  
 6.7. Licensed Product Storage 
  
 Each Party shall properly store Licensed Product under conditions that will not adversely affect the quality or normal shelf life thereof. 
  
 6.8. HAPTOGUARD Responsibilities 
  
 HAPTOGUARD shall be responsible for all packaging, labeling, inserts,
promotional materials and any other materials which accompany, are distributed, used or referred to in any way by HAPTOGUARD, its Affiliates in connection with the Licensed Product and same shall conform to all legal requirements. Subject to
applicable legal requirements and space limitations, all Licensed Product labeling, packaging, inserts and promotional materials shall indicate that the Licensed Product is sold by HAPTOGUARD. 
  
 6.9. Reciprocal Indemnification Provisions 
  
 (a) OXIS Indemnification- OXIS shall defend,
indemnify and hold HAPTOGUARD, its Affiliates, HAPTOGUARD Sublicensees, and the officers, directors, employees and agents of each, harmless from and against any and all liabilities, damages, claims, demands, costs, or expenses (including reasonable
attorneys’ fees) claimed by any third party for any property or other economic loss or damage or injury or death suffered by it to the extent the same is determined to have been caused by or due to ***** 
  
 (b) HAPTOGUARD Indemnification- HAPTOGUARD shall
defend, indemnify and hold OXIS, its Affiliates, and OXIS Unaffiliated Sublicensees and subcontractors, and the officers, directors and employees and agents of each harmless from and against any and all liabilities, damages, claims, demands or
costs, or expenses (including reasonable attorneys’ fees) claimed by any third party for any property or other economic loss or damage, injury or death suffered by it to the extent the same is determined to have been caused by ***** 

 
 6.10. Conditions of Indemnification 
  
 With respect to any indemnification obligations of either Party to the other
Party under this Agreement, the following conditions must be met for such indemnification obligations to become applicable: (a) the indemnified Party shall notify the indemnifying Party promptly in writing of any claim which may give rise to an
obligation on the part of the indemnifying Party hereunder; (b) the indemnifying Party shall be allowed to timely undertake the sole control of the defense of any such action and claim, including all negotiations for the settlement, or 

  

 12 

 
compromise of such claim or action at its sole expense; and (c) the indemnified Party shall render reasonable assistance, information, co-operation and
authority to permit the indemnifying Party to defend such action, it being agreed that any out-of-pocket expenses or other expenses incurred by the indemnified Party in rendering the same shall be borne or reimbursed promptly by the indemnifying
Party. 
  
 6.11. Priority of Supply 
  
 So long as HAPTOGUARD shall provide OXIS with its forecast for short term
and long term requirements in timely fashion, OXIS shall cooperate to anticipate HAPTOGUARD short term and long-term requirements for Licensed Product supply and will take reasonable measures to assure that HAPTOGUARD and its HAPTOGUARD Sublicensees
requirements as set forth in HAPTOGUARD Forecast can be met. OXIS shall make best efforts to ensure HaptoGuard is given the highest priority for supply of the Licensed Products by its manufacturer. 
  
 6.12. Inability to Manufacture or Supply 
  
 If OXIS is unable to supply Licensed Product, as ordered pursuant to Section
6, for sixty (60) or more days after the agreed delivery time for any reason, (including but not limited to a Force Majeure event), save for reasons due to HAPTOGUARD and/or HAPTOGUARD Affiliate, including without limitation failure by HAPTOGUARD
and/or HAPTOGUARD Affiliate to notify OXIS of OXIS’s failure to deliver Licensed Product ordered, then HAPTOGUARD may, at its option, responsibility and expense, elect to manufacture or have a Third Party manufacture Licensed Product for use in
the Field until such time as OXIS can demonstrate to HAPTOGUARD’s reasonable satisfaction that OXIS is capable of resuming the manufacture Licensed Product, as applicable. 
  
 6.13. Regulatory Inspections 
  
 Each Party shall allow representatives of the U.S. FDA and any other regulatory agency or authority with jurisdiction over
the manufacture, marketing and distribution of the Licensed Product to tour and inspect all facilities utilized by such Party in the manufacture, testing, packaging, storage, and shipment of Licensed Product sold under this Agreement, and shall
co-operate with such representatives in every reasonable manner. Each Party shall also provide the other Party with a copy of any U.S. FDA Form 483 notices of adverse findings, regulatory letters or similar notifications it receives from any other
governmental authority setting forth adverse findings or non compliance with any applicable laws, regulations or standards relating to the items supplied by it hereunder within five (5) days of its own receipt thereof. Each Party shall also provide
the other Party with a copy of its proposed written response to such governmental authority before submission and shall incorporate any changes thereto which the other Party may reasonably request. 
  

 13 

 6.14 Manufacturing Changes 
  
 During the Term, OXIS shall not make any material changes to its manufacturing operations for Licensed Product without the
prior written consent of HAPTOGUARD, which consent shall not be unreasonably withheld. 
  
 6.15 Recall Notification 
  
 Each Party shall promptly notify the other Party in writing of any facts relating to the advisability of the recall, destruction or withholding from the market of the Licensed Product anywhere in the world (collectively,
“Recall”) 
  
 6.16. Recall Implementation

  
 If at any time (A) any governmental or regulatory
authority issues a request, directive or order for a Recall; (B) a court of competent jurisdiction orders a Recall; or (C) HAPTOGUARD reasonably determines, following consultation with OXIS (except in emergency situations in which there is
insufficient time for such consultation), that a Recall is necessary or advisable, HAPTOGUARD shall take all appropriate corrective actions to effect the Recall and OXIS shall provide HAPTOGUARD with such cooperation in connection with the Recall as
HAPTOGUARD may reasonably request. 
  
 6.17. Recall Costs and
Expenses 
  
 ***** 
  
 6.18 ADVERSE DRUG EXPERIENCES 
  
 In order to guarantee that all applicable regulatory requirements as well as
the Parties’ interests regarding pharmacovigilance of the Licensed Product can be met, the parties shall exchange appropriate information. The parties shall make sufficient efforts to promptly establish and adopt sufficient procedures
concerning this exchange. Therefore the Parties shall negotiate a separate agreement on pharmacovigilance. 
  

	7.	CONFIDENTIALITY 

  
 7.1 Confidentiality. The parties agree that, during the Term, and for a period of five (5) years thereafter, each party (the
“Receiving Party”) will maintain in confidence, and will not use, all Confidential Information disclosed to it by the other party (the “Disclosing Party”) under this Agreement or the Term Sheet dated June 16, 2004,
except to the extent expressly authorized by this Agreement or otherwise agreed in writing by the parties. The parties agree that the financial terms of the Agreement will be considered Confidential Information of both parties. The Receiving Party
shall use at least the same standard of care as it uses to protect proprietary or confidential information of its own (but at least reasonable care) to ensure that its employees, agents, consultants and other representatives do not disclose or make
any unauthorized use of the Disclosing Party’s Confidential Information. Each party will promptly notify the other upon discovery of any unauthorized use or disclosure of the other party’s Confidential Information.

  

 14 

 Public Disclosures. Subject to the further provisions of this Section, neither Party shall originate any written
publicity, news release or public announcement, whether to the public or press, concerning this Agreement, including the subject matter to which it relates, performance under it or any of its terms, or any amendment hereto save only such
announcements that are i) approved by both parties in which such approval shall not be unreasonable withheld; and ii) required by law (or the applicable rules of any securities exchange or market on which a Party’s securities are listed or
traded) to be made or that are otherwise agreed by the Parties or expressly permitted in this Agreement. Such announcements shall be factual and as brief as reasonable under the circumstances. In addition, each Party agrees to submit to the other
Party, for review and written approval, any question and answer sheet or similar materials (“Q & A”) prior to using such materials as the basis for written or oral disclosures, which written or oral disclosures must, in any event, be
consistent in content with the information contained in the approved Q & A. Routine references to this Agreement and the arrangements hereunder shall be allowed in the usual course of business, and shall be consistent with any approved Q & A
relating thereto. Once information has been approved for disclosure as part of an approved Q & A or publication under this Section, either Party may use such approved information in written publicity, news releases, public announcements and
other future communications with Third Parties. If a Party decides to make an announcement or any filing with a governmental agency or securities exchange or market as required by law or the applicable rules of any securities exchange or market on
which a Party’s securities are listed or traded, it will give the other Party at least three (3) calendar days advance notice, where possible, of the text of the announcement or content of the filing so that the other Party will have an
opportunity to comment upon the announcement or filing. To the extent that the receiving Party reasonably requests that any information in the materials proposed to be disclosed be maintained as confidential, the disclosing Party shall use
commercially reasonable efforts to request confidential treatment of such information pursuant to Rule 406 of the Securities Act of 1933 or Rule 25b-2 of the Securities Exchange Act of 1934, as applicable (or any other applicable regulation relating
to the confidential treatment of information), except to the extent that the disclosing Party receives advice from its legal counsel that such Confidential Information is required to be disclosed under applicable laws or regulations. 

  
 7.2 Exceptions. The obligations of
confidentiality contained in Section 7.1 will not apply to the extent that it can be established by the Receiving Party by competent written evidence that such Confidential Information: 
  
 (a) was already known to the Receiving Party, other than under an obligation of confidentiality, at
the time of disclosure by the Disclosing Party; 
  
 (b) was generally available to the public or otherwise part of the public domain at the time of its disclosure to the Receiving Party; 
  
 (c) became generally available to the public or otherwise part of the public domain after its disclosure and other than through any
act or omission of the Receiving Party in breach of this Agreement; 
  
 (d) was independently discovered or developed by the Receiving Party without the use of Confidential Information of the Disclosing Party; or 
  

 15 

 (e) was disclosed to the Receiving Party, other than under an obligation of
confidentiality, by a Third Party who had no obligation not to disclose such information to others. 
  
 7.3 Authorized Disclosure. The Receiving Party may disclose the Confidential Information of the Disclosing Party to the extent such
disclosure is reasonably necessary in the following instances: 
  
 (a) filing, prosecuting or maintaining the Licensed Patents in accordance with this Agreement; 
  
 (b) practicing the licenses granted hereunder or preparing and submitting regulatory filings with respect to Licensed Products;

  
 (c) prosecuting or defending
litigation or complying with applicable court orders or governmental laws, rules or regulations including, but not limited to, disclosures required by the FDA or the Securities and Exchange Commission; or 
  
 (d) disclosure to Affiliates, Sublicensees,
employees, consultants, agents or other Third Parties who have a need to know such information for purposes of this Agreement or in connection with due diligence or similar investigations, and disclosure to potential Third Party investors in
confidential financing documents, provided, in each case, that any such Affiliate, Sublicensee, employee, consultant, agent or Third Party is subject to obligations of confidentiality and non-use comparable to those set forth in this Section 6.

  
 Notwithstanding the foregoing, in the event a party is
required to make a disclosure of the other party’s Confidential Information pursuant to Section 7.3(c), it will, except where impracticable, give reasonable advance notice to the other party of such disclosure and use efforts to secure
confidential treatment of such information at least as diligent as such party would use to protect its own confidential information, but in no event less than reasonable efforts. In any event, the parties agree to take all reasonable action to avoid
disclosure of Confidential Information hereunder. The parties will consult with each other on the provisions of this Agreement to be redacted in any filings made by the parties with the Securities and Exchange Commission or as otherwise required by
law and on any disclosure to Third Parties. 
  

	8.	REPRESENTATIONS AND WARRANTIES 

  
 8.1 Representations and Warranties of OXIS. OXIS represents and warrants to HaptoGuard that: 
  
 (a) OXIS has as of the Effective Date, and will have
during the Term, sufficient rights and power to grant the licenses to HaptoGuard which it purports to grant herein free and clear of any and all liens and any requirements of charges, fees, rights, conditions or restrictions of any kind and, as of
the Effective Date; 
  
 (b) has not and
will not grant, license, convey, assign, and/or transfer to any Third Party any rights to Licensed Patents, Licensed Compounds, Licensed Know-How, and Licensed Products, inconsistent with the licenses and other rights granted hereunder; 

 

 16 

 (c) is the sole owner, and has the entire right, title and interest in the
Licensed Patent, Licensed Compounds, Licensed Products, and Licensed Know-How; and such Licensed Patents are valid, in full force, and enforceable. 
  
 (d) there are, as of the Effective Date, and during the Term shall be, no outstanding liens, encumbrances, agreements or
understandings of any kind, requirements of charges, fees, rights, conditions or restrictions of any kind, either written, oral or implied, regarding the Licensed Patents or Licensed Products to which OXIS or its Affiliates is a party or which are
binding upon OXIS its Affiliates which are inconsistent or in conflict with any provision of this Agreement; 
  
 (e) as of the Effective Date, OXIS or its Affiliates has received no written claim or accusation that the practice of the Licensed
Products or the manufacture, use or sale of Licensed Products infringes or may infringe any Third Party patent; and 
  
 (f) as of the Effective Date, OXIS or its Affiliates has not received a written notification of any interference proceeding,
opposition proceeding, cancellation proceeding or other protest proceeding relating to the Licensed Patents being instituted against OXIS or its Affiliates. 
  
 8.2 Mutual Representations and Warranties. Each party hereby represents and warrants to the other party that: 
  
 (a) it is duly authorized to execute and deliver this
Agreement and to perform its obligations hereunder; 
  
 (b) this Agreement is a legal and valid obligation binding upon it and enforceable in accordance with its terms; and 
  
 (c) the execution, delivery and performance of this Agreement do not conflict with any agreement, instrument or understanding, oral
or written, to which it is a party or by which it may be bound, nor violate any law or regulation of any court, governmental body or administrative or other agency having jurisdiction over it. 
  
 8.3 Disclaimer. Except as expressly set forth herein, NEITHER
PARTY MAKES ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, AND EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES OF TITLE, NON-INFRINGEMENT, MERCHANTIBILITY, AND FITNESS FOR A PARTICULAR PURPOSE. 
  
 8.4 Performance by Affiliates. The parties recognize that each
may perform some or all of its obligations under this Agreement through Affiliates and/or Sublicensees; provided, however, that each party shall remain responsible and be guarantor of the performance by its Affiliates and/or Sublicensees and
shall cause its Affiliates and/or Sublicensees to comply with the provisions of this Agreement in connection with such performance, and that such performance through Affiliates and/or Sublicensees shall not adversely affect the rights of the other
party. 
  

 17 

	9.	TERM; TERMINATION 

  
 9.1 Term. The term of this Agreement will commence as of the Effective Date of this Agreement and, unless sooner terminated as provided
hereunder, will terminate upon the expiration of the last Royalty Term (the “Term”). Upon expiration of the Royalty Term in a given jurisdiction, HaptoGuard shall continue to have a license on the terms described in Section 2.1,
except that such license shall be fully paid, perpetual, irrevocable and nonexclusive. 
  
 9.2 Termination by HaptoGuard. HaptoGuard shall have the right to terminate this Agreement for any reason or for no reason upon one hundred and eighty (180) days’ written notice to OXIS. Any payment
under Section 3 made after the date HaptoGuard notifies OXIS of termination under this Section 9.2 shall be the pro rata amount due for the period prior to the effective date of such termination. 
  
 9.3 Termination by OXIS. In the event that HaptoGuard fails to
timely make any payment or comply with any of its task under Exhibit C and such failure continues for thirty (30) days following Notice by OXIS, OXIS shall have the right at any time to terminate this Agreement forthwith upon written notice to
HaptoGuard.  
  
 9.4 Termination for
Cause. Each party shall have the right to terminate this Agreement upon thirty (30) days’ written notice to the other upon the occurrence of any of the following: 
  
 (a) Upon or after bankruptcy, insolvency, dissolution or winding up or assignment for the benefit of
creditors of the other party (other than a dissolution or winding up for the purpose of reconstruction or amalgamation) or a petition is filed for any of the foregoing and is not removed within ninety (90) days; or 
  
 (b) Upon or after the breach of any material
provision of this Agreement by the other party, including, with respect to HaptoGuard, its Affiliates, (other than as provided in Section 9.3) if the breaching party has not cured such breach within the thirty (30) day period following written
notice of termination by the non-breaching party. 
  
 9.5
Effect of Termination; Surviving Obligations.  
  
 (a) Upon termination of this Agreement by OXIS pursuant to Section 9.3 or by either party pursuant to Section 9.4, all rights and obligations of the parties under this Agreement shall terminate (except that if
OXIS terminates this Agreement only as to a particular country or countries under Section 9.4 (b) then the rights and obligations of the parties under this Agreement shall terminate only as to such country or countries), except as set forth in this
Section 9.5. 
  
 (b) Upon termination of
this Agreement by HaptoGuard pursuant to Section 9.2 (where HaptoGuard has not committed a breach of this Agreement permitting termination by OXIS under Section 9.3 or 9.4) all rights to the Licensed Patents, Licensed Compounds, Licensed Know-How,
Licensed Process, and Licensed Product and the Licensed Compounds shall revert to OXIS. 
  

 18 

 (c) Expiration or termination of this Agreement shall not relieve the parties of
any obligation accruing prior to such expiration or termination. Except as expressly set forth elsewhere in this Agreement, the obligations and the rights of the parties shall survive expiration or termination of this Agreement. 
  
 9.6 Rights in Bankruptcy. All rights and licenses granted under
or pursuant to this Agreement by either party to the other party are, and will otherwise be deemed to be, for purposes of Section 365(n) of the U.S. Bankruptcy Code, licenses of right to “intellectual property” as defined under Section 101
of the U.S. Bankruptcy Code. The parties agree that the party not subject to bankruptcy proceedings, as licensee of such rights under this Agreement, will retain and may fully exercise all of its rights and elections under the U.S. Bankruptcy Code.
The parties further agree that, in the event of the commencement of a bankruptcy proceeding by or against any party under the U.S. Bankruptcy Code, the other party will be entitled to a complete duplicate of (or complete access to, as appropriate)
any such intellectual property and all embodiments of such intellectual property, and same, if not already in its possession, will be promptly delivered to them (a) upon any such commencement of a bankruptcy proceeding upon written request therefor
by the party not subject to bankruptcy proceedings, unless the other party elects to continue to perform all of its obligations under this Agreement, or (b) if not delivered under (a) above, following the rejection of this Agreement by or on behalf
of either party upon written request therefor by the other party. 
  
 9.7 Remedies. In the event of any breach of any provision of this Agreement, in addition to the termination rights set forth herein, each party shall have all other rights and remedies at law or equity to enforce this
Agreement. 
  

	10.	INDEMNIFICATION; DISPUTE RESOLUTION 

  

	 	10.1	Indemnification. 

  
 (a) HaptoGuard hereby agrees to save, defend, indemnify and hold harmless OXIS, its directors, officers, employees, agents and
Affiliates (and its directors, officers, employees and agents) (each, a “OXIS Indemnitee”) from and against any and all losses, damages, liabilities, expenses and costs, including reasonable legal expenses and attorneys’ fees
(“Losses”), to which a OXIS Indemnitee may become subject as a result of any claim, demand, action or other proceeding by any Third Party to the extent such Losses arise out of (a) the practice by HaptoGuard of the license granted
under Section 2.1, or (b) the development, manufacture, handling, storage, sale or other disposition of any Licensed Product by HaptoGuard and its Affiliates and Sublicensees, except to the extent such Losses result from the willful misconduct of
any OXIS Indemnitee. 
  
 (b) OXIS hereby
agrees to save, defend, indemnify and hold harmless HaptoGuard, its directors, officers, employees and agents, its Affiliates (and its directors, officers, employees and agents) and its Sublicensees (and its directors, officers, employees and
agents) (each, a “HaptoGuard Indemnitee”) from and against any and all Losses to which a HaptoGuard Indemnitee may become subject as a result of any claim, demand, action or other 

  

 19 

 
proceeding by any Third Party to the extent such Losses arise out of the material breach by OXIS of any of its representations, warranties or obligations
hereunder, except to the extent such Losses result from the willful misconduct of any HaptoGuard Indemnitee. 
  
 (c) In the event a party seeks indemnification under Section 10.1(a) or 10.1 (b), it shall inform the other party (the
“Indemnifying Party”) of a claim as soon as reasonably practicable after it receives notice of the claim, shall permit the Indemnifying Party to assume direction and control of the defense of the claim (including the right to settle
the claim solely for monetary consideration), and shall cooperate as requested (at the expense of the Indemnifying Party) in the defense of the claim. 
  
 10.2 Limitation of Liability. EXCEPT FOR LIABILITY FOR BREACH OF CONFIDENTIALITY OR FOR INFRINGEMENT OR MISAPPROPRIATION, NEITHER PARTY
SHALL BE ENTITLED TO RECOVER FROM THE OTHER PARTY ANY INDIRECT, SPECIAL, INCIDENTIAL, CONSEQUENTIAL OR EXEMPLARY DAMAGES, INCLUDING BUT NOT LIMITED TO, LOST PROFITS, ARISING FROM OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS OF ANY NOTICE
OF THE POSSIBILITY OF SUCH DAMAGES. IN NO EVENT SHALL HAPTOGUARD’S LIABILITY HEREIN SHALL EXCEED IN THE AGGREGATE THE AMOUNTS ACTUALLY PAID OR PAYABLE TO OXIS UNDER THIS AGREEMENT. 
  
 10.3 Insurance. From and after such time as HaptoGuard or any of its Sublicensees first commences human
clinical trials of Licensed Product, HaptoGuard shall, or shall cause each such Sublicensee to, at its own expense, maintain product liability insurance in an amount consistent with industry standards during the Term. Such liability insurance shall
name OXIS as a named co-insured, and HaptoGuard shall provide to OXIS regularly, and no less frequently than annually. Certificates evidencing OXIS coverage as a named co-insured and specifying the limits of such coverage. 
  
 10.4 Dispute Resolution. All disputes arising out of or related
to this Agreement, including disputes that may involve the parent companies, subsidiaries and Affiliates of any party performing hereunder (“Disputes”), shall be resolved in accordance with this Section 10.4. 
  
 (a) Any Dispute shall be settled by binding
arbitration by one arbitrator selected by the parties, or if they cannot agree, each party shall select an arbitrator and the two arbitrators shall select a third arbitrator. The decision of the arbitrator(s) shall be final and binding on the
parties. The arbitration shall be conducted in New York, New York . The arbitral tribunal shall exert its best efforts to conduct the proceedings so as to issue an award within nine (9) months of the appointment of the arbitrator(s). 
  
 (b) The merits of any Dispute shall be decided in
accordance with the law governing this Agreement, without application of any principle of conflict of laws. Each party expressly waives any right it may have to a trial by jury of any Dispute, and also expressly waives any right it may have to seek
or to be awarded special or punitive damages on account of any matter that is the subject of a Dispute. Nothing herein shall limit or restrict a party’s ability to seek injunctive or other equitable relief in the event of a breach or
anticipated breach of Section 6. 
  

 20 

 (c) The arbitral tribunal may grant any relief appropriate under the applicable
law, but may not include any penalty or element of punitive or exemplary damages. The arbitral tribunal may award the costs and expenses of the arbitration. Any party may seek emergency, interim or provisional relief prior to the appointment of an
arbitrator from any court of competent jurisdiction, without prejudice to the agreement to arbitrate herein contained. After appointment of an arbitrator, any request for such relief shall be addressed to the arbitrator, who shall have the power to
enter an interim award granting any emergency, interim or provisional relief to which a party may be entitled under applicable law. 
  
 (d) Any award of money shall be in U.S. dollars. The award of the tribunal may be entered and enforced in any court of competent
jurisdiction. A court called upon to enforce such an award may require a party resisting enforcement to pay the reasonable attorney fees and costs of the party seeking enforcement. 
  
 (e) Any duty to arbitrate under this Agreement shall remain in effect and enforceable after
termination of this Agreement for any reason. 
  
 (f) Each party has the right before or during the arbitration to seek and obtain from the appropriate court provisional remedies, such as attachment, preliminary injunction or replevin, to avoid irreparable harm, maintain the status
quo, or preserve the subject matter of the arbitration. This Section 10.4 shall not apply to any dispute, controversy or claim that concerns (i) the validity or infringement of a patent, trademark or copyright; or (ii) any antitrust, anti-monopoly
or competition law or regulation, whether or not statutory. 
  

	11.	MISCELLANEOUS PROVISIONS 

  
 11.1 Governing Law. This Agreement shall be governed by, and construed and enforced in accordance with, the
laws of the State of New York, excluding its conflicts of laws principles.  
  
 11.2 Entire Agreement; Modification. This Agreement (including the Exhibits hereto) is both a final expression of the parties’ agreement and a complete and exclusive statement with respect to all of
its terms. This Agreement supersedes all prior and contemporaneous agreements and communications, whether oral, written or otherwise, concerning any and all matters contained herein. No rights or licenses with respect to any intellectual property of
either party are granted or deemed granted hereunder or in connection herewith, other than those rights expressly granted in this Agreement. No trade customs, courses of dealing or courses of performance by the parties shall be relevant to modify,
supplement or explain any term(s) used in this Agreement. This Agreement may not be modified or supplemented by any purchase order, change order, acknowledgment, order acceptance, standard terms of sale, invoice or the like. This Agreement may only
be modified or supplemented in a writing expressly stated for such purpose and signed by the parties to this Agreement. 
  
 11.3 Relationship Between the Parties. The parties’ relationship, as established by this Agreement, is solely that of independent
contractors. This Agreement does not create any partnership, joint venture or similar business relationship between the parties. Neither party is a legal representative of the other party, and neither party can assume or create any obligation,

  

 21 

 
representation, warranty or guarantee, express or implied, on behalf of the other party for any purpose whatsoever. 
  
 11.4 Non-Waiver. The failure of a party to insist upon strict
performance of any provision of this Agreement or to exercise any right arising out of this Agreement shall neither impair that provision or right nor constitute a waiver of that provision or right, in whole or in part, in that instance or in any
other instance. Any waiver by a party of a particular provision or right shall be in writing, shall be as to a particular matter and, if applicable, for a particular period of time and shall be signed by such party. 
  
 11.5 Assignment. Except as expressly provided hereunder,
neither this Agreement nor any rights or obligations hereunder may be assigned or otherwise transferred by either party without the prior written consent of the other party (which consent shall not be unreasonably withheld); provided,
however, that either party may assign this Agreement and its rights and obligations hereunder without the other party’s consent in connection with the transfer or sale of all or substantially all of the business of such party to which this
Agreement relates to an Affiliate or Third Party provided the successor’s financial strength is at least as great as the assignor’s., whether by merger, sale of stock, sale of assets or otherwise. In the event of such
transaction, however, intellectual property rights of the acquiring party to such transaction (if other than one of the parties to this Agreement), which are not specific to Licensed Compound or Licensed Product, shall not be included in the
technology licensed hereunder. The rights and obligations of the parties under this Agreement shall be binding upon and inure to the benefit of the successors and permitted assigns of the parties. Any assignment not in accordance with this Agreement
shall be void. 
  
 11.6 No Third Party Beneficiaries.
This Agreement is neither expressly nor impliedly made for the benefit of any party other than those executing it. 
  
 11.7 Severability. If, for any reason, any part of this Agreement is adjudicated invalid, unenforceable or illegal by a court of competent
jurisdiction, such adjudication shall not affect or impair, in whole or in part, the validity, enforceability or legality of any remaining portions of this Agreement. All remaining portions shall remain in full force and effect as if the original
Agreement had been executed without the invalidated, unenforceable or illegal part. 
  
 11.8 Notices. Any notice to be given under this Agreement must be in writing and delivered either in person, by any method of mail (postage prepaid) requiring return receipt, or by overnight courier or
facsimile confirmed thereafter by any of the foregoing, to the party to be notified at its address(es) given below, or at any address such party has previously designated by prior written notice to the other. Notice shall be deemed sufficiently
given for all purposes upon the earlier of: (a) the date of actual receipt; (b) if mailed, five (5) business days after the date of postmark; or (c) if delivered by overnight courier with guaranteed next day delivery, the next business day the
overnight courier regularly makes deliveries. 
  

 22 

 If to HaptoGuard, notices must be addressed to: 
  
 HaptoGuard, Inc. 
 C/o Eitan Pearl Latzer Cohen Zedek, LLP 
 10 Rockefeller Plaza, Suite 1001 
 New York, New York 10020 
 Telephone: +212-632-3480 
 Facsimile: +
212-632-3489 
 Attention: Chief Executive Officer 
  
 With copies to: 
  
 Eitan Pearl Latzer Cohen Zedek, LLP 
 10
Rockefeller Plaza, Suite 1001 
 New York, New York 10020 
 Attention: Mark S. Cohen, Esq 
 Telephone: +212-632-3480 
 Facsimile: + 212-632-3489 
  
 If to OXIS, notices must be addressed to: 
  
 OXIS International, Inc. 
 6040 N. Cutter
Circle, Suite 317 
 Portland, Oregon 97217 
 Telephone: +503-283-3911 
 Facsimile: + 503-283-4058 
 Attention: Chief Executive Officer 
  
 11.9 Force Majeure. Each party shall be excused from liability for the failure or delay in performance of any obligation under this
Agreement other than failure to pay when due by reason of any event beyond such party’s reasonable control including but not limited to Acts of God, fire, flood, explosion, earthquake, or other natural forces, war, terrorism, civil unrest,
accident, destruction or other casualty, any lack or failure of transportation facilities, any lack or failure of supply of raw materials, any strike or labor disturbance, or any other event beyond reasonable control of the parties similar to those
enumerated above. Such excuse from liability shall be effective only to the extent and duration of the event(s) causing the failure or delay in performance and provided that the party has not caused such event(s) to occur. Notice of a party’s
failure or delay in performance due to force majeure must be given to the other party within ten (10) calendar days after its occurrence. All delivery dates under this Agreement that have been affected by force majeure shall be tolled for the
duration of such force majeure. In no event shall any party be required to prevent or settle any labor disturbance or dispute. 
  
 11.10 Legal Fees. If any party to this Agreement resorts to any legal action or arbitration in connection with this Agreement, the
prevailing party shall be entitled to recover reasonable fees of attorneys and other professionals in addition to all court costs and arbitrator’s fees which that party may incur as a result. 
  

 23 

 11.11 Headings. The headings contained in this Agreement have been added for convenience
only and shall not be construed as limiting or used in the interpretation of this Agreement. 
  
 11.12 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original document, and all
of which, together with this writing, shall be deemed one instrument. 
  
 [REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] 
  

 24 

 IN WITNESS WHEREOF, the parties hereto have duly
executed this EXCLUSIVE LICENSE AGREEMENT, including the Exhibit attached hereto and incorporated herein by reference. 
  

									
	OXIS INTERNATIONAL.	 	 	 	HAPTOGUARD, INC.
					
	By:	 	 	 	 	 	By:	 	 
					
	 Name:
	 	 	 	 	 	 Name:
	 	 
					
	 Title:
	 	 	 	 	 	 Title:
	 	 
					
	 	 	 	 	 	 	By:	 	 
					
	 	 	 	 	 	 	 Name:
	 	 
					
	 	 	 	 	 	 	 Title:
	 	 

  

  
 ***** 
  

  
 ***** 
  

  
 *****Indenture Relating to Senior Floating Rate Notes

 Exhibit 4.1 
  
 EXECUTION VERSION 
  

  
 YELLOW ROADWAY CORPORATION

 Issuer 
  
 Senior Floating Rate Notes Due 2008 
  
 INDENTURE 
  
 Dated as of May 24,
2005 
  
 SUNTRUST BANK 
 Trustee 
  

  
 CROSS-REFERENCE TABLE

  

				
	   TIA
Section

	  	Indenture
Section

	 
	 310(a)(1)
	  	7.10	 
	 (a)(2)
	  	7.10	 
	 (a)(3)
	  	N.A.	 
	 (a)(4)
	  	N.A.	 
	 (b)
	  	7.08; 	7.10
	 (c)
	  	N.A.	 
	 311(a)
	  	7.11	 
	 (b)
	  	7.11	 
	 (c)
	  	N.A.	 
	 312(a)
	  	2.05	 
	 (b)
	  	11.03	 
	 (c)
	  	11.03	 
	 313(a)
	  	7.06	 
	 (b)(1)
	  	N.A.	 
	 (b)(2)
	  	7.06	 
	 (c)
	  	11.02	 
	 (d)
	  	7.06	 
	 314(a)
	  	4.02	 
	 	  	11.02	 
	 (b)
	  	N.A.	 
	 (c)(1)
	  	11.04	 
	 (c)(2)
	  	11.04	 
	 (c)(3)
	  	N.A.	 
	 (d)
	  	N.A.	 
	 (e)
	  	11.05	 
	 (f)
	  	N.A.	 
	 315(a)
	  	7.01	 
	 (b)
	  	7.05; 	11.02
	 (c)
	  	7.01	 
	 (d)
	  	7.01	 
	 (e)
	  	6.11	 
	 316(a)(last sentence)
	  	11.0	 
	 (a)(1)(A)
	  	6.05	 
	 (a)(1)(B)
	  	6.04	 
	 (a)(2)
	  	N.A.	 
	 (b)
	  	6.07	 
	 317(a)(1)
	  	6.08	 
	 (a)(2)
	  	6.09	 
	 (b)
	  	2.04	 
	 318(a)
	  	11.01	 
	 N.A. means Not Applicable.
	  	 	 

	Note:  	This Cross-Reference Table shall not, for any purpose, be deemed to be part of the Indenture. 

  

  
 TABLE OF CONTENTS 

 

					
	 	  	 	  	Page

	ARTICLE 1
	
	Definitions and Incorporation by Reference
			
	SECTION 1.01.	  	 Definitions
	  	1
	SECTION 1.02.	  	 Other Definitions
	  	8
	SECTION 1.03.	  	 Incorporation by Reference of Trust Indenture Act
	  	8
	SECTION 1.04.	  	 Rules of Construction
	  	8
	
	ARTICLE 2
	
	The Securities
			
	SECTION 2.01.	  	 Form and Dating
	  	9
	SECTION 2.02.	  	 Execution and Authentication
	  	9
	SECTION 2.03.	  	 Registrar and Paying Agent
	  	10
	SECTION 2.04.	  	 Paying Agent To Hold Money in Trust
	  	10
	SECTION 2.05.	  	 Securityholder Lists
	  	11
	SECTION 2.06.	  	 Transfer and Exchange
	  	11
	SECTION 2.07.	  	 Replacement Securities
	  	11
	SECTION 2.08.	  	 Outstanding Securities
	  	12
	SECTION 2.09.	  	 Temporary Securities
	  	12
	SECTION 2.10.	  	 Cancellation
	  	12
	SECTION 2.11.	  	 Defaulted Interest
	  	13
	SECTION 2.12.	  	 CUSIP Numbers, ISINs, etc.
	  	13
	SECTION 2.13.	  	 Issuance of Additional Securities
	  	13
	
	ARTICLE 3
	
	Redemption
			
	SECTION 3.01.	  	 Notices to Trustee
	  	14
	SECTION 3.02.	  	 Selection of Securities to Be Redeemed
	  	14
	SECTION 3.03.	  	 Notice of Redemption
	  	14
	SECTION 3.04.	  	 Effect of Notice of Redemption
	  	15
	SECTION 3.05.	  	 Deposit of Redemption Price
	  	16
	SECTION 3.06.	  	 Securities Redeemed in Part
	  	16
	
	ARTICLE 4
	
	Covenants
			
	SECTION 4.01.	  	 Payment of Securities
	  	16
	SECTION 4.02.	  	 SEC Reports
	  	16

  

 i 

					
	SECTION 4.03.	  	 Limitation on Liens
	  	17
	SECTION 4.04.	  	 Future Guarantors
	  	17
	SECTION 4.05.	  	 Existence
	  	18
	SECTION 4.06.	  	 Maintenance of Properties
	  	18
	SECTION 4.07.	  	 Payment of Taxes and Other Claims
	  	18
	SECTION 4.08.	  	 Compliance Certificate
	  	18
	SECTION 4.09.	  	 Further Instruments and Acts
	  	19
	
	ARTICLE 5
	
	Successor Company
			
	SECTION 5.01.	  	 When Company May Merge or Transfer Assets
	  	19
	
	ARTICLE 6
	
	Defaults and Remedies
			
	SECTION 6.01.	  	 Events of Default
	  	20
	SECTION 6.02.	  	 Acceleration
	  	22
	SECTION 6.03.	  	 Other Remedies
	  	22
	SECTION 6.04.	  	 Waiver of Past Defaults
	  	22
	SECTION 6.05.	  	 Control by Majority
	  	23
	SECTION 6.06.	  	 Limitation on Suits
	  	23
	SECTION 6.07.	  	 Rights of Holders to Receive Payment
	  	24
	SECTION 6.08.	  	 Collection Suit by Trustee
	  	24
	SECTION 6.09.	  	 Trustee May File Proofs of Claim
	  	24
	SECTION 6.10.	  	 Undertaking for Costs
	  	24
	SECTION 6.11.	  	 Waiver of Stay or Extension Laws
	  	25
	
	ARTICLE 7
	
	Trustee
			
	SECTION 7.01.	  	 Duties of Trustee
	  	25
	SECTION 7.02.	  	 Rights of Trustee
	  	26
	SECTION 7.03.	  	 Individual Rights of Trustee
	  	27
	SECTION 7.04.	  	 Trustee’s Disclaimer
	  	27
	SECTION 7.05.	  	 Notice of Defaults
	  	27
	SECTION 7.06.	  	 Reports by Trustee to Holders
	  	27
	SECTION 7.07.	  	 Compensation and Indemnity
	  	28
	SECTION 7.08.	  	 Replacement of Trustee
	  	28
	SECTION 7.09.	  	 Successor Trustee by Merger
	  	29
	SECTION 7.10.	  	 Eligibility; Disqualification
	  	30
	SECTION 7.11.	  	 Preferential Collection of Claims Against Company
	  	30

  

 ii 

					
	ARTICLE 8
	
	Discharge of Indenture; Defeasance
			
	SECTION 8.01.	  	 Discharge of Liability on Securities; Defeasance
	  	30
	SECTION 8.02.	  	 Conditions to Defeasance
	  	31
	SECTION 8.03.	  	 Application of Trust Money
	  	32
	SECTION 8.04.	  	 Repayment to Company
	  	32
	SECTION 8.05.	  	 Indemnity for Government Obligations
	  	33
	SECTION 8.06.	  	 Reinstatement
	  	33
	
	ARTICLE 9
	
	Amendments
			
	SECTION 9.01.	  	 Without Consent of Holders
	  	33
	SECTION 9.02.	  	 With Consent of Holders
	  	34
	SECTION 9.03.	  	 Compliance with Trust Indenture Act
	  	35
	SECTION 9.04.	  	 Revocation and Effect of Consents and Waivers
	  	35
	SECTION 9.05.	  	 Notation on or Exchange of Securities
	  	36
	SECTION 9.06.	  	 Trustee To Sign Amendments
	  	36
	
	ARTICLE 10
	
	Subsidiary Guaranties
			
	SECTION 10.01.	  	 Guaranties
	  	36
	SECTION 10.02.	  	 Limitation on Liability
	  	38
	SECTION 10.03.	  	 Successors and Assigns
	  	38
	SECTION 10.04.	  	 No Waiver
	  	38
	SECTION 10.05.	  	 Modification
	  	38
	SECTION 10.06.	  	 Release of Subsidiary Guarantor
	  	38
	SECTION 10.07.	  	 Contribution
	  	39
	SECTION 10.08.	  	 Execution of Guaranty Agreement for Future Guarantors
	  	40
	
	ARTICLE 11
	
	Miscellaneous
			
	SECTION 11.01.	  	 Trust Indenture Act Controls
	  	40
	SECTION 11.02.	  	 Notices
	  	40
	SECTION 11.03.	  	 Communication by Holders with Other Holders
	  	41
	SECTION 11.04.	  	 Certificate and Opinion as to Conditions Precedent
	  	41
	SECTION 11.05.	  	 Statements Required in Certificate or Opinion
	  	41
	SECTION 11.06.	  	 When Securities Disregarded
	  	42
	SECTION 11.07.	  	 Rules by Trustee, Paying Agent and Registrar
	  	42
	SECTION 11.08.	  	 Legal Holidays
	  	42

  

 iii 

					
	SECTION 11.09.	  	 Governing Law
	  	42
	SECTION 11.10.	  	 No Recourse Against Others
	  	42
	SECTION 11.11.	  	 Successors
	  	43
	SECTION 11.12.	  	 Multiple Originals
	  	43
	SECTION 11.13.	  	 Table of Contents; Headings
	  	43

  
 Rule
144A/Regulation S Appendix 
  

			
	Exhibit 1 –	  	Form of Initial Security
		
	Exhibit A –	  	Form of Exchange Security or Private Exchange Security
		
	Exhibit B –	  	Form of Supplemental Indenture for Future Guarantors
		
	Schedule I –	  	List of Guarantors

  

 iv 

 INDENTURE dated as of May 24, 2005, among YELLOW ROADWAY CORPORATION, a Delaware
corporation (the “Company”), the Subsidiary Guarantors listed on Schedule I hereto and SUNTRUST BANK, a national banking corporation associated under the laws of the state of Georgia (the “Trustee”). 
  
 Each party agrees as follows for the benefit of the other parties and for the
equal and ratable benefit of the Holders of the Company’s Initial Securities, Exchange Securities and Private Exchange Securities (collectively, the “Securities”): 
  
 ARTICLE 1 
  
 Definitions and Incorporation by Reference 
  
 SECTION 1.01. Definitions. 
  
 “Additional Securities” means Securities issued under this Indenture after the Issue Date and in compliance with Section 2.13, it being
understood that any Securities issued in exchange for or replacement of any Initial Security issued on the Issue Date shall not be an Additional Security, including any such Securities issued pursuant to a Registration Rights Agreement. 

 
 “Affiliate” of any specified Person means any other Person,
directly or indirectly, controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control” when used with respect to any Person means the power to direct the
management and policies of such Person, directly or indirectly, whether through the ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the
foregoing. 
  
 “Board of Directors” means the Board of
Directors of the Company or any committee thereof duly authorized to act on behalf of such Board. 
  
 “Business Day” means each day which is not a Legal Holiday. 
  
 “Calculation Agent” means the financial institution appointed from time to time by the Company to calculate the
interest rate payable on the Securities in respect of each Interest Period, which initially shall be the Trustee. 
  
 “Capital Stock” of any Person means any and all shares, interests (including partnership interests), rights to purchase, warrants, options,
participations or other equivalents of or interests in (however designated) equity of such Person, including any preferred stock, but excluding any debt securities convertible into such equity. 
  
 “Captive Insurance Entity” means a Subsidiary of the Company that
engages in no activities other than issuing or otherwise providing insurance to the Company and its affiliates, and activities directly related to such activities. 
  

 “Code” means the Internal Revenue Code of 1986, as amended. 
  
 “Company” means the party named as such in this Indenture until a
successor replaces it and, thereafter, means the successor and, for purposes of any provision contained herein and required by the TIA, each other obligor on the indenture securities. 
  
 “Default” means any event which is, or after notice or passage of time or both would be, an Event of Default.

  
 “Determination Date” with respect to an Interest
Period will be the second London Banking Day preceding the first day of such Interest Period. 
  
 “Domestic Subsidiary” means any Subsidiary of the Company that is organized under the laws of the United States of America or any State thereof or the District of Columbia. 
  
 “Exchange Act” means the U.S. Securities Exchange Act of 1934, as
amended. 
  
 “Excluded Subsidiary” means a Receivables
Entity or Captive Insurance Entity. 
  
 “GAAP” means
generally accepted accounting principles in the United States of America, including those set forth in: 
  
 (1) the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants;

  
 (2) statements and pronouncements of the
Financial Accounting Standards Board; 
  
 (3)
such other statements by such other entity as approved by a significant segment of the accounting profession; and 
  
 (4) the rules and regulations of the SEC governing the inclusion of financial statements (including pro forma financial statements) in
periodic reports required to be filed pursuant to Section 13 of the Exchange Act, including opinions and pronouncements in staff accounting bulletins and similar written statements from the accounting staff of the SEC. All ratios and computations
based on GAAP contained in this Indenture shall be computed in conformity with GAAP. 
  
 “Guaranty Agreement” means a supplemental indenture, in the form attached hereto as Exhibit B, pursuant to which a Subsidiary Guarantor guarantees payment of the Company’s obligations with
respect to the Securities. 
  

 2 

 “Holder” or “Securityholder” means the Person in whose name a Security is registered
on the Registrar’s books. 
  
 “Indebtedness” means,
with respect to any Person on any date of determination (without duplication): 
  
 (1) any obligation for money borrowed and every obligation evidenced by a bond, note, debenture or similar instrument; and 
  
 (2) all obligations of the type referred to in clause (1) of
other Persons which are guaranteed as to payment of principal or interest by such Person; 
  
 “Indenture” means this Indenture as amended or supplemented from time to time. 
  
 “Interest Period” means the period commencing on and including an interest payment date and ending on and including the day immediately
preceding the next succeeding interest payment date, with the exception that the first Interest Period shall commence on and include the Issue Date and end on and include August 14, 2005. 
  
 “Issue Date” means the date on which the Securities are originally issued. 
  
 “Legal Holiday” means a Saturday, a Sunday or a day on which
banking institutions are not required to be open in the State of New York. 
  
 “LIBOR”, with respect to an Interest Period, will be the rate (expressed as a percentage per annum) for deposits in U.S. dollars for a three-month period beginning on the second London Banking Day after the
Determination Date that appears on Telerate Page 3750 as of 11:00 a.m., London time, on the Determination Date. If Telerate Page 3750 does not include such a rate or is unavailable on a Determination Date, the Calculation Agent will request the
principal London office of each of four major banks in the London interbank market, as selected by the Calculation Agent, to provide such bank’s offered quotation (expressed as a percentage per annum), as of approximately 11:00 a.m., London
time, on such Determination Date, to prime banks in the London interbank market for deposits in a Representative Amount in U.S. dollars for a three-month period beginning on the second London Banking Day after the Determination Date. If at least two
such offered quotations are so provided, LIBOR for the Interest Period will be the arithmetic mean of such quotations. If fewer than two such quotations are so provided, the Calculation Agent will request each of three major banks in New York City,
as selected by the Calculation Agent, to provide such bank’s rate (expressed as a percentage per annum), as of approximately 11:00 a.m., New York City time, on such Determination Date, for loans in a Representative Amount in U.S. dollars to
leading European banks for a three-month period beginning on the second London Banking Day after the Determination Date. If at least two such rates are so provided, LIBOR for the Interest Period will be the arithmetic mean of such rates. If fewer
than two such rates are so provided, then LIBOR for the Interest Period will be LIBOR in effect with respect to the immediately preceding Interest Period. 
  

 3 

 “Lien” means any mortgage, pledge, security interest, encumbrance, lien or charge of any kind
(including any conditional sale or other title retention agreement or lease in the nature thereof). 
  
 “London Banking Day” is any day on which dealings in U.S. dollars are transacted or, with respect to any future date, are expected to be
transacted in the London interbank market. 
  
 “Merger”
means the merger of Yankee II LLC, a Delaware limited liability company and a Wholly Owned Subsidiary of the Company, with and into USF pursuant to the Merger Agreement. 
  
 “Merger Agreement” means the Agreement and Plan of Merger by and among the Company, Yankee II LLC and USF dated as
of February 27, 2005, as amended as of May 1, 2005, and as it may be further amended or otherwise modified, and in effect. 
  
 “Officer” means the Chairman of the Board, the President, the Chief Financial Officer, any Senior Vice President, any Vice President, the
Treasurer or the Secretary of the Company. 
  
 “Officers’ Certificate” means a certificate signed by two Officers. 
  
 “Opinion of Counsel” means a written opinion from legal counsel who is acceptable to the Trustee. The counsel may be an employee of or counsel to the Company or the Trustee. 
  
 “Person” means any individual, corporation, partnership, limited
liability company, joint venture, association, joint-stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. 
  
 “Purchase Money Note” means a promissory note of a Receivables Entity evidencing the deferred purchase price of
Receivables (and related assets) and/or a line of credit, which may be irrevocable, from the Company or any of its subsidiaries in connection with a Qualified Receivables Transaction with a Receivables Entity, which deferred purchase price or line
is repayable from cash available to the Receivables Entity, other than amounts required to be established as reserves pursuant to agreements, amounts paid to investors in respect of interest, principal and other amounts owing to such investors and
amounts owing to such investors and amounts paid in connection with the purchase of newly generated Receivables. 
  
 “Qualified Receivables Transaction” means any transaction or series of transactions that may be entered into by the Company or any of its
Subsidiaries pursuant to which the Company or any of its Subsidiaries may sell, convey or otherwise transfer to (1) a Receivables Entity (in the case of a transfer by the Company or any of its other Subsidiaries) and (2) any other Person (in the
case of a transfer by a Receivables Entity), or may grant a security interest in, any Receivables (whether now existing or arising in 

  

 4 

 
the future) of the Company or any of its Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such
Receivables, all contracts and all guarantees or other obligations in respect of such accounts receivable, the proceeds of such Receivables and other assets which are customarily transferred, or in respect of which security interests are customarily
granted, in connection with asset securitizations involving Receivables. 
  
 “Receivable” means a right to receive payment arising from a sale or lease of goods or the performance of services by a Person pursuant to an arrangement with another Person pursuant to which such other
Person is obligated to pay for goods or services under terms that permit the purchase of such goods and services on credit and shall include, in any event, any items of property that would be classified as an “account,” “chattel
paper,” “payment intangible” or “instrument” under the Uniform Commercial Code as in effect in the State of New York and any “supporting obligations” as so defined. 
  
 “Receivables Entity” means a Wholly Owned Subsidiary (or another
Person in which the Company or any of its other Subsidiaries makes an investment and to which the Company or any of its other Subsidiaries transfers Receivables and related assets) which engages in no activities other than in connection with the
financing of Receivables and which is designated by the Board of Directors (as provided below) as a Receivables Entity: 
  
 (1) no portion of the Indebtedness or any other obligations (contingent or otherwise) of which: 
  
 (A) is guaranteed by the Company or any of its other
Subsidiaries (excluding guarantees of obligations (other than the principal of, and interest on, Indebtedness) pursuant to the Standard Securitization Undertakings); 
  
 (B) is recourse to or obligates the Company or any of its other Subsidiaries in any way other than pursuant
to the Standard Securitization Undertakings; or 
  
 (C) subjects any property or asset of the Company or any of its other Subsidiaries, directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to Standard Securitization Undertakings; 
  
 (2) with which neither the Company nor any of its other
Subsidiaries has any material contract, agreement, arrangement or understanding (except in connection with a Purchase Money Note or Qualified Receivables Transaction) other than on terms no less favorable to the Company or such Subsidiary than those
that might be obtained at the time from Persons that are not affiliates of the 

  

 5 

 
Company, other than fees payable in the ordinary course of business in connection with servicing Receivables; and 
  
 (3) to which neither the Company nor any of its other
Subsidiaries has any obligation to maintain or preserve such entity’s financial condition or cause such entity to achieve certain levels of operating results. 
  
 Any such designation by the Board of Directors shall be evidenced to the Trustee by filing with the Trustee a resolution of the Board of
Directors giving effect to such designation and an Officers’ Certificate certifying that such designation complied with the foregoing conditions. 
  
 “Registration Rights Agreement” means the Registration Rights Agreement dated May 24, 2005, between the Company, certain subsidiaries of the
Company listed on Schedule B to the Purchase Agreement, and Credit Suisse First Boston LLC, as representative of the initial purchasers of the Securities. 
  
 “Representative Amount” means a principal amount of not less than $1,000,000 for a single transaction in the relevant market at the relevant
time. 
  
 “Roadway” means Roadway LLC, a Delaware
limited liability company, and its successors. 
  
 “SEC”
means the U.S. Securities and Exchange Commission. 
  
 “Securities Act” means the U.S. Securities Act of 1933, as amended. 
  
 “Significant Domestic Subsidiary” means any Significant Subsidiary that is a Domestic Subsidiary. 
  
 “Significant Subsidiary” means each of Roadway, YTI, USF and, at the relevant time of determination, any other Subsidiary of the Company that
would be a “Significant Subsidiary” of the Company within the meaning of Rule 1-02 under Regulation S-X promulgated by the SEC; provided, however, that a Person will be a Significant Subsidiary only so long as it is a Subsidiary of the
Company. 
  
 “Standard Securitization Undertakings”
means representations, warranties, covenants and indemnities entered into by the Company or any of its Subsidiaries which are reasonably customary in securitization of Receivables transactions. 
  
 “Subsidiary” means, with respect to any Person, any corporation,
association, partnership or other business entity of which more than 50% of the total voting power of shares of Voting Stock is at the time owned or controlled, directly or indirectly, by: 
  
 (1) such Person; 
  

 6 

 (2) such Person and one or more Subsidiaries of such Person; or 
  
 (3) one or more Subsidiaries of such Person. 
  
 “Subsidiary Guarantor” means each Subsidiary of the Company that
executes this Indenture as a guarantor on the Issue Date and each other Subsidiary of the Company that thereafter guarantees the Securities pursuant to the terms of this Indenture; provided, however, that a Person will be a Subsidiary
Guarantor only so long as it guarantees payment of the Securities. 
  
 “Subsidiary Guaranty” means a guarantee by a Subsidiary Guarantor of the Company’s obligations with respect to the Securities. 
  
 “TIA” means the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) as in effect on the date of this Indenture. 

 
 “Trustee” means SunTrust Bank until a successor replaces it and,
thereafter, means the successor. 
  
 “Trust Officer”
means the Chairman of the Board, the President or any other officer or assistant officer of the Trustee assigned by the Trustee to administer its corporate trust matters. 
  
 “USF” means USF Corporation, a Delaware corporation, and its successors. 
  
 “Uniform Commercial Code” means the New York Uniform Commercial
Code as in effect from time to time. 
  
 “U.S. Government
Obligations” means direct obligations (or certificates representing an ownership interest in such obligations) of the United States of America (including any agency or instrumentality thereof) for the payment of which the full faith and credit
of the United States of America is pledged and which are not callable at the issuer’s option. 
  
 “Voting Stock” of a Person means all classes of Capital Stock of such Person then outstanding and normally entitled (without regard to the
occurrence of any contingency) to vote in the election of directors, managers or trustees thereof. 
  
 “Wholly Owned Subsidiary” means a Subsidiary of the Company, all of the Capital Stock of which (other than directors’ qualifying shares or
similar shares) is owned by the Company or another Wholly Owned Subsidiary. 
  
 “YTI” means Yellow Transportation, Inc., an Indiana corporation, and its successors. 
  

 7 

 SECTION 1.02. Other Definitions. 
  

			
	 Term

	  	Defined in
Section

	 “Appendix”
	  	2.01
	 “Bankruptcy Law”
	  	6.01
	 “covenant defeasance option”
	  	    8.01(b)
	 “Custodian”
	  	6.01
	 “Event of Default”
	  	6.01
	 “Guaranteed Obligations”
	  	10.01  
	 “legal defeasance option”
	  	    8.01(b)
	 “Paying Agent”
	  	2.03
	 “Registrar”
	  	2.03
	 “Successor Company”
	  	5.01

  
 SECTION 1.03.
Incorporation by Reference of Trust Indenture Act. This Indenture is subject to the mandatory provisions of the TIA which are incorporated by reference in and made a part of this Indenture. The following TIA terms have the following meanings:

  
 “Commission” means the SEC; 
  
 “indenture securities” means the Securities and the Subsidiary
Guaranties; 
  
 “indenture security holder” means a
Securityholder; 
  
 “indenture to be qualified” means
this Indenture; 
  
 “indenture trustee” or
“institutional trustee” means the Trustee; and 
  
 “obligor” on the indenture securities means the Company, each Subsidiary Guarantor and any other obligor on the indenture securities. 
  
 All other TIA terms used in this Indenture that are defined by the TIA, defined by TIA reference to another statute or defined by SEC rule have the
meanings assigned to them by such definitions. 
  
 SECTION 1.04.
Rules of Construction. Unless the context otherwise requires: 
  
 (1) a term has the meaning assigned to it; 
  
 (2) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 
  
 (3) “or” is not exclusive; 
  
 (4) “including” means including without limitation; 
  

 8 

 (5) words in the singular include the plural and words in the plural include the
singular; 
  
 (6) unsecured Indebtedness shall
not be deemed to be subordinate or junior to secured Indebtedness merely by virtue of its nature as unsecured Indebtedness; 
  
 (7) secured Indebtedness shall not be deemed to be subordinate or junior to any other secured Indebtedness merely because it has a junior
priority with respect to the same collateral; and 
  
 (8) all references to the date the Securities were originally issued shall refer to the Issue Date. 
  
 ARTICLE 2 
  
 The Securities 
  
 SECTION 2.01. Form and
Dating. Provisions relating to the Initial Securities, the Private Exchange Securities and the Exchange Securities are set forth in the Rule 144A/Regulation S/IAI Appendix attached hereto (the “Appendix”) which is hereby incorporated
in, and expressly made part of, this Indenture. The Initial Securities and the Trustee’s certificate of authentication shall be substantially in the form of Exhibit 1 to the Appendix which is hereby incorporated in, and expressly made a part
of, this Indenture. The Exchange Securities, the Private Exchange Securities and the Trustee’s certificate of authentication shall be substantially in the form of Exhibit A, which is hereby incorporated in and expressly made a part of this
Indenture. The Securities may have notations, legends or endorsements required by law, stock exchange rule, agreements to which the Company is subject, if any, or usage (provided that any such notation, legend or endorsement is in a form acceptable
to the Company). Each Security shall be dated the date of its authentication. The terms of the Securities set forth in the Appendix and Exhibit A are part of the terms of this Indenture. 
  
 SECTION 2.02. Execution and Authentication. Two Officers shall sign the Securities for the Company by manual or
facsimile signature. The Company’s seal, if any, may be in the form of a facsimile thereof and may be impressed, affixed, imprinted or reproduced on the Securities and may be in facsimile form. 
  
 If an Officer whose signature is on a Security no longer holds that office at
the time the Trustee authenticates the Security, the Security shall be valid nevertheless. 
  
 A Security shall not be valid until an authorized signatory of the Trustee manually signs the certificate of authentication on the Security. The signature shall be conclusive evidence that the Security has been
authenticated under this Indenture. 
  
 On the Issue Date, the
Trustee shall authenticate and deliver $150,000,000 million of Senior Floating Rate Notes Due 2008. At any time and from time to time thereafter, the Trustee shall authenticate and deliver Securities for original issue in an 

  

 9 

 
aggregate principal amount specified in such order, in each case upon a written order of the Company signed by two Officers or by an Officer and either an
Assistant Treasurer or an Assistant Secretary of the Company; provided, however, that the Trustee shall be entitled to receive, upon Trustee’s timely request, an Officers’ Certificate and an Opinion of Counsel of the Company
in connection with the authentication of such Securities. Such order shall specify the amount of the Securities to be authenticated and the date on which the original issue of Securities is to be authenticated. 
  
 The Trustee may appoint an authenticating agent reasonably acceptable to the
Company to authenticate the Securities. Unless limited by the terms of such appointment, an authenticating agent may authenticate Securities whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes
authentication by such agent. An authenticating agent has the same rights as any Registrar, Paying Agent or agent for service of notices and demands. 
  
 SECTION 2.03. Registrar and Paying Agent. The Company shall maintain an office or agency where Securities may be presented for registration of
transfer or for exchange (the “Registrar”) and an office or agency where Securities may be presented for payment (the “Paying Agent”). The Registrar shall keep a register of the Securities and of their transfer and exchange. The
Company may have one or more co-registrars and one or more additional paying agents. The term “Paying Agent” includes any additional paying agent. 
  
 The Company shall enter into an appropriate agency agreement with any Registrar, Paying Agent or co-registrar not a party to this Indenture, which shall
incorporate the terms of the TIA. The agreement shall implement the provisions of this Indenture that relate to such agent. The Company shall timely notify the Trustee of the name and address of any such agent. If the Company fails to maintain a
Registrar or Paying Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to Section 7.07. The Company or any Wholly Owned Subsidiary incorporated or organized within The United States of America
may act as Paying Agent, Registrar, co-registrar or transfer agent. 
  
 The Company initially appoints the Trustee as Registrar and Paying Agent in connection with the Securities. 
  
 SECTION 2.04. Paying Agent To Hold Money in Trust. Prior to 11:00 a.m., New York City time on each due date of the principal and interest on any
Security, the Company shall deposit (including by means of wire transfer of immediately available funds) with the Paying Agent a sum sufficient to pay such principal and interest when so becoming due. The Company shall require each Paying Agent
(other than the Trustee) to agree in writing that the Paying Agent shall hold in trust for the benefit of Securityholders or the Trustee all money held by the Paying Agent for the payment of principal of or interest on the Securities and shall
notify the Trustee of any default by the Company in making any such payment. If the Company or a Subsidiary acts as Paying Agent, it shall segregate the money held by it as Paying Agent and hold it as a separate trust fund. The Company at any time
may require a Paying Agent to pay all money held 

  

 10 

 
by it to the Trustee and to account for any funds disbursed by the Paying Agent. Upon complying with this Section, the Paying Agent shall have no further
liability for the money delivered to the Trustee. 
  
 SECTION
2.05. Securityholder Lists. The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses of Securityholders. If the Trustee is not the Registrar, the Company
shall furnish to the Trustee, in writing at least seven Business Days before each interest payment date and at such other times as the Trustee may reasonably request in writing, a list in such form and as of such date as the Trustee may reasonably
require of the names and addresses of Securityholders. 
  
 SECTION
2.06. Transfer and Exchange. The Securities shall be issued in registered form and shall be transferable only upon the surrender of the Securities being transferred for registration of transfer. When a Security is presented to the Registrar
or a co-registrar with a request to register a transfer, the Registrar shall register the transfer as requested if the requirements of this Indenture and Section 8-401(1) of the Uniform Commercial Code are met. When Securities are presented to the
Registrar or a co-registrar with a request to exchange them for an equal principal amount of Securities of other denominations, the Registrar shall make the exchange as requested if the same requirements are met. 
  
 The Company may require payment of a sum sufficient to cover any tax or other
governmental charge that may be imposed in relation to any registration of transfer or exchange, and a reasonable fee for such registration of transfer or exchange except, in each case, for any exchange pursuant to Section 2.09, 3.06 or 9.05.

  
 The Company shall not be required (i) to issue, register the
transfer of or exchange any Securities (A) for a period of 15 days next preceding any selection for redemption of Securities of such series or (B) between a record date and the next succeeding interest payment date, or (ii) to register the transfer
of or exchange any Securities selected, called or being called for redemption (except in the case of Securities to be redeemed in part, the portion not to be redeemed). 
  
 SECTION 2.07. Replacement Securities. If (i) a mutilated Security is surrendered to the Registrar or (ii) the Company
and the Trustee receive evidence to their satisfaction of the loss, destruction or theft of a Security and subject to the satisfaction of all indemnity or security requirements required by the Trustee or the Company as herein referenced and the
absence of notice received by the Trustee or the Company that such Security has been acquired by a bona fide purchaser, then the Company shall issue and the Trustee shall authenticate and deliver a replacement Security if the requirements of Section
8-405 of the Uniform Commercial Code are met and the Holder satisfies any other reasonable requirements of the Trustee. If required by the Trustee or the Company, such Holder shall furnish security or an indemnity bond sufficient in the judgment of
the Company and the Trustee to protect the Company, the Trustee, the Paying Agent, the Registrar and any co-registrar from any loss which any of them may suffer if a Security is replaced. If any Security that has matured or is about to mature or
which has been called 

  

 11 

 
for redemption shall become mutilated or destroyed, lost or stolen, the Company may, instead of issuing a replacement Security, pay or authorize the payment
of same (without surrender thereof except in the case of a mutilated Security) if the applicant for such payment shall furnish the Company and the Trustee with such security or indemnity as either may require to save it harmless from all risk,
however remote, and in case of destruction, loss or theft, evidence to the satisfaction of the Company and the Trustee of the destruction, loss or theft of such Security and of the ownership thereof. The Company and the Trustee may charge the Holder
for taxes or other governmental charges imposed in relation thereto and any other expenses they incur in connection with replacing a Security. 
  
 Every replacement Security is an additional obligation of the Company. 
  
 SECTION 2.08. Outstanding Securities. Securities outstanding at any time will consist of all Securities theretofore
authenticated and delivered under this Indenture except for those theretofore canceled by the Trustee, those delivered to the Trustee for cancellation or those described in this Section as not outstanding. A Security does not cease to be outstanding
because the Company or an Affiliate of the Company holds the Security. 
  
 If a Security has been paid pursuant to Section 2.07 or is replaced pursuant to Section 2.07, it ceases to be outstanding unless and until the Trustee and the Company receive proof satisfactory to them that, in the case of such replaced
Security, the replaced Security is held by a protected purchaser (as defined in Section 8-303 of the Uniform Commercial Code). 
  
 If the Paying Agent (other than the Company or an Affiliate of the Company) segregates and holds in trust, in accordance with this Indenture, on a
redemption date or payment date money sufficient to pay all principal and interest payable on that date with respect to the Securities (or portions thereof) to be redeemed or maturing, as the case may be, then on and after that date such Securities
(or portions thereof) cease to be outstanding and interest on them ceases to accrue. 
  
 SECTION 2.09. Temporary Securities. Until definitive Securities are ready for delivery, the Company may prepare and the Trustee, upon receipt of a written order of an Officer of the Company, shall authenticate
and deliver temporary Securities. Temporary Securities shall be substantially in the form of definitive Securities but may have variations that the Company considers appropriate for temporary Securities. Without unreasonable delay, the Company shall
prepare and the Trustee shall authenticate and deliver definitive Securities and deliver them in exchange for temporary Securities, and until delivery of such definitive Securities, Holders of temporary Securities shall be entitled to all benefits
of this Indenture. 
  
 SECTION 2.10. Cancellation. The
Company at any time may deliver Securities to the Trustee for cancellation. The Registrar and the Paying Agent shall forward to the Trustee any Securities surrendered to them for registration of transfer, exchange or payment. The Trustee and no one
else shall cancel and destroy (subject to 

  

 12 

 
the record retention requirements of the Exchange Act) all Securities surrendered for registration of transfer, exchange, payment, redemption or cancellation
and deliver a certificate of such destruction to the Company unless the Company directs the Trustee to deliver canceled Securities to the Company. If the Company shall acquire any of the Securities, however, such acquisition shall not operate as a
redemption or satisfaction of the Indebtedness represented thereby unless and until the same are delivered or surrendered to the Trustee for cancellation. The Company may not issue new Securities to replace Securities it has redeemed, paid or
delivered to the Trustee for cancellation. 
  
 SECTION 2.11.
Defaulted Interest. If the Company defaults in a payment of interest on the Securities, the Company shall pay interest on such defaulted interest at the rate so provided in the Securities, to the extent lawful. The Company may pay the
defaulted interest to the persons who are Securityholders on a subsequent special record date. The Company shall fix or cause to be fixed any such special record date and payment date to the reasonable satisfaction of the Trustee and shall promptly
mail to each Securityholder a notice that states the special record date, the payment date and the amount of defaulted interest to be paid. 
  
 SECTION 2.12. CUSIP Numbers, ISINs, etc. The Company in issuing the Securities may use “CUSIP” numbers, ISINs and “Common Code”
numbers (in each case if then generally in use) and, if so, the Trustee shall use “CUSIP” numbers, ISINs and “Common Code” numbers in notices of redemption as a convenience to Holders; provided, however, that any such notice may
state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the
Securities, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company shall timely advise the Trustee in writing of any change in any “CUSIP” numbers, ISINs or “Common Code” numbers
applicable to the Securities. 
  
 SECTION 2.13. Issuance of
Additional Securities. After the Issue Date, the Company shall be entitled to issue Additional Securities under this Indenture, which Securities shall have identical terms as the Initial Securities issued on the Issue Date, other than with
respect to the date of issuance and issue price. All the Securities issued under this Indenture shall be treated as a single class for all purposes of this Indenture including waivers, amendments, redemptions and offers to purchase. 
  
 With respect to any Additional Securities, the Company shall set forth in a
resolution of the Board of Directors and an Officers’ Certificate, a copy of each which shall be delivered to the Trustee, the following information: 
  
 (1) the aggregate principal amount of such Additional Securities to be authenticated and delivered pursuant to this Indenture; 

 
 (2) the issue price, the issue date and the CUSIP number,
ISIN or “Common Code” number (as the case may be) of such Additional Securities; provided, however, that no Additional Securities may be issued at a price that 

  

 13 

 
would cause such Additional Securities to have “original issue discount” within the meaning of Section 1273 of the Code; and 
  
 (3) whether such Additional Securities shall be Initial
Securities or shall be issued in the form of Exchange Securities as set forth in Exhibit A. 
  
 In addition, upon the request of the Trustee, the Company shall cause an Opinion of Counsel to be furnished to the Trustee with respect to the authentication and delivery of Additional Securities under this Indenture.

  
 ARTICLE 3 
  
 Redemption 
  
 SECTION 3.01. Notices to Trustee. If the Company elects to redeem
Securities pursuant to paragraph 5 of the Securities or is required to redeem Securities pursuant to paragraph 6 of the Securities, it shall notify the Trustee in writing of the redemption date, the redemption price, the principal amount of
Securities to be redeemed and the paragraph of the Securities pursuant to which the redemption will occur. 
  
 In the case of redemption pursuant to paragraph 5 of the Securities, the Company shall give each notice to the Trustee provided for in this Section at
least 45 days before the redemption date unless the Trustee consents to a shorter period. In the case of redemption pursuant to paragraph 6 of the Securities, the Company shall given the notice to the Trustee provided for in this Section no later
than the second Business Day following December 31, 2005 or following the date the Merger Agreement is terminated, as applicable. In each case, such notice shall be accompanied by an Officers’ Certificate and an Opinion of Counsel from the
Company to the effect that such redemption will comply with the conditions herein. 
  
 SECTION 3.02. Selection of Securities to Be Redeemed. If fewer than all the Securities are to be redeemed, the Trustee shall select the Securities (or portions thereof) to be redeemed in compliance with the
requirements of the principal national securities exchange, if any, on which the Securities are listed or, if the Securities are not so listed or there are no such requirements, on a pro rata basis, by lot or by such method as the Trustee shall deem
fair and appropriate, in each case, to the extent practicable. The Trustee shall make the selection from outstanding Securities not previously called for redemption. Securities in denominations of $2,000 or less will be redeemed in whole but not in
part. The Trustee may select for redemption portions of the principal of Securities that have denominations larger than $2,000, but only in whole multiples of $1,000 in excess of $2,000. Provisions of this Indenture that apply to Securities called
for redemption also apply to portions of Securities called for redemption. The Trustee shall notify the Company promptly of the Securities or portions of Securities to be redeemed. 
  
 SECTION 3.03. Notice of Redemption. At least 30 days but not more than 60 days before a redemption date in the case
of a redemption pursuant to paragraph 5 of the Securities, and no later than the second Business Day following 

  

 14 

 
December 31, 2005 or following the date the Merger Agreement is terminated, as applicable, in the case of a redemption pursuant to paragraph 6 of the
Securities, the Company shall mail a notice of redemption by first-class mail to each Holder of Securities to be redeemed at such Holder’s registered address. 
  
 The notice shall identify the Securities to be redeemed and shall state: 
  
 (1) the redemption date; 
  
 (2) the redemption price; 
  
 (3) the name and address of the Paying Agent; 
  
 (4) that Securities called for redemption must be
surrendered to the Paying Agent to collect the redemption price; 
  
 (5) if fewer than all the outstanding Securities are to be redeemed, the identification and principal amounts of the particular Securities (or portion thereof) to be redeemed; 
  
 (6) that, unless the Company defaults in making such
redemption payment, interest on Securities (or portion thereof) called for redemption ceases to accrue on and after the redemption date; 
  
 (7) the paragraph of the Securities pursuant to which the Securities called for redemption are being redeemed; 
  
 (8) the “CUSIP” number, ISIN or “Common
Code” number, if any, printed on the Securities being redeemed; and 
  
 (9) that no representation is made as to the correctness or accuracy of the “CUSIP” number, ISIN, or “Common Code” number, if any, listed in such notice or printed on the Securities. 
  
 At the Company’s written request, the Trustee shall give the notice of
redemption in the Company’s name and at the Company’s expense. In such event, the Company shall provide the Trustee with the information required by this Section. 
  
 SECTION 3.04. Effect of Notice of Redemption. Once notice of redemption is mailed, Securities called for redemption
become due and payable on the redemption date and at the redemption price stated in the notice. Upon surrender to the Paying Agent, such Securities shall be paid at the redemption price stated in the notice, plus accrued interest to the redemption
date, and such Securities shall be canceled by the Trustee. On or after the redemption date, interest shall cease to accrue on the Securities or portions of them called for redemption unless the Company defaults in the making of the redemption
payment on such redemption date. If a Security is redeemed on or after an interest record date but on or prior to the related interest payment date, then any accrued and unpaid interest shall be paid to the person in whose name such Security is

  

 15 

 
registered at the close of business on such record date. Failure to give notice or any defect in the notice to any Holder shall not affect the validity of
the notice to any other Holder. 
  
 SECTION 3.05. Deposit of
Redemption Price. Prior to 11:00 a.m., New York, City time on each redemption date, the Company shall deposit (including by means of wire transfer of immediately available funds) with the Paying Agent (or, if the Company or a Subsidiary is the
Paying Agent, shall segregate and hold in trust) money sufficient to pay the redemption price of and accrued interest on all Securities to be redeemed on that date other than Securities or portions of Securities called for redemption which have been
delivered by the Company to the Trustee for cancellation. 
  
 SECTION 3.06. Securities Redeemed in Part. Upon cancelation of a Security that is redeemed in part, the Company shall issue and the Trustee shall authenticate and deliver for the Holder (at the Company’s expense) a new Security
equal in principal amount to the unredeemed portion of the Security canceled. 
  
 ARTICLE 4 
  
 Covenants

  
 SECTION 4.01. Payment of Securities. The Company
shall punctually pay the principal of, premium (if any) and interest on the Securities on the dates and in the manner provided in the Securities and in this Indenture. Principal, premium (if any) and interest shall be considered paid on the date due
if on such date the Trustee or the Paying Agent holds in accordance with this Indenture money sufficient to pay all principal, premium (if any) and interest then due. 
  
 The Company shall pay interest on overdue principal at the rate specified therefor in the Securities, and it shall pay
interest on overdue installments of interest at the same rate to the extent lawful. 
  
 SECTION 4.02. SEC Reports. Notwithstanding that the Company may not be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company shall electronically file with the SEC (to
the extent the SEC will accept such filings), so long as the Securities are outstanding, such annual and other reports that the Company is required to file (or would otherwise be required to file) with the SEC pursuant to Sections 13 and 15(d) of
the Exchange Act and applicable to a U.S. corporation subject to such Sections, such reports to be so filed and provided at the times specified for the filings of such reports under such Sections and containing all the information, audit reports and
exhibits required for such reports. The Company agrees that it shall not take any action for the purpose of causing the SEC not to permit or accept any such filings. If, notwithstanding the foregoing, the SEC will not permit or accept such filings
for any reason, the Company shall post the reports specified in the initial sentence of this paragraph on its website within the time periods that would apply if the Company were required to file those reports with the SEC. 
  

 16 

 In addition, the Company shall furnish to the Holders of the Securities and to prospective investors,
upon the requests of such Holders, any information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act so long as any Securities are not freely transferable under the Securities Act. The Company also shall comply with the
other provisions of TIA § 314(a). 
  
 SECTION 4.03.
Limitation on Liens. The Company shall not, and shall not permit any Subsidiary of the Company to, create, assume, incur or permit to exist any Lien upon any Capital Stock or Indebtedness, whether owned on the Issue Date or thereafter
acquired, of any Subsidiary to secure any Indebtedness of the Company, any Subsidiary of the Company or any other Person without in any such case making effective provision whereby all of the Securities shall be directly secured equally and ratably
with such Indebtedness; provided, however, there shall be excluded from the operation of the foregoing provisions (1) any Lien upon Capital Stock or Indebtedness of any Person existing at the time such Person becomes a Subsidiary or
existing or created upon Capital Stock or Indebtedness of a Subsidiary at the time of acquisition of such Capital Stock or Indebtedness, (2) any Lien upon Capital Stock or Indebtedness of a Subsidiary which is in effect and existing on the Issue
Date and (3) any Lien upon Capital Stock or Indebtedness of an Excluded Subsidiary, and in each case, any extension, renewal or replacement (or successive extensions, renewals or replacements) in whole or in part of any such Lien; provided
further, however, (y) that the principal amount of the Indebtedness secured thereby may not exceed (A) the principal amount of the Indebtedness so secured at the time of such extension, renewal or replacement plus (B) fees and expenses,
including premiums and defeasance costs, if any, related to such extension, renewal or replacement and (z) such Lien must be limited to all or such part of the Capital Stock or Indebtedness which secured the Lien so extended, renewed or replaced.

  
 When a Lien securing Indebtedness that gave rise to this
covenant’s requirement that the Securities be equally and ratably secured thereby is released or terminated, as the case may be, by the holder or holders thereof, other than the Holders, then the corresponding Lien that secures the Securities
shall be deemed automatically released or terminated, as the case may be, without further act or deed on the part of any Person unless there exists another Lien that would require such corresponding Lien to be created, and in such event and at the
Company’s request to the Trustee, the Trustee shall execute and deliver to or at the direction of the Company one or more instruments of release or termination, as the case may be, with respect to such corresponding Lien as the Company shall
reasonably request. 
  
 SECTION 4.04. Future Guarantors.
The Company shall cause each Significant Domestic Subsidiary (other than an Excluded Subsidiary) that guarantees payment of any Indebtedness of the Company or any Indebtedness of any Significant Subsidiary (other than, in each case, Indebtedness
under bank credit facilities), in each case, after the Issue Date, to, in each case, at the same time, execute and deliver to the Trustee a Guaranty Agreement, dated effective as of the effective date of such guarantee, pursuant to which such
Significant Domestic Subsidiary shall guarantee payment of the Securities on the same terms and conditions as those set forth in Article 10 of this 

  

 17 

 
Indenture; provided, however, if any such guaranteed Indebtedness is subordinated to any other Indebtedness of the Company or such Subsidiary,
as the case may be, such guaranteed Indebtedness must be subordinated to the guarantee of the Securities to at least the same extent. Within 20 Business Days following the consummation of the Merger, the Company shall cause USF and USF Holland Inc.
to guarantee payment of the Securities in the same manner as described in the preceding sentence. 
  
 SECTION 4.05. Existence. Subject to Article 5, the Company shall do or cause to be done all things necessary to preserve and keep in full force and
effect its existence, rights (charter and statutory) and franchises; provided, however, that the Company shall not be required to preserve any such right or franchise if the Board of Directors shall determine that the preservation
thereof is no longer desirable in the conduct of the business of the Company and that the loss thereof is not disadvantageous in any material respect to the Holders. 
  
 SECTION 4.06. Maintenance of Properties. The Company shall cause all material properties used or useful in the
conduct of its business or the business of any Subsidiary to be maintained and kept in good condition, repair and working order (ordinary wear and tear excepted) and supplied with all necessary equipment and will cause to be made all necessary
repairs, renewals, replacements, betterments and improvements thereof, all as in the judgment of the Company may be consistent with sound business practice and necessary so that the business carried on in connection therewith may be properly
conducted at all times; provided, however, that nothing in this Section shall prevent the Company from discontinuing the operation or maintenance of any such properties if such discontinuance is, in the judgment of the Company,
desirable in the conduct of its business or the business of any Subsidiary and would not reasonably be expected to have an adverse effect on the ability of the Company to perform its obligations hereunder or under the Securities. 
  
 SECTION 4.07. Payment of Taxes and Other Claims. The Company shall pay
or discharge or cause to be paid or discharged, before the same shall become delinquent, (1) all material taxes, assessments and governmental charges levied or imposed upon the Company or any Subsidiary or upon the income, profits or property of the
Company or any Subsidiary, if failure to pay or discharge the same could reasonably be expected to have an adverse effect on the ability of the Company to perform its obligations hereunder or under the Securities, and (2) all lawful claims for
labor, materials and supplies which, if unpaid, would by law become a material Lien upon the property of the Company or any Subsidiary, if failure to pay or discharge the same could reasonably be expected to have an adverse effect on the ability of
the Company to perform its obligations hereunder or under the Securities; provided, however, that the Company shall not be required to pay or discharge or cause to be paid or discharged any such tax, assessment, charge or claim whose
amount, applicability or validity is being contested in good faith, and if reasonably required, by appropriate proceedings. 
  
 SECTION 4.08. Compliance Certificate. The Company shall deliver to the Trustee within 120 days after the end of each fiscal year of the Company an
Officers’ Certificate stating that in the course of the performance by the signers of their duties as 

  

 18 

 
Officers of the Company they would normally have knowledge of any Default and whether or not the signers know of any Default that occurred during such period
and is then continuing. If they do, the certificate shall describe such Default, its status and what action the Company is taking or proposes to take with respect thereto. The Company also shall comply with TIA § 314(a)(4). 
  
 SECTION 4.09. Further Instruments and Acts. Upon request of the
Trustee, the Company will execute and deliver such further instruments and do such further acts as may be reasonably necessary or proper to carry out more effectively the purpose of this Indenture. 
  
 ARTICLE 5 
  
 Successor Company 
  
 SECTION 5.01. When Company May Merge or Transfer Assets. The Company shall not consolidate with or merge with or into, or convey, transfer or lease
(as lessor), in one transaction or a series of related transactions, directly or indirectly, all or substantially all its assets to, any Person, unless: 
  
 (1) the resulting, surviving or transferee Person if other than the Company (the “Successor Company”) shall be a Person
organized and existing under the laws of the United States of America, any State thereof or the District of Columbia and the Successor Company (if not the Company) shall expressly assume, by an indenture supplemental thereto, executed and delivered
to the Trustee, in form satisfactory to the Trustee, all the obligations of the Company under the Securities and this Indenture; 
  
 (2) immediately after giving pro forma effect to such transaction, no Default shall have occurred and be continuing; and

  
 (3) the Company shall have delivered to the
Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that such consolidation, merger, transfer or lease and such supplemental indenture (if any) comply with the applicable provisions of this Indenture. 
  
 The Successor Company shall be the successor to the Company and shall succeed
to, and be substituted for, and may exercise every right and power of, the Company under this Indenture, and the predecessor Company, except in the case of a lease by the Company (as lessor) of all or substantially all of its assets, shall be
released from all covenants, liabilities and other obligations under this Indenture and the Securities. 
  

 19 

 ARTICLE 6 
  
 Defaults and Remedies 
  
 SECTION 6.01. Events of Default. An “Event of Default” occurs if: 
  
 (1) the Company defaults in any payment of interest on any Security when the same becomes due and payable,
and such default continues for a period of 30 days; 
  
 (2) the Company (A) defaults in the payment of the principal of any Security when the same becomes due and payable at its stated maturity, upon mandatory or optional redemption, upon declaration of acceleration or otherwise, or (B) fails to
redeem Securities when required pursuant to this Indenture or the Securities; 
  
 (3) the Company or, so long as the Securities are guaranteed by a Subsidiary Guarantor, such Subsidiary Guarantor, fails to comply with any of its agreements contained in the Securities or this Indenture (other than
those referred to in clause (1) or (2) above) and such failure continues for 60 days after the notice specified below; 
  
 (4) a default under any Indebtedness by the Company or any Subsidiary of the Company (other than an Excluded Subsidiary) having an
aggregate principal amount outstanding of at least $40 million, or under any mortgage, indenture or instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness by the Company or any Subsidiary of the
Company (other than an Excluded Subsidiary) having an aggregate principal amount outstanding of at least $40 million, whether such Indebtedness now exists or shall hereafter be created, which default (A) shall constitute a failure to pay principal
of, or premium, if any, or interest on such Indebtedness when due and payable after the expiration of any applicable grace period with respect thereto or (B) shall have resulted in such Indebtedness becoming or being declared due and payable in its
entirety prior to the stated date on which it would otherwise have become due and payable, and such failure to pay is not cured or such accelerated maturity date is not rescinded or annulled within a period of 10 days after (i) the Company’s
receipt of written notice from the Trustee or (ii) the Company’s and the Trustee’s written notice from Holders of at least 10% in principal amount of the outstanding Securities, in each case, which written notice shall specify such default
and require the Company to cause such Indebtedness to be discharged or cause such acceleration to be rescinded or annulled, as the case may be; 
  
 (5) the Company or any Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: 
  
 (A) commences a voluntary case; 
  

 20 

 (B) consents to the entry of an order for relief against it in an involuntary case;

  
 (C) consents to the appointment of a
Custodian of it or for any substantial part of its property; or 
  
 (D) makes a general assignment for the benefit of its creditors; 
  
 or takes any comparable action under any foreign laws relating to insolvency; 
  
 (6) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 
  
 (A) is for relief against the Company or any Significant
Subsidiary in an involuntary case; 
  
 (B)
appoints a Custodian of the Company or any Significant Subsidiary or for any substantial part of its property; or 
  
 (C) orders the winding up or liquidation of the Company or any Significant Subsidiary; 
  
 or any similar relief is granted under any foreign laws and the order or decree remains
unstayed and in effect for 60 days; or 
  
 (7)
any Subsidiary Guaranty of a Subsidiary Guarantor ceases to be in full force and effect (except as provided in this Indenture) or any Subsidiary Guarantor denies or disaffirms its obligations under its Subsidiary Guaranty. 
  
 The foregoing will constitute Events of Default whatever the reason for any
such Event of Default and whether it is voluntary or involuntary or is effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body. 
  
 The term “Bankruptcy Law” means Title 11, United States
Code, or any similar Federal or state law for the relief of debtors. The term “Custodian” means any receiver, trustee, assignee, liquidator, custodian or similar official under any Bankruptcy Law. 
  
 A Default under clause (3) is not an Event of Default until the Trustee or
the Holders of at least 25% in principal amount of the outstanding Securities notify the Company of the Default and the Company does not cure such Default within the time specified after receipt of such notice. Such notice must specify the Default,
demand that it be remedied and state that such notice is a “Notice of Default”. 
  
 The Company shall deliver to the Trustee, within 30 days after the occurrence thereof, unless such Default shall have been cured or waived before giving of such notice, written notice in the form of an Officers’
Certificate of any Event of Default 

  

 21 

 
under clause (7) and any event which with the giving of notice or the lapse of time would become an Event of Default under clause (3), its status and what
action the Company is taking or proposes to take with respect thereto. 
  
 SECTION 6.02. Acceleration. If an Event of Default (other than an Event of Default specified in Section 6.01(5) or (6) with respect to the Company) occurs and is continuing, the Trustee by notice to the Company, or the Holders of at
least 25% in principal amount of the outstanding Securities by notice to the Company and the Trustee, may declare the principal of and accrued but unpaid interest on all the Securities to be due and payable. Upon such a declaration, such principal
and interest shall be due and payable immediately. If an Event of Default specified in Section 6.01(5) or (6) with respect to the Company occurs, the principal of and interest on all the Securities shall automatically become and be immediately due
and payable without any declaration or other act on the part of the Trustee or any Securityholders. The Holders of a majority in principal amount of the Securities by notice to the Trustee may rescind an acceleration and its consequences if the
rescission would not conflict with any judgment or decree already rendered and if all existing Events of Default have been cured or waived except nonpayment of principal or interest that has become due solely because of acceleration. Upon any such
rescission, the parties hereto shall be restored respectively to their several positions and rights hereunder, and all rights, remedies and powers of the parties hereto shall continue as though no proceeding had been taken. If the Trustee or any
Holder shall then proceed to enforce any right under this Indenture and such proceeding shall have been discontinued or abandoned because of such rescission or for any other reason or shall have been determined adversely to the Trustee or such
Holder, then in every such case the parties hereto shall be restored respectively to their several positions and rights hereunder, and all rights, remedies and powers of the parties hereto shall continue as though no such proceeding had been taken.
No such rescission shall affect any subsequent Default or impair any right consequent thereto. 
  
 SECTION 6.03. Other Remedies. If an Event of Default occurs and is continuing, the Trustee may pursue any available remedy to collect the payment of principal of or interest on the Securities or to enforce the
performance of any provision of the Securities or this Indenture. 
  
 The Trustee may maintain a proceeding even if it does not possess any of the Securities or does not produce any of them in the proceeding. A delay or omission by the Trustee or any Securityholder in exercising any right or remedy accruing
upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. No remedy is exclusive of any other remedy. All available remedies are cumulative. 
  
 SECTION 6.04. Waiver of Past Defaults. The Holders of a majority in
principal amount of the Securities by written notice to the Trustee (accompanied by a supporting Officers’ Certificate, if requested by the Trustee) may waive an existing Default or Event of Default, as the case may be, and its consequences
except (a) a Default or Event of Default, as the case may be, in the payment of the principal of or interest on a Security, (b) a Default or Event of Default, as the case may be, arising from the failure to 

  

 22 

 
redeem any Security when required pursuant to this Indenture or (c) a Default or Event of Default, as the case may be, in respect of a provision that under
Section 9.02 cannot be amended without the consent of each Securityholder affected. When a Default or Event of Default, as the case may be, is waived, it ceases to exist, and it is deemed cured, but no such waiver shall extend to any subsequent or
other Default or Event of Default, as the case may be, or impair any consequent right. 
  
 SECTION 6.05. Control by Majority. The Holders of a majority in principal amount of the Securities outstanding may direct the time, method and place of conducting any proceeding for exercising any remedy
available to the Trustee or of exercising any trust or power conferred on the Trustee. However, the Trustee may refuse to follow any direction that conflicts with law or this Indenture or, subject to Section 7.01, that the Trustee determines is
unduly prejudicial to the rights of other Securityholders or would involve the Trustee in personal liability; provided, however, that the Trustee may take any other action deemed proper by the Trustee that is not inconsistent with such
direction. Prior to taking any action hereunder, the Trustee shall be entitled to indemnification satisfactory to it in its sole discretion against any loss, liability or expense caused by taking or not taking such action. 
  
 SECTION 6.06. Limitation on Suits. Except to enforce the right to
receive payment of principal, premium (if any) or interest when due, no Securityholder may pursue any remedy with respect to this Indenture or the Securities unless: 
  
 (1) such Holder has given to the Trustee written notice stating that an Event of Default is continuing;

  
 (2) the Holders of at least 25% in principal
amount of the outstanding Securities have made a written request to the Trustee to pursue the remedy; 
  
 (3) such Holder or Holders have offered to the Trustee reasonable security or indemnity against any loss, liability or expense;

  
 (4) the Trustee has not complied with such
request within 60 days after receipt thereof and the offer of security or indemnity; and 
  
 (5) the Holders of a majority in principal amount of the outstanding Securities have not given the Trustee a direction inconsistent with
such request during such 60-day period. 
  
 A Securityholder may
not use this Indenture to prejudice the rights of another Securityholder or to obtain a preference or priority over another Securityholder. In the event that the Definitive Securities are not issued to any beneficial owner promptly after the
Registrar has received a request from the Holder of a Global Security to issue such Definitive Securities to such beneficial owner of its nominee, the Company expressly agrees and acknowledges, with respect to the right of any Holder to pursue a
remedy pursuant to this Indenture, the right of such beneficial holder of Securities to pursue such remedy with respect to the portion of the Global Security that represents such beneficial holder’s Securities as if such Definitive Securities
had been issued. 
  

 23 

 SECTION 6.07. Rights of Holders to Receive Payment. Notwithstanding any other provision of this
Indenture, the right of any Holder to receive payment of principal of and interest on the Securities held by such Holder, on or after the respective due dates expressed in the Securities, or to bring suit for the enforcement of any such payment on
or after such respective dates, shall not be impaired or affected without the consent of such Holder. 
  
 SECTION 6.08. Collection Suit by Trustee. If an Event of Default specified in Section 6.01(1) or (2) occurs and is continuing, the Trustee may
recover judgment in its own name and as trustee of an express trust against the Company for the whole amount then due and owing (together with interest on any unpaid interest to the extent lawful) and the amounts provided for in Section 7.07.

  
 SECTION 6.09. Trustee May File Proofs of Claim. The
Trustee may file such proofs of claim and other papers or documents as may be necessary or advisable in order to have the claims of the Trustee and the Securityholders allowed in any judicial proceedings relative to the Company, its creditors or its
property and, unless prohibited by law or applicable regulations, may vote on behalf of the Holders in any election of a trustee in bankruptcy or other Person performing similar functions, and any Custodian in any such judicial proceeding is hereby
authorized by each Holder to make payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for the reasonable compensation, expenses,
disbursements and advances of the Trustee, its agents and its counsel, and any other amounts due the Trustee under Section 7.07. 
  
 Priorities. If the Trustee collects any money or property pursuant to this Article 6, it shall pay out the money or property in the following
order: 
  
 FIRST: to the Trustee for amounts due
under Section 7.07; 
  
 SECOND: to
Securityholders for amounts due and unpaid on the Securities for principal and interest, ratably, without preference or priority of any kind, according to the amounts due and payable on the Securities for principal and interest, respectively; and

  
 THIRD: to the Company. 
  
 The Trustee may fix a record date and payment date for any payment to
Securityholders pursuant to this Section. At least 15 days before such record date, the Company shall mail to each Securityholder and the Trustee a notice that states the record date, the payment date and amount to be paid. 
  
 SECTION 6.10. Undertaking for Costs. In any suit for the enforcement
of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of
the suit, and the court in its discretion may assess reasonable costs, including reasonable attorneys’ fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims 

  

 24 

 
or defenses made by the party litigant. This Section does not apply to a suit by the Trustee, a suit by a Holder pursuant to Section 6.07 or a suit by
Holders of more than 10% in aggregate principal amount of the Securities. 
  
 SECTION 6.11. Waiver of Stay or Extension Laws. The Company (to the extent it may lawfully do so) shall not at any time insist upon, or plead, or in any manner whatsoever claim or take the benefit or advantage
of, any stay or extension law wherever enacted, now or at any time hereafter in force, which may affect the covenants or the performance of this Indenture; and the Company (to the extent that it may lawfully do so) hereby expressly waives all
benefit or advantage of any such law, and shall not hinder, delay or impede the execution of any power herein granted to the Trustee, but shall suffer and permit the execution of every such power as though no such law had been enacted. 

 
 ARTICLE 7 
  
 Trustee 
  
 SECTION 7.01. Duties of Trustee. (a) After an Event of Default has occurred and prior to its cure or waiver, the Trustee shall exercise the rights
and powers vested in it by this Indenture and use the same degree of care and skill in their exercise as a prudent Person would exercise or use under the circumstances in the conduct of such Person’s own affairs. 
  
 (b) Prior to the occurrence of an Event of Default and after the cure or
waiver thereof: 
  
 (1) the Trustee undertakes to
perform such duties and only such duties as are specifically set forth in this Indenture and no implied covenants or obligations shall be read into this Indenture against the Trustee; and 
  
 (2) in the absence of bad faith on its part, the Trustee may
conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture. However, the Trustee shall
examine the certificates and opinions to determine whether or not they conform to the requirements of this Indenture (but need not confirm or investigate the accuracy of mathematical calculations or other facts stated therein). 
  
 (c) The Trustee may not be relieved from liability for its own negligent
action, its own negligent failure to act or its own willful misconduct, except that: 
  
 (1) this paragraph does not limit the effect of paragraph (b) of this Section; 
  
 (2) the Trustee shall not be liable for any error of
judgment made in good faith by a Trust Officer unless it is proved that the Trustee was negligent in ascertaining the pertinent facts; and 
  

 25 

 (3) the Trustee shall not be liable with respect to any action it takes or omits to take
in good faith in accordance with a direction received by it pursuant to Section 6.05. 
  
 (d) Every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b), (c) and (g) of this Section. 
  
 (e) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with
the Company. 
  
 (f) Money held in trust by the Trustee need not
be segregated from other funds except to the extent required by law. 
  
 (g) No provision of this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur financial liability in the performance of any of its duties hereunder or in the exercise of any of its rights or powers, if it
shall have reasonable grounds to believe that repayment of such funds or adequate indemnity against such risk or liability is not reasonably assured to it. 
  
 (h) Every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee shall be subject to the
provisions of this Section and to the provisions of the TIA. 
  
 SECTION 7.02. Rights of Trustee. (a) The Trustee may conclusively rely on any document believed by it to be genuine and to have been signed or presented by the proper person. The Trustee need not investigate any fact or matter stated
in the document. 
  
 (b) Before the Trustee acts or refrains from
acting pursuant to any request, direction, order or demand of the Company made pursuant to the provisions of this Indenture, it may require an Officers’ Certificate or an Opinion of Counsel, except that in the case of any such request,
direction, order or demand as to which the furnishing of such document is specifically required by any provision of this Indenture relating to such particular request, direction, order or demand, no additional certificate or opinion need be
furnished. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officers’ Certificate or Opinion of Counsel. 
  
 (c) The Trustee may act through agents and shall not be responsible for the misconduct or negligence of any agent appointed
with due care. 
  
 (d) The Trustee shall not be liable for any
action it takes or omits to take in good faith which it believes to be authorized or within its rights or powers; provided, however, that the Trustee’s conduct does not constitute willful misconduct or negligence. 
  
 (e) The Trustee may consult with counsel, and the advice or opinion of
counsel with respect to legal matters relating to this Indenture and the Securities shall be full and complete authorization and protection from liability in respect to any action 

  

 26 

 
taken, omitted or suffered by it hereunder in good faith and in accordance with the advice or opinion of such counsel. 
  
 (f) The Trustee shall not be deemed to have notice of any Default or Event of
Default unless a Trust Officer has actual knowledge thereof or unless written notice of any event which is in fact such a Default or Event of Default is received by the Trustee, and such notice references the Securities and this Indenture.

  
 (g) The rights, privileges, protections, immunities and
benefits given to the Trustee, including its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and to each agent, custodian and other Person employed by the Trustee to act
hereunder. 
  
 SECTION 7.03. Individual Rights of Trustee.
The Trustee (or any of its Affiliates) in its individual or any other capacity may become the owner or pledgee of Securities and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. Any
Paying Agent, Registrar, co-registrar or co-paying agent may do the same with like rights. However, the Trustee must comply with Sections 7.10 and 7.11. 
  
 SECTION 7.04. Trustee’s Disclaimer. The Trustee shall not be responsible for and makes no representation as to the validity or adequacy of
this Indenture or the Securities, it shall not be accountable for the Company’s use of the proceeds from the Securities, and it shall not be responsible for any statement of the Company in the Indenture or in any document issued in connection
with the sale of the Securities or in the Securities other than the Trustee’s certificate of authentication. 
  
 SECTION 7.05. Notice of Defaults. If a Default occurs, is continuing and is known to the Trustee, the Trustee shall mail to each Securityholder
notice of the Default within 90 days after it is known to the Trustee, unless such Default shall have been cured or waived before giving of such notice. Except in the case of a Default in the payment of principal of or interest on any Security
(including payments pursuant to the mandatory redemption provisions of such Security, if any), the Trustee may withhold the notice if and so long as a committee of its Trust Officers in good faith determines that withholding the notice is not
opposed to the interests of the Securityholders. 
  
 SECTION 7.06.
Reports by Trustee to Holders. As promptly as practicable after each May 15 beginning with the May 15 following the date of this Indenture, and in any event prior to July 15 in each year, the Trustee shall mail to each Securityholder a brief
report dated as of May 15 that complies with TIA § 313(a). The Trustee also shall comply with TIA § 313(b). 
  
 A copy of each report at the time of its mailing to Securityholders shall be filed with the SEC and each securities exchange (if any) on which the
Securities are listed. The Company agrees to notify promptly the Trustee whenever the Securities become listed on any stock exchange and of any delisting thereof. 
  

 27 

 SECTION 7.07. Compensation and Indemnity. The Company shall pay to the Trustee from time to time
such compensation for its services as the Company and the Trustee shall from time to time agree in writing. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express trust. The Company shall reimburse
the Trustee upon request for all reasonable out-of-pocket disbursements, advances and expenses incurred or made by it in accordance with any of the provisions of this Indenture, including costs of collection, in addition to the compensation for its
services. Such expenses shall include the reasonable compensation and expenses, disbursements and advances of the Trustee’s agents, counsel, accountants and experts. The Company shall indemnify the Trustee against any and all loss, liability or
expense (including attorneys’ fees) incurred by it arising out of or in connection with the administration of this trust and the performance of its duties hereunder, including, without limitation, costs or expenses of defending itself against
any claim of liability (whether asserted by the Company or any Securityholder or any other Person) in connection with the exercise or performance of any of its powers or duties hereunder. The Trustee shall notify the Company promptly of any claim
for which it may seek indemnity. Failure by the Trustee to so notify the Company shall not relieve the Company of its obligations hereunder, except to the extent the Company has been materially prejudiced by such failure. The Company shall defend
the claim and the Trustee shall cooperate in the defense. The Trustee may have separate counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay any settlement made without its consent, which
consent shall not be unreasonably withheld. The Company need not reimburse any expense or indemnify against any loss, liability or expense incurred by the Trustee through the Trustee’s own willful misconduct, negligence or bad faith.

  
 To secure the Company’s payment obligations in this
Section, the Trustee shall have a lien prior to the Securities on all money or property held or collected by the Trustee other than money or property held in trust to pay principal of and interest on particular Securities. 
  
 The Company’s payment obligations pursuant to this Section shall survive
the discharge of this Indenture, any rejection or termination of this Indenture under any Bankruptcy Law or the resignation or removal of the Trustee. When the Trustee incurs expenses after the occurrence of a Default specified in Section 6.01(5) or
(6) with respect to the Company, the expenses are intended to constitute expenses of administration under the Bankruptcy Law. 
  
 SECTION 7.08. Replacement of Trustee. The Trustee may resign at any time by so notifying the Company. The Holders of a majority in principal amount
of the Securities may remove the Trustee by so notifying the Trustee and the Company in writing and may appoint a successor Trustee. The Company shall remove the Trustee if: 
  
 (1) the Trustee fails to comply with Section 7.10; 
  

 28 

 (2) the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered
with respect to the Trustee under any Bankruptcy Law or applicable receivership laws; 
  
 (3) a receiver, other public officer or Custodian takes charge of the Trustee or its property; or 
  
 (4) the Trustee otherwise becomes incapable of acting.

  
 In addition, the Company may remove the Trustee upon 60 days’ prior
written notice to the Trustee, with or without cause. 
  
 If the
Trustee resigns, is removed by the Company or by the Holders of a majority in principal amount of the Securities and such Holders do not reasonably promptly appoint a successor Trustee, or if a vacancy exists in the office of Trustee for any reason
(the Trustee in such event being referred to herein as the retiring Trustee), the Company shall promptly appoint a successor Trustee. 
  
 A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Thereupon the resignation or removal
of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to Securityholders at their last
known address as they appear on the Registrar’s books. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee, subject to the lien provided for in Section 7.07. 
  
 If a successor Trustee does not take office within 60 days after the retiring
Trustee resigns or is removed, the retiring Trustee or the Holders of 10% in principal amount of the Securities may petition any court of competent jurisdiction for the appointment of a successor Trustee. 
  
 If the Trustee fails to comply with Section 7.10, any Securityholder may
petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 
  
 Notwithstanding the replacement of the Trustee pursuant to this Section, the Company’s obligations under Section 7.07 shall continue for the benefit
of the retiring Trustee. 
  
 SECTION 7.09. Successor Trustee by
Merger. If the Trustee consolidates with, merges or converts into, or transfers all or substantially all its corporate trust business or assets to, another corporation or banking association, the resulting, surviving or transferee corporation
without any further act shall be the successor Trustee. 
  
 In
case at the time such successor or successors by merger, conversion or consolidation to the Trustee shall succeed to the trusts created by this Indenture any of the Securities shall have been authenticated but not delivered, any such successor to
the Trustee may adopt the certificate of authentication of any predecessor trustee, and deliver 

  

 29 

 
such Securities so authenticated; and in case at that time any of the Securities shall not have been authenticated, any successor to the Trustee may
authenticate such Securities either in the name of any predecessor hereunder or in the name of the successor to the Trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Securities or in this
Indenture provided that the certificate of the Trustee shall have. 
  
 SECTION 7.10. Eligibility; Disqualification. The Trustee shall at all times satisfy the requirements of TIA § 310(a). The Trustee shall have a combined capital and surplus of at least $50,000,000 as set forth in its most recent
published annual report of condition. The Trustee shall comply with TIA § 310(b); provided, however, that there shall be excluded from the operation of TIA § 310(b)(1) any indenture or indentures under which other securities
or certificates of interest or participation in other securities of the Company are outstanding if the requirements for such exclusion set forth in TIA § 310(b)(1) are met. 
  
 SECTION 7.11. Preferential Collection of Claims Against Company. The Trustee shall comply with TIA § 311(a),
excluding any creditor relationship listed in TIA § 311(b). A Trustee who has resigned or been removed shall be subject to TIA § 311(a) to the extent indicated. 
  
 ARTICLE 8 
  
 Discharge of Indenture; Defeasance 
  
 SECTION 8.01. Discharge of Liability on Securities; Defeasance. (a) When (1) the Company delivers to the Trustee all outstanding Securities (other
than Securities replaced or paid pursuant to Section 2.07) for cancelation or (2) all outstanding Securities not previously delivered to the Trustee for cancelation have or will become due and payable, whether at maturity or on a redemption date as
a result of the mailing of a notice of redemption pursuant to Article 3 hereof and, in the case of clause (2), the Company irrevocably deposits with the Trustee funds sufficient to pay at maturity or upon redemption all such outstanding Securities,
including interest thereon to maturity or such redemption date (other than Securities replaced or paid pursuant to Section 2.07), and if in either case the Company pays or has deposited for payment all other sums then payable hereunder by the
Company, then this Indenture shall, subject to Section 8.01(c), cease to be of further effect. The Trustee shall acknowledge satisfaction and discharge of this Indenture on demand of the Company accompanied by an Officers’ Certificate and an
Opinion of Counsel and at the cost and expense of the Company. 
  
 (b) Subject to Sections 8.01(c) and 8.02, the Company at any time may terminate (1) all its obligations under the Securities and this Indenture (“legal defeasance option”), and, subject to paragraph (c) of this Section, after
giving effect to such legal defeasance, the Holders of the Securities will not be entitled to the benefits of the Indenture, or (2) its obligations under Sections 4.02, 4.03, 4.04, 4.05, 4.06 and 4.07 and the operation of Sections 6.01(3) (to the
extent applicable to such defeased covenants), 6.01(4), 6.01(5), 6.01(6) and 6.01(7) (but, in the case of Sections 6.01(5) and (6), with 

  

 30 

 
respect only to Significant Subsidiaries) (“covenant defeasance option”). The Company may exercise its legal defeasance option notwithstanding its
prior exercise of its covenant defeasance option. 
  
 If the
Company exercises its legal defeasance option, payment of the Securities may not be accelerated because of an Event of Default with respect thereto. If the Company exercises its covenant defeasance option, payment of the Securities may not be
accelerated because of an Event of Default specified in Sections 6.01(3) (but only to the extent noted in the preceding paragraph), 6.01(4), 6.01(5), 6.01(6) and 6.01(7) (but, in the case of Sections 6.01(5) and (6), with respect only to Significant
Subsidiaries). If the Company exercises its legal defeasance option or its covenant defeasance option, each Subsidiary Guarantor, if any, shall be released from all its obligations with respect to its Subsidiary Guaranty. 
  
 Upon satisfaction of the conditions set forth herein and upon request of the
Company, the Trustee shall acknowledge in writing the discharge of those obligations that the Company terminates. 
  
 (c) Notwithstanding clauses (a) and (b) above, the Company’s obligations in Sections 2.03, 2.04, 2.05, 2.06, 2.07, 2.08, 7.07 and 7.08 and in this
Article 8 shall survive until the Securities have been paid in full. Thereafter, the Company’s obligations in Sections 7.07, 8.04 and 8.05 shall survive. 
  

SECTION 8.02. Conditions to Defeasance. The Company may exercise its legal defeasance option or its covenant defeasance option only if:

  
 (1) the Company irrevocably deposits in trust
with the Trustee money or U.S. Government Obligations, or a combination thereof, for the payment of principal of and interest on the Securities to maturity or redemption, as the case may be; 
  
 (2) the Company delivers to the Trustee a certificate from a
nationally recognized firm of independent accountants selected by the Company expressing their opinion that the payments of principal and interest when due and without reinvestment on the deposited U.S. Government Obligations plus any deposited
money without investment will provide cash at such times and in such amounts as will be sufficient to pay principal and interest when due on all the Securities to maturity or redemption, as the case may be; 
  
 (3) 123 days pass after the deposit is made and during the
123-day period no Default specified in Sections 6.01(5) or (6) with respect to the Company occurs which is continuing at the end of the period; 
  
 (4) the deposit does not constitute a default under any other agreement binding on the Company, other than a Default or an Event of
Default under this Indenture which results from the borrowing of funds to be applied to such deposit and the grant of any Lien securing such borrowings; 
  

 31 

 (5) the Company delivers to the Trustee an Opinion of Counsel to the effect that the
trust resulting from the deposit does not constitute, or is qualified as, a regulated investment company under the Investment Company Act of 1940; 
  
 (6) in the case of the legal defeasance option, the Company shall have delivered to the Trustee an Opinion of Counsel stating that (A) the
Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (B) since the date of this Indenture there has been a change in the applicable Federal income tax law, in either case to the effect that, and based
thereon such Opinion of Counsel shall confirm that, the Securityholders will not recognize income, gain or loss for Federal income tax purposes as a result of such defeasance and will be subject to Federal income tax on the same amounts, in the same
manner and at the same times as would have been the case if such defeasance had not occurred; 
  
 (7) in the case of the covenant defeasance option, the Company shall have delivered to the Trustee an Opinion of Counsel to the effect
that the Securityholders will not recognize income, gain or loss for Federal income tax purposes as a result of such covenant defeasance and will be subject to Federal income tax on the same amounts, in the same manner and at the same times as would
have been the case if such covenant defeasance had not occurred; and 
  
 (8) the Company delivers to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent to the defeasance and discharge of the Securities as contemplated by this
Article 8 have been complied with. 
  
 Before or after a deposit,
the Company may make arrangements satisfactory to the Trustee for the redemption of Securities at a future date in accordance with Article 3. 
  
 SECTION 8.03. Application of Trust Money. The Trustee shall hold in trust money or U.S. Government Obligations deposited with it pursuant to this
Article 8. It shall apply the deposited money and the money from U.S. Government Obligations through the Paying Agent and in accordance with this Indenture to the payment of principal of and interest on the Securities. 
  
 SECTION 8.04. Repayment to Company. The Trustee and the Paying Agent
shall promptly turn over to the Company upon written request any excess money or securities held by them at any time. 
  
 Subject to any applicable abandoned property law, the Trustee and the Paying Agent shall pay to the Company upon request any money held by them for the
payment of principal or interest that remains unclaimed for two years, and, thereafter, Securityholders entitled to the money must look to the Company for payment as general creditors. 
  

 32 

 SECTION 8.05. Indemnity for Government Obligations. The Company shall pay and shall indemnify the
Trustee against any tax, fee or other charge imposed on or assessed against deposited U.S. Government Obligations or the principal and interest received on such U.S. Government Obligations. 
  
 SECTION 8.06. Reinstatement. If the Trustee or Paying Agent is unable
to apply any money or U.S. Government Obligations in accordance with this Article 8 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such
application, the Company’s and each Subsidiary Guarantor’s obligations under this Indenture, each Subsidiary Guaranty and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to this Article 8 until
such time as the Trustee or Paying Agent is permitted to apply all such money or U.S. Government Obligations in accordance with this Article 8; provided, however, that, if the Company has made any payment of interest on or principal of any
Securities because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the money or U.S. Government Obligations held by the Trustee or Paying Agent.

  
 ARTICLE 9 
  
 Amendments 
  
 SECTION 9.01. Without Consent of Holders. The Company, the Subsidiary
Guarantors and the Trustee may amend this Indenture or the Securities without notice to or consent of any Securityholder: 
  
 (1) to cure any ambiguity, omission, defect or inconsistency; 
  
 (2) to comply with Article 5 or with the second proviso in Section 10.06; 
  
 (3) to provide for uncertificated Securities in addition to
or in place of certificated Securities; provided, however, that the uncertificated Securities are issued in registered form for purposes of Section 163(f) of the Code or in a manner such that the uncertificated Securities are described
in Section 163(f)(2)(B) of the Code; 
  
 (4) to
add guarantees with respect to the Securities, including any Subsidiary Guaranties, or to secure the Securities, or to release a Subsidiary Guarantor or a collateral security (or a portion thereby) as permitted by, and pursuant to the
provisions of, this Indenture; 
  
 (5) to add to
the covenants of the Company or any Subsidiary Guarantor for the benefit of the Holders or to surrender any right or power herein conferred upon the Company or any Subsidiary Guarantor; 
  
 (6) to comply with any requirements of the SEC in connection with qualifying, or maintaining the
qualification of, this Indenture under the TIA; 
  

 33 

 (7) to make any change that does not adversely affect the rights of any Securityholder
(and for the purpose of the foregoing, any change to this Indenture, the Securities or the Subsidiary Guaranties made to conform such documents, or any of them, to the descriptions thereof in the Offering Circular, dated May 19, 2005 in connection
with the initial issuance of the Securities shall be deemed not to adversely affect the rights of any Holder); 
  
 (8) to make any amendment to the provisions of this Indenture relating to the transfer and legending of Securities; provided,
however, that (a) compliance with this Indenture as so amended would not result in Securities being transferred in violation of the Securities Act or any other applicable securities law and (b) such amendment does not materially and adversely
affect the rights of Holders to transfer Securities. 
  
 After an
amendment under this Section becomes effective, the Company shall mail to Securityholders a notice briefly describing such amendment. The failure to give such notice to all Securityholders, or any defect therein, shall not impair or affect the
validity of an amendment under this Section. 
  
 SECTION 9.02.
With Consent of Holders. The Company, the Subsidiary Guarantors and the Trustee may amend this Indenture or the Securities with the written consent of the Holders of at least a majority in principal amount of the Securities then outstanding
(including consents obtained in connection with a tender offer or exchange for the Securities) and any past default or compliance with any provisions may also be waived with the consent of the Holders of at least a majority in principal amount of
the Securities then outstanding. However, without the consent of each Securityholder affected thereby, an amendment or waiver may not: 
  
 (1) reduce the principal amount of Securities whose Holders must consent to an amendment; 
  
 (2) reduce the rate of or extend the time for payment of
interest on any Security; 
  
 (3) reduce the
principal of or change the stated maturity of any Security; 
  
 (4) reduce the amount payable upon the redemption of any Security or change the time at which any Security may be redeemed, in each case, with respect to optional redemption, in Article 3 hereof or paragraph 5 of the
Securities; 
  
 (5) make any Security payable in
money other than that stated in the Security; 
  
 (6) impair the right of any Holder of the Securities to institute suit for the enforcement of any payment on or with respect to such Holder’s Securities; 
  

 34 

 (7) make any changes in the ranking or priority of any Security that would adversely
affect the Securityholders; 
  
 (8) make any
change in Section 6.04 or 6.07 or the second or third sentence of this Section; or 
  
 (9) release any Subsidiary Guarantor from its Subsidiary Guaranty other than in accordance with this Indenture or change any Subsidiary
Guaranty in a manner that would adversely affect the Securityholders. 
  
 In
addition, without the consent of Holders representing 90% of the principal amount of the Securities then outstanding, an amendment or waiver may not reduce the amount payable upon the redemption of any Security or change the time at which the
Securities must be redeemed, in each case as described in paragraph 6 of the Securities, or otherwise modify the provisions relating to special mandatory redemption described in paragraph 6 or 7 of the Securities or Section 3.03 of this Indenture.

  
 The consent of the Holders is not necessary under this Section
to approve the particular form of any proposed amendment, but it shall be sufficient if such consent approves the substance thereof. 
  
 After an amendment under this Section becomes effective, the Company shall mail to Securityholders a notice briefly describing such amendment. The failure
to give such notice to all Securityholders, or any defect therein, however, shall not impair or affect the validity of an amendment under this Section. 
  
 SECTION 9.03. Compliance with Trust Indenture Act. Every amendment to this Indenture or the Securities shall comply with the TIA as then in effect.

  
 SECTION 9.04. Revocation and Effect of Consents and
Waivers. A consent to an amendment or a waiver by a Holder of a Security shall bind the Holder and every subsequent Holder of that Security or portion of the Security that evidences the same debt as the consenting Holder’s Security, even if
notation of the consent or waiver is not made on the Security. However, any such Holder or subsequent Holder may revoke the consent or waiver as to such Holder’s Security or portion of the Security if the Trustee receives the notice of
revocation before the date the amendment or waiver becomes effective. After an amendment or waiver becomes effective, it shall bind every Securityholder. An amendment or waiver becomes effective upon the execution of such amendment or waiver by the
Trustee. 
  
 The Company may, but shall not be obligated to, fix a
record date for the purpose of determining the Securityholders entitled to give their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding
the immediately preceding paragraph, those Persons who were Securityholders at such record date (or their duly designated proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take
any such action, whether or not such Persons continue to be 

  

 35 

 
Holders after such record date. No such consent shall be valid or effective for more than 120 days after such record date. 
  
 SECTION 9.05. Notation on or Exchange of Securities. If an amendment
changes the terms of a Security, the Trustee may require the Holder of the Security to deliver it to the Trustee. The Trustee may place an appropriate notation on the Security regarding the changed terms and return it to the Holder. Alternatively,
if the Company or the Trustee so determines, the Company in exchange for the Security shall issue and the Trustee shall authenticate a new Security that reflects the changed terms. Failure to make the appropriate notation or to issue a new Security
shall not affect the validity of such amendment. 
  
 SECTION 9.06.
Trustee To Sign Amendments. The Trustee shall sign any amendment authorized pursuant to this Article 9 if the amendment does not adversely affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may but
need not sign it. In signing such amendment the Trustee shall be entitled to receive indemnity reasonably satisfactory to it and to receive, and (subject to Section 7.01) shall be fully protected in relying upon, an Officers’ Certificate and an
Opinion of Counsel stating that such amendment is authorized or permitted by this Indenture. 
  
 ARTICLE 10 
  
 Subsidiary
Guaranties 
  
 SECTION 10.01. Guaranties. Each
Subsidiary Guarantor hereby unconditionally and irrevocably guarantees, jointly and severally, to each Holder and to the Trustee and its successors and permitted assigns the full and punctual payment of principal of, premium (if any) and interest on
the Securities when due, whether at maturity, by acceleration, by redemption or otherwise, and all other monetary obligations of the Company under this Indenture and the Securities (the foregoing being hereinafter collectively called the
“Guaranteed Obligations”). Each Subsidiary Guarantor further agrees that the Guaranteed Obligations may be extended or renewed, in whole or in part, without notice or further assent from such Subsidiary Guarantor and that such Subsidiary
Guarantor will remain bound under this Article 10 notwithstanding any extension or renewal of any Guaranteed Obligation. 
  
 Each Subsidiary Guarantor waives presentation to, demand of, payment from and protest to the Company of any of the Guaranteed Obligations and also waives
notice of protest for nonpayment. Each Subsidiary Guarantor waives notice of any default under the Securities or the Guaranteed Obligations. The obligations of each Subsidiary Guarantor hereunder shall not be affected by (1) the failure of any
Holder or the Trustee to assert any claim or demand or to enforce any right or remedy against the Company or any other Person (including any Subsidiary Guarantor) under this Indenture, the Securities or any other agreement or otherwise; (2) any
extension or renewal of any thereof; (3) any rescission, waiver, amendment or modification of any of the terms or provisions of this Indenture, the Securities or any other agreement; (4) the release of any security held by any Holder or the Trustee
for the Guaranteed Obligations or any of them; 

  

 36 

 
(5) the failure of any Holder or the Trustee to exercise any right or remedy against any other guarantor of the Guaranteed Obligations; or (6) except as set
forth in Section 10.06, any change in the ownership of such Subsidiary Guarantor. 
  
 Each Subsidiary Guarantor further agrees that its Subsidiary Guaranty herein constitutes a guarantee of payment when due (and not a guarantee of collection) and waives any right to require that any resort be had by
any Holder or the Trustee to any security held for payment of the Guaranteed Obligations. 
  
 Except as expressly set forth in Sections 8.01(b), 10.02 and 10.06, the obligations of each Subsidiary Guarantor hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason,
including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense of setoff, counterclaim, recoupment or termination whatsoever or by reason of the invalidity, illegality or unenforceability of the
Guaranteed Obligations or otherwise. Without limiting the generality of the foregoing, the obligations of each Subsidiary Guarantor herein shall not be discharged or impaired or otherwise affected by the failure of any Holder or the Trustee to
assert any claim or demand or to enforce any remedy under this Indenture, the Securities or any other agreement, by any waiver or modification of any thereof, by any default, failure or delay, willful or otherwise, in the performance of the
obligations, or by any other act or thing or omission or delay to do any other act or thing which may or might in any manner or to any extent vary the risk of such Subsidiary Guarantor or would otherwise operate as a discharge of such Subsidiary
Guarantor as a matter of law or equity. 
  
 Each Subsidiary
Guarantor further agrees that its guarantee herein shall continue to be effective or be reinstated, as the case may be, if at any time payment, or any part thereof, of principal of or interest on any Guaranteed Obligation is rescinded or must
otherwise be restored by any Holder or the Trustee upon the bankruptcy or reorganization of the Company or otherwise. 
  
 In furtherance of the foregoing and not in limitation of any other right which any Holder or the Trustee has at law or in equity against any Subsidiary
Guarantor by virtue hereof, upon the failure of the Company to pay the principal of or interest on any Guaranteed Obligation when and as the same shall become due, whether at maturity, by acceleration, by redemption or otherwise, each Subsidiary
Guarantor hereby promises to and shall, upon receipt of written demand by the Trustee, forthwith pay, or cause to be paid, in cash or otherwise in immediately available funds, to the Holders or the Trustee an amount equal to the sum of (A) the
unpaid amount of such Guaranteed Obligations, (B) accrued and unpaid interest on such Guaranteed Obligations (but only to the extent not prohibited by law) and (C) all other monetary Guaranteed Obligations of the Company then due and owing to the
Holders and the Trustee. 
  
 Each Subsidiary Guarantor further
agrees that, as between it, on the one hand, and the Holders and the Trustee, on the other hand, (i) the maturity of the Guaranteed Obligations hereby may be accelerated as provided in Article 6 for the purposes of such Subsidiary Guarantor’s
Subsidiary Guaranty herein, notwithstanding 

  

 37 

 
any stay, injunction or other prohibition preventing such acceleration in respect of the Guaranteed Obligations guaranteed hereby, and (ii) in the event of
any declaration of acceleration of such Guaranteed Obligations as provided in Article 6, such Guaranteed Obligations (whether or not due and payable) shall forthwith become due and payable by such Subsidiary Guarantor for the purposes of this
Section. 
  
 Each Subsidiary Guarantor also agrees to pay any and
all costs and expenses (including reasonable attorneys’ fees) incurred by the Trustee or any Holder in enforcing any rights under this Section. 
  
 SECTION 10.02. Limitation on Liability. Any term or provision of this Indenture to the contrary notwithstanding, the maximum aggregate amount of
the Guaranteed Obligations guaranteed hereunder by any Subsidiary Guarantor shall not exceed the maximum amount that can be hereby guaranteed without rendering this Indenture, as it relates to such Subsidiary Guarantor, voidable under applicable law
relating to fraudulent conveyance or fraudulent transfer or similar laws affecting the rights of creditors generally. 
  
 SECTION 10.03. Successors and Assigns. This Article 10 shall be binding upon each Subsidiary Guarantor and its successors and assigns and shall
enure to the benefit of the successors and assigns of the Trustee and the Holders and, in the event of any transfer or assignment of rights by any Holder or the Trustee, the rights and privileges conferred upon that party in this Indenture and in
the Securities shall automatically extend to and be vested in such transferee or assignee, all subject to the terms and conditions of this Indenture. 
  
 SECTION 10.04. No Waiver. Neither a failure nor a delay on the part of either the Trustee or the Holders in exercising any right, power or
privilege under this Article 10 shall operate as a waiver thereof, nor shall a single or partial exercise thereof preclude any other or further exercise of any right, power or privilege. The rights, remedies and benefits of the Trustee and the
Holders herein expressly specified are cumulative and not exclusive of any other rights, remedies or benefits which either may have under this Article 10 at law, in equity, by statute or otherwise. 
  
 SECTION 10.05. Modification. No modification, amendment or waiver of
any provision of this Article 10, nor the consent to any departure by any Subsidiary Guarantor therefrom, shall in any event be effective unless the same shall be in writing and signed by the Trustee, and then such waiver or consent shall be
effective only in the specific instance and for the purpose for which given. No notice to or demand on any Subsidiary Guarantor in any case shall entitle such Subsidiary Guarantor to any other or further notice or demand in the same, similar or
other circumstances. 
  

 38 

 SECTION 10.06. Release of Subsidiary Guarantor. A Subsidiary Guarantor will be released from its
obligations under this Article 10 (other than any obligation that may have arisen under Section 10.07) 
  
 (1) upon the sale (including any sale pursuant to any exercise of remedies by a holder of Indebtedness of the Company or of such
Subsidiary Guarantor), transfer or other disposition (including by way of consolidation or merger) of a Subsidiary Guarantor, including the sale or disposition of Capital Stock of a Subsidiary Guarantor following which such Subsidiary Guarantor is
no longer a Subsidiary of the Company, 
  
 (2)
upon the sale, transfer or other disposition of all or substantially all the assets of such Subsidiary Guarantor, 
  
 (3) at such time as such Subsidiary Guarantor does not have any Indebtedness outstanding that would have required such Subsidiary
Guarantor to enter into a Guaranty Agreement pursuant to Section 4.04, whether or not it became a Subsidiary Guarantor by operation of Section 4.04, and the Company provides an Officers’ Certificate to the Trustee certifying that no such
Indebtedness is outstanding and that the Company elects to have such Subsidiary Guarantor released from this Article 10, 
  
 (4) upon legal defeasance or covenant defeasance of the Securities pursuant to Article 8, or if the Company’s obligations under this
Indenture are discharged in accordance with the terms of this Indenture, 
  
 (5) upon the liquidation or dissolution of such Subsidiary Guarantor, 
  
 (6) at such times as such Subsidiary Guarantor is or becomes an Excluded Subsidiary, or 
  
 (7) otherwise upon the full satisfaction of the
Company’s obligations under this Indenture; 
  
 provided, however, that in the case of clauses (1) and (2) above, such sale or other disposition is made to a Person other than the Company or a Subsidiary Guarantor; provided further, however, that in the case of a
sale or other disposition described in clauses (1) and (2) above to a resulting, surviving or transferee Person that would constitute a Subsidiary of the Company (other than an Excluded Subsidiary), such Person will expressly assume such Subsidiary
Guarantor’s obligations under its Subsidiary Guaranty. 
  
 At the request of
the Company, the Trustee shall execute and deliver an appropriate instrument evidencing such release. 
  
 SECTION 10.07. Contribution. Each Subsidiary Guarantor that makes a payment under its Subsidiary Guaranty shall be entitled upon payment in full of
all Guaranteed Obligations under this Indenture to a contribution from each other Subsidiary Guarantor in an amount equal to such other Subsidiary Guarantor’s pro rata portion of such payment based on the respective net assets of all the
Subsidiary Guarantors at the time of such payment determined in accordance with GAAP. 
  

 39 

 SECTION 10.08. Execution of Guaranty Agreement for Future Guarantors. Each Person so required
pursuant to Section 4.04 shall execute and deliver to the Trustee a Guaranty Agreement pursuant to which such Person shall become a Subsidiary Guarantor under this Article 10 and shall guarantee payment of the Securities. Concurrently with the
execution and delivery of such Guaranty Agreement, the Company shall deliver to the Trustee an Opinion of Counsel and an Officers’ Certificate to the effect that such Guaranty Agreement has been duly authorized, executed and delivered by such
Person and that, subject to the application of bankruptcy, insolvency, moratorium, fraudulent conveyance or transfer and other similar laws relating to creditors’ rights generally and to the principles of equity, whether considered in a
proceeding at law or in equity, the guarantee of such guarantor is a legal, valid and binding obligation of such guarantor, enforceable against such guarantor in accordance with its terms and/or to such other matters as the Trustee may reasonably
request. 
  
 ARTICLE 11 
  
 Miscellaneous 
  
 SECTION 11.01. Trust Indenture Act Controls. If any provision of this
Indenture limits, qualifies or conflicts with another provision which is required to be included in this Indenture by the TIA, the required provision shall control. 
  
 SECTION 11.02. Notices. Any notice or communication shall be in writing and delivered in person, mailed by
first-class mail or by a nationally recognized overnight air carrier providing next day delivery, addressed as follows: 
  
 if to the Company or any Subsidiary Guarantor: 
  
 Yellow Roadway Corporation 
 10990 Roe Avenue

 Overland Park, Kansas 66211 
 Telephone: (913) 696-6171 
 Facsimile:  (913) 696-6116 
  
 Attention of Daniel J. Churay, Esq. 
  

 40 

 if to the Trustee: 
  
 SunTrust Bank 
 Corporate Trust Administration 
 25 Park Place, 24th Floor 
 Atlanta, Georgia 30303-2900 
 Telephone: (404) 588-7093 
 Facsimile:
 (404) 588-7335 
  
 Attention of Felicia H. Powell

  
 The Company, any Subsidiary Guarantor or the Trustee by notice
to the other may designate additional or different addresses for subsequent notices or communications. 
  
 Any notice or communication mailed to a Securityholder shall be mailed to the Securityholder at the Securityholder’s address as it appears on the
registration books of the Registrar and shall be sufficiently given if so mailed within the time prescribed. 
  
 Failure to mail a notice or communication to a Securityholder or any defect in it shall not affect its sufficiency with respect to other Securityholders.
If a notice or communication is mailed in the manner provided above, it is duly given, whether or not the addressee receives it. 
  
 SECTION 11.03. Communication by Holders with Other Holders. Securityholders may communicate pursuant to TIA § 312(b) with other
Securityholders with respect to their rights under this Indenture or the Securities. The Company, any Subsidiary Guarantor, the Trustee, the Registrar and anyone else shall have the protection of TIA § 312(c). 
  
 SECTION 11.04. Certificate and Opinion as to Conditions Precedent.
Upon any request or application by the Company to the Trustee to take or refrain from taking any action under this Indenture, the Company shall furnish to the Trustee: 
  
 (1) an Officers’ Certificate in form and substance reasonably satisfactory to the Trustee stating that,
in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and 
  
 (2) an Opinion of Counsel in form and substance reasonably satisfactory to the Trustee stating that, in the opinion of such counsel, all
such conditions precedent have been complied with. 
  
 SECTION
11.05. Statements Required in Certificate or Opinion. Each certificate or opinion with respect to compliance with a covenant or condition provided for in this Indenture shall include: 
  
 (1) a statement that the individual making such certificate
or opinion has read such covenant or condition; 
  

 41 

 (2) a brief statement as to the nature and scope of the examination or investigation upon
which the statements or opinions contained in such certificate or opinion are based; 
  
 (3) a statement that, in the opinion of such individual, he has made such examination or investigation as is necessary to enable him to
express an informed opinion as to whether or not such covenant or condition has been complied with; and 
  
 (4) a statement as to whether or not, in the opinion of such individual, such covenant or condition has been complied with. 
  
 SECTION 11.06. When Securities Disregarded. In determining whether the
Holders of the required principal amount of Securities have concurred in any direction, waiver or consent, Securities owned by the Company or by any Person directly or indirectly controlling or controlled by or under direct or indirect common
control with the Company shall be disregarded and deemed not to be outstanding, except that, for the purpose of determining whether the Trustee shall be protected in relying on any such direction, waiver or consent, only Securities which the Trustee
knows are so owned shall be so disregarded. Also, subject to the foregoing, only Securities outstanding at the time shall be considered in any such determination. 
  
 SECTION 11.07. Rules by Trustee, Paying Agent and Registrar. The Trustee may make reasonable rules for action by or a
meeting of Securityholders. The Registrar and the Paying Agent may make reasonable rules for their functions. 
  
 SECTION 11.08. Legal Holidays. If a payment date is a Legal Holiday, payment shall be made on the next succeeding day that is not a Legal Holiday,
and no interest shall accrue for the intervening period. If a regular record date is a Legal Holiday, the record date shall not be affected. 
  
 SECTION 11.09. Governing Law. This Indenture and the Securities shall be governed by, and construed in accordance with, the laws of the State of
New York. 
  
 SECTION 11.10. No Recourse Against Others. No
past or future director, officer, employee, incorporator or owner of any Capital Stock, as such, of the Company or any Subsidiary Guarantor shall have any liability for any obligations of the Company under the Securities or this Indenture or of such
Subsidiary Guarantor under its Subsidiary Guaranty or this Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Security, each Securityholder waives and releases all such liability.
The waiver and release are part of the consideration for the issue of the Securities. 
  

 42 

 SECTION 11.11. Successors. All agreements of the Company in this Indenture and the Securities
shall bind its successors. All agreements of the Trustee in this Indenture shall bind its successors. 
  
 SECTION 11.12. Multiple Originals. The parties may sign any number of copies of this Indenture, and copies of this Indenture may be separately
executed by the different parties hereto in separate counterparts. Each signed copy shall be an original, but all of them together represent the same agreement. One signed copy is enough to prove this Indenture. 
  
 SECTION 11.13. Table of Contents; Headings. The table of contents,
cross-reference sheet and headings of the Articles and Sections of this Indenture have been inserted for convenience of reference only, are not intended to be considered a part hereof and shall not modify or restrict any of the terms or provisions
hereof. 
  
 (signatures follow) 
  

 43 

 IN WITNESS WHEREOF, the parties have caused this Indenture to be duly executed and delivered as of the
date first written above. 
  

					
	YELLOW ROADWAY CORPORATION,
		
	By	 	 
	 	 	 Name:
	 	 
	 	 	 Title:
	 	 
	
	SUBSIDIARY GUARANTORS,
	
	ROADWAY LLC
	ROADWAY EXPRESS, INC.
	ROADWAY NEXT DAY CORPORATION
	YELLOW TRANSPORTATION, INC.
	YELLOW RELOCATION SERVICES, INC.
	YELLOW ROADWAY TECHNOLOGIES, INC.
	MIQ LLC
	MERIDIAN IQ, INC.
	GLOBE.COM LINES, INC.
	MISSION SUPPLY COMPANY
		
	By	 	 
	 	 	 Name:
	 	Brenda Landry
	 	 	 Title:
	 	Vice President and Assistant Secretary

  

					
	SUNTRUST BANK,
		
	By	 	 
	 	 	 Name:
	 	 
	 	 	 Title:
	 	 

  

 2 

  
 RULE 144A/REGULATION S
APPENDIX 
  
 PROVISIONS RELATING TO INITIAL SECURITIES,

 PRIVATE EXCHANGE SECURITIES 
 AND EXCHANGE SECURITIES 
  

	 	1.	Definitions 

  
 1.1 Definitions 
  
 For the
purposes of this Appendix the following terms shall have the meanings indicated below: 
  
 “Applicable Procedures” means, with respect to any transfer or transaction involving a Temporary Regulation S Global Security or beneficial interest therein, the rules and procedures of the Depository for
such a Temporary Regulation S Global Security, to the extent applicable to such transaction and as in effect from time to time. 
  
 “Definitive Security” means a certificated Initial Security or Exchange Security or Private Exchange Security, in each case, registered in the
name of the Holder thereof, issued in accordance with the applicable provision of Section 2 and bearing, if required, the appropriate restricted securities legend set forth in Section 2.3(e). 
  
 “Depository” means The Depository Trust Company, its nominees and
their respective successors. 
  
 “Distribution Compliance
Period”, with respect to any Securities represented by the Temporary Regulation S Global Security, means the period of 40 consecutive days beginning on and including the later of (i) the day on which such Securities are first offered to Persons
other than distributors (as defined in Regulation S under the Securities Act) in reliance on Regulation S and (ii) the issue date with respect to such Securities. 
  
 “Exchange Securities” means (1) the Senior Floating Rate Notes Due 2008 issued pursuant to the Indenture in
connection with a Registered Exchange Offer pursuant to a Registration Rights Agreement and (2) Additional Securities, if any, issued pursuant to a registration statement filed with the SEC under the Securities Act. 
  
 “IAI” means an institutional “accredited investor”, as
defined in Rule 501(a)(1), (2), (3) and (7) of Regulation D under the Securities Act. 
  
 “Initial Purchasers” means (1) with respect to the Initial Securities issued on the Issue Date, Credit Suisse First Boston LLC, J.P. Morgan Securities Inc., Banc of America Securities LLC, Piper Jaffray
& Co. and Wachovia Capital Markets, LLC and (2) with respect to each issuance of Additional Securities, the Persons purchasing such Additional Securities under the related Purchase Agreement. 
  
 “Initial Securities” means (1) $150,000,000 aggregate principal
amount of Senior Floating Rate Notes Due 2008 issued on the Issue Date and (2) Additional 

  

 
Securities, if any, issued in a transaction exempt from the registration requirements of the Securities Act. 
  
 “Private Exchange” means the offer by the Company, pursuant to a
Registration Rights Agreement, to the Initial Purchasers to issue and deliver to each Initial Purchaser, in exchange for the Initial Securities held by the Initial Purchaser as part of its initial distribution, a like aggregate principal amount of
Private Exchange Securities. 
  
 “Private Exchange
Securities” means any Senior Floating Rate Notes Due 2008 issued in connection with a Private Exchange. 
  
 “Purchase Agreement” means (1) with respect to the Initial Securities issued on the Issue Date, the Purchase Agreement dated May 18,
2005, among the Company and the Initial Purchasers, and (2) with respect to each issuance of Additional Securities, the purchase agreement or underwriting agreement among the Company and the Persons purchasing such Additional Securities. 

 
 “QIB” means a “qualified institutional buyer” as
defined in Rule 144A. 
  
 “Registered Exchange Offer”
means the offer by the Company, pursuant to a Registration Rights Agreement, to certain Holders of Initial Securities, to issue and deliver to such Holders, in exchange for the Initial Securities, a like aggregate principal amount of Exchange
Securities registered under the Securities Act. 
  
 “Registration Rights Agreement” means (1) with respect to the Initial Securities issued on the Issue Date, the Registration Rights Agreement dated May 24, 2005, among the Company and the Initial Purchasers and (2) with respect to
each issuance of Additional Securities issued in a transaction exempt from the registration requirements of the Securities Act, the registration rights agreement, if any, among the Company and the Persons purchasing such Additional Securities under
the related Purchase Agreement. 
  
 “Rule 144A
Securities” means all Securities offered and sold to QIBs in reliance on Rule 144A. 
  
 “Securities” means the Initial Securities, the Exchange Securities and the Private Exchange Securities, treated as a single class. 
  
 “Securities Custodian” means the custodian with respect to a Global Security (as appointed by the Depository), or
any successor Person thereto and shall initially be the Trustee. 
  
 “Shelf Registration Statement” means the registration statement issued by the Company in connection with the offer and sale of Initial Securities or Private Exchange Securities pursuant to a Registration Rights Agreement.

  

 2 

 “Transfer Restricted Securities” means Securities that bear or are required to bear the legend
relating to restrictions on transfer relating to the Securities Act set forth in Section 2.3(e) hereto. 
  
 1.2 Other Definitions 
  

			
	 Term

	  	Defined in
Section:

	 “Agent Members”
	  	2.1(b)
	 “Global Securities”
	  	2.1(a)
	 “IAI Global Security”
	  	2.1(a)
	 “Permanent Regulation S Global Security”
	  	2.1(a)
	 “Regulation S”
	  	2.1(a)
	 “Regulation S Global Security”
	  	2.1(a)
	 “Rule 144A”
	  	2.1(a)
	 “Rule 144A Global Security”
	  	2.1(a)
	 “Temporary Regulation S Global Security”
	  	2.1(a)

  
 1.3 Other Terms and
Rules of Construction. Capitalized terms used and not otherwise defined in this Appendix shall have the meanings assigned in the Indenture of which the Appendix is a part, and in which it is incorporated by reference, and to which reference is
further made for rules of construction with respect to this Appendix, except as follows: 
  
 (1) references to Sections, Exhibits and the like in this Appendix means Sections in, and Exhibits and the like to, this Appendix; and

  
 (2) the terms “hereto”,
“hereunder”, “hereof” and words of similar import used in this Appendix refer to this Appendix. 
  

	 	2.	The Securities. 

  
 2.1 (a) Form and Dating. The Initial Securities will be offered and sold by the Company pursuant to a Purchase Agreement. The Initial Securities
will be resold initially only to (i) QIBs in reliance on Rule 144A under the Securities Act (“Rule 144A”) and (ii) Persons other than U.S. Persons (as defined in Regulation S) in reliance on Regulation S under the Securities Act
(“Regulation S”). Initial Securities may thereafter be transferred to, among others, QIBs, IAIs and purchasers in reliance on Regulation S, subject to the restrictions on transfer set forth herein. Initial Securities initially resold
pursuant to Rule 144A shall be issued initially in the form of one or more permanent global Securities in definitive, fully registered form (collectively, the “Rule 144A Global Security”); Initial Securities transferred to IAIs shall be
issued initially in the form of one or more permanent global Securities in definitive, fully registered form (collectively, the “IAI Global Security”); and Initial Securities initially resold pursuant to Regulation S shall be issued
initially in the form of one or more temporary global securities in fully registered form (collectively, the “Temporary Regulation S Global Security”), in each case without interest coupons and with the global 

  

 3 

 
securities legend and the applicable restricted securities legend set forth in Exhibit 1 hereto, which shall be deposited on behalf of the purchasers of the
Initial Securities represented thereby with the Securities Custodian and registered in the name of the Depository or a nominee of the Depository, duly executed by the Company and authenticated by the Trustee as provided in this Indenture.

  
 Except as set forth in this Section 2.1(a), beneficial
ownership interests in the Temporary Regulation S Global Security will not be exchangeable for interests in the Rule 144A Global Security, the IAI Global Security, a permanent global security (the “Permanent Regulation S Global Security”,
and together with the Temporary Regulation S Global Security, the “Regulation S Global Security”) or any other Security prior to the expiration of the Distribution Compliance Period and then, after the expiration of the Distribution
Compliance Period, may be exchanged for interests in a Rule 144A Global Security, an IAI Global Security or the Permanent Regulation S Global Security only upon certification in form and substance reasonably satisfactory to the Trustee that (i)
beneficial ownership interests in such Temporary Regulation S Global Security are owned either by non-U.S. persons or U.S. persons who purchased such interests in a transaction that did not require registration under the Securities Act, (ii) in the
case of an exchange for an IAI Global Security, certification that the interest in the Temporary Regulation S Global Security is being transferred to an IAI under the Securities Act that is an institutional accredited investor acquiring the
securities for its own account or for the account of an IAI or pursuant to another exemption from the registration requirements under the Securities Act which is accompanied by an opinion of counsel regarding the availability of such exemption, and
in either such case, such transfer being made in accordance with applicable securities laws of any State of the United States or any other jurisdiction and (iii) in the case of an exchange for an interest in a Rule 144A Global Security,
certification that the interest in the Temporary Regulation S Global Security is being made to a Person whom the transferor reasonably believes is a QIB in a transaction meeting the requirements of Rule 144A or pursuant to another exemption from the
registration requirements under the Securities Act which is accompanied by an opinion of counsel regarding the availability of such exemption. 
  
 Beneficial interests in IAI Global Securities may be exchanged for interests in Rule 144A Global Securities if (1) such exchange occurs in connection with
a transfer of Securities in compliance with Rule 144A and (2) the transferor of the beneficial interest in the IAI Global Security first delivers to the Trustee a written certificate (in form and substance reasonably satisfactory to the Trustee) to
the effect that the beneficial interest in the IAI Global Security is being transferred to a Person (a) who the transferor reasonably believes to be a QIB, (b) purchasing for its own account or the account of a QIB in a transaction meeting the
requirements of Rule 144A, and (c) in accordance with all applicable securities laws of the States of the United States and other jurisdictions. 
  
 Beneficial interests in Rule 144A Global Securities may be exchanged for an interest in IAI Global Securities if (1) such exchange occurs in connection
with a transfer of the securities in compliance with an exemption under the Securities Act and (2) the transferor of the Rule 144A Global Security first delivers to the Trustee a written 

  

 4 

 
certificate (substantially in the form of Exhibit 2) to the effect that (A) the Rule 144A Global Security is being transferred (a) to an “accredited
investor” within the meaning of 501(a)(1),(2),(3) and (7) under the Securities Act that is an institutional “accredited investor” acquiring the securities for its own account or for the account of such an institutional accredited
investor, in each case in a minimum principal amount of the securities of $250,000, for investment purposes and not with a view to or for offer or sale in connection with any distribution in violation of the Securities Act and (B) in accordance with
all applicable securities laws of the States of the United States and other jurisdictions. 
  
 Beneficial interests in a Rule 144A Global Security or an IAI Global Security may be transferred to a Person who takes delivery in the form of an interest in a Regulation S Global Security, whether before or after the
expiration of the Distribution Compliance Period, only if the transferor first delivers to the Trustee a written certificate (in the form provided in the Indenture) to the effect that such transfer is being made in accordance with Rule 903 or 904 of
Regulation S or Rule 144 (if applicable). 
  
 The Rule 144A Global
Security, the IAI Global Security, the Temporary Regulation S Global Security and the Permanent Regulation S Global Security are collectively referred to herein as “Global Securities”. The aggregate principal amount of the Global
Securities may from time to time be increased or decreased by adjustments made on the records of the Trustee and the Depository or its nominee as hereinafter provided. 
  
 (b) Book-Entry Provisions. This Section 2.1(b) shall apply only to a Global Security deposited with or on behalf of
the Depository. 
  
 The Company shall execute and the Trustee
shall, in accordance with this Section 2.1(b), authenticate and deliver initially one or more Global Securities that (a) shall be registered in the name of the Depository for such Global Security or Global Securities or the nominee of such
Depository and (b) shall be delivered by the Trustee to such Depository or pursuant to such Depository’s instructions or held by the Trustee as custodian for the Depository. 
  
 Members of, or participants in, the Depository (“Agent Members”) shall have no rights under this Indenture with
respect to any Global Security held on their behalf by the Depository or by the Trustee as the custodian of the Depository or under such Global Security, and the Company, the Trustee and any agent of the Company or the Trustee shall be entitled to
treat the Depository as the absolute owner of such Global Security for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to any
written certification, proxy or other authorization furnished by the Depository or impair, as between the Depository and its Agent Members, the operation of customary practices of such Depository governing the exercise of the rights of a holder of a
beneficial interest in any Global Security. 
  

 5 

 (c) Definitive Securities. Except as provided in this Section 2.1 or Section 2.3 or 2.4, owners of
beneficial interests in Global Securities shall not be entitled to receive physical delivery of Definitive Securities. 
  
 2.2 Authentication. The Trustee shall authenticate and deliver: (1) on the Issue Date, an aggregate principal amount of $150,000,000 million Senior
Floating Rate Notes Due 2008, (2) any Additional Securities for an original issue in an aggregate principal amount specified in the written order of the Company pursuant to Section 2.02 of the Indenture and (3) Exchange Securities or Private
Exchange Securities for issue only in a Registered Exchange Offer or a Private Exchange, respectively, pursuant to a Registration Rights Agreement, for a like principal amount of Initial Securities, in each case upon a written order of the Company
signed by two Officers or by an Officer and either an Assistant Treasurer or an Assistant Secretary of the Company. Such order shall specify the amount of the Securities to be authenticated and the date on which the original issue of Securities is
to be authenticated. 
  
 2.3 Transfer and Exchange.

  
 (a) Transfer and Exchange of Definitive Securities.
When Definitive Securities are presented to the Registrar with a request: 
  

	 	(x)	to register the transfer of such Definitive Securities; or 

  

	 	(y)	to exchange such Definitive Securities for an equal principal amount of Definitive Securities of other authorized denominations, 

  
 the Registrar shall register the transfer or make the exchange as requested if its reasonable
requirements for such transaction are met; provided, however, that the Definitive Securities surrendered for transfer or exchange: 
  
 (i) shall be duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the
Registrar, duly executed by the Holder thereof or its attorney duly authorized in writing; and 
  
 (ii) if such Definitive Securities are required to bear a restricted securities legend, they are being transferred or exchanged pursuant
to an effective registration statement under the Securities Act, pursuant to Section 2.3(b) or pursuant to clause (A), (B) or (C) below, and are accompanied by the following additional information and documents, as applicable: 
  
 (A) if such Definitive Securities are being delivered to the
Registrar by a Holder for registration in the name of such Holder, without transfer, a certification from such Holder to that effect; or 
  
 (B) if such Definitive Securities are being transferred to the Company, a certification to that effect; or 
  

 6 

 (C) if such Definitive Securities are being transferred (x) pursuant to an exemption from
registration in accordance with Rule 144A, Regulation S or Rule 144 under the Securities Act; or (y) in reliance upon another exemption from the requirements of the Securities Act: (i) a certification to that effect (in the form set forth on the
reverse of the Security) and (ii) if the Company so requests, an opinion of counsel or other evidence reasonably satisfactory to it as to the compliance with the restrictions set forth in the legend set forth in Section 2.3(e)(i). 
  
 (b) Restrictions on Transfer of a Definitive Security for a Beneficial
Interest in a Global Security. A Definitive Security may not be exchanged for a beneficial interest in a Rule 144A Global Security, an IAI Global Security or a Permanent Regulation S Global Security except upon satisfaction of the requirements
set forth below. Upon receipt by the Trustee of a Definitive Security, duly endorsed or accompanied by appropriate instruments of transfer, in form satisfactory to the Trustee, together with: 
  
 (i) certification, in the form set forth on the reverse of
the Security, that such Definitive Security is either (A) being transferred to a QIB in accordance with Rule 144A, (B) being transferred to an IAI or (C) being transferred after expiration of the Distribution Compliance Period by a Person who
initially purchased such Security in reliance on Regulation S to a buyer who elects to hold its interest in such Security in the form of a beneficial interest in the Permanent Regulation S Global Security; and 
  
 (ii) written instructions directing the Trustee to make, or
to direct the Securities Custodian to make, an adjustment on its books and records with respect to such Rule 144A Global Security (in the case of a transfer pursuant to clause (b)(i)(A)), IAI Global Security (in the case of a transfer pursuant to
clause (b)(1)(B)) or Permanent Regulation S Global Security (in the case of a transfer pursuant to clause (b)(i)(B)) to reflect an increase in the aggregate principal amount of the Securities represented by the Rule 144A Global Security, IAI Global
Security or Permanent Regulation S Global Security, as applicable, such instructions to contain information regarding the Depository account to be credited with such increase, 
  
 then the Trustee shall cancel such Definitive Security and cause, or direct the Securities Custodian to cause, in accordance with the
standing instructions and procedures existing between the Depository and the Securities Custodian, the aggregate principal amount of Securities represented by the Rule 144A Global Security, IAI Global Security or Permanent Regulation S Global
Security, as applicable, to be increased by the aggregate principal amount of the Definitive Security to be exchanged and shall credit or cause to be credited to the account of the Person specified in such instructions a beneficial interest in the
Rule 144A Global Security, IAI Global Security or Permanent Regulation S Global Security, as applicable, equal to the principal amount of the Definitive Security so canceled. If no Rule 144A Global Securities, IAI Global Securities or Permanent
Regulation S Global Securities, as applicable, are then outstanding, the Company shall 

  

 7 

 
issue and the Trustee shall authenticate, upon written order of the Company in the form of an Officers’ Certificate of the Company, a new Rule 144A
Global Security, IAI Global Security or Permanent Regulation S Global Security, as applicable, in the appropriate principal amount. 
  
 (c) Transfer and Exchange of Global Securities. 
  
 (i) The transfer and exchange of Global Securities or beneficial interests therein shall be effected through the Depository, in accordance
with this Indenture (including applicable restrictions on transfer set forth herein, if any) and the procedures of the Depository therefor. A transferor of a beneficial interest in a Global Security shall deliver to the Registrar a written order
given in accordance with the Depository’s procedures containing information regarding the participant account of the Depository to be credited with a beneficial interest in the Global Security. The Registrar shall, in accordance with such
instructions instruct the Depository to credit to the account of the Person specified in such instructions a beneficial interest in the Global Security and to debit the account of the Person making the transfer the beneficial interest in the Global
Security being transferred. 
  
 (ii) If the
proposed transfer is a transfer of a beneficial interest in one Global Security to a beneficial interest in another Global Security, the Registrar shall reflect on its books and records the date and an increase in the principal amount of the Global
Security to which such interest is being transferred in an amount equal to the principal amount of the interest to be so transferred, and the Registrar shall reflect on its books and records the date and a corresponding decrease in the principal
amount of the Global Security from which such interest is being transferred. 
  
 (iii) Notwithstanding any other provisions of this Appendix (other than the provisions set forth in Section 2.4), a Global Security may not be transferred as a whole except by the Depository to a nominee of the
Depository or by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or any such nominee to a successor Depository or a nominee of such successor Depository. 
  
 (iv) In the event that the Global Security is exchanged for
Definitive Securities pursuant to Section 2.4 of this Appendix, prior to the consummation of a Registered Exchange Offer or the effectiveness of a Shelf Registration Statement with respect to such Securities, such Securities may be exchanged only in
accordance with such procedures as are substantially consistent with the provisions of this Section 2.3 (including the certification requirements set forth on the reverse of the Initial Securities intended to ensure that such transfers comply with
Rule 144A, Regulation S or another applicable exemption under the Securities Act, as the case may be) and such other procedures as may from time to time be adopted by the Company. 
  

 8 

 (d) Restrictions on Transfer of Temporary Regulation S Global Securities. During the Distribution
Compliance Period, beneficial ownership interests in Temporary Regulation S Global Securities may only be sold, pledged or transferred in accordance with the Applicable Procedures and only (i) to the Company, (ii) in an offshore transaction in
accordance with Regulation S (other than a transaction resulting in an exchange for an interest in a Permanent Regulation S Global Security), (iii) pursuant to an effective registration statement under the Securities Act, in each case in accordance
with any applicable securities laws of any State of the United States. 
  
 (e) Legend. 
  
 (i) Except as
permitted by the following paragraphs (ii), (iii) and (iv), each Security certificate evidencing the Global Securities (and all Securities issued in exchange therefor or in substitution thereof), in the case of Securities offered otherwise than in
reliance on Regulation S shall bear a legend in substantially the following form: 
  
 THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THIS SECURITY MAY NOT
BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THIS SECURITY IS HEREBY NOTIFIED THAT THE SELLER OF THIS SECURITY MAY BE RELYING ON THE EXEMPTION FROM THE
PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. 
  
 THE HOLDER OF THIS SECURITY AGREES FOR THE BENEFIT OF THE COMPANY THAT (A) THIS SECURITY MAY BE OFFERED, RESOLD, PLEDGED OR OTHERWISE TRANSFERRED, ONLY (I) TO THE COMPANY, (II) IN THE UNITED STATES TO A PERSON WHOM
THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (III) OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION IN ACCORDANCE
WITH RULE 904 UNDER THE SECURITIES ACT, (IV) TO AN INSTITUTIONAL “ACCREDITED INVESTOR” WITHIN THE MEANING OF RULE 501(A)(1),(2),(3) OR (7) UNDER THE SECURITIES ACT THAT IS NOT A QUALIFIED INSTITUTIONAL BUYER THAT IS PURCHASING FOR ITS OWN
ACCOUNT OF ANOTHER INSTITUTIONAL ACCREDITED INVESTOR, IN 

  

 9 

 
EACH CASE IN A MINIMUM PRINCIPAL AMOUNT OF $250,000 (V) PURSUANT TO EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF
AVAILABLE) OR (VI) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH OF CASES (I) THROUGH (VI) IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND (B) THE HOLDER WILL, AND EACH
SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER OF THIS SECURITY FROM IT OF THE RESALE RESTRICTIONS REFERRED TO IN (A) ABOVE. 
  
 Each certificate evidencing a Security offered in reliance on Regulation S shall, in addition to the foregoing, bear a legend in
substantially the following form: 
  
 THIS SECURITY (OR ITS
PREDECESSOR) WAS ORIGINALLY ISSUED IN A TRANSACTION ORIGINALLY EXEMPT FROM REGISTRATION UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE TRANSFERRED IN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR
BENEFIT OF, ANY U.S. PERSON EXCEPT PURSUANT TO AN AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND ALL APPLICABLE STATE SECURITIES LAWS. TERMS USED ABOVE HAVE THE MEANINGS GIVEN TO THEM IN REGULATION S UNDER THE
SECURITIES ACT. 
  
 Each Definitive Security
shall also bear the following additional legend: 
  
 IN
CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS.

  
 (ii) Upon any sale or transfer of a Transfer
Restricted Security (including any Transfer Restricted Security represented by a Global Security) pursuant to Rule 144 under the Securities Act, the Registrar shall permit the transferee thereof to exchange such Transfer Restricted Security for a
certificated Security that does not bear the legend set forth above and rescind any restriction on the transfer of such Transfer Restricted Security, if the transferor thereof certifies in writing to the Registrar that such sale or transfer was made
in reliance on Rule 144 (such certification to be in the form set forth on the reverse of the Security). 
  

 10 

 (iii) After a transfer of any Initial Securities or Private Exchange Securities pursuant
to and during the period of the effectiveness of a Shelf Registration Statement with respect to such Initial Securities or Private Exchange Securities, as the case may be, all requirements pertaining to legends on such Initial Security or such
Private Exchange Security will cease to apply, the requirements requiring any such Initial Security or such Private Exchange Security issued to certain Holders be issued in global form will cease to apply, and a certificated Initial Security or
Private Exchange Security or an Initial Security or Private Exchange Security in global form, in each case without restrictive transfer legends, will be available to the transferee of the Holder of such Initial Securities or Private Exchange
Securities upon exchange of such transferring Holder’s certificated Initial Security or Private Exchange Security or directions to transfer such Holder’s interest in the Global Security, as applicable. 
  
 (iv) Upon the consummation of a Registered Exchange Offer
with respect to the Initial Securities, all requirements pertaining to such Initial Securities that Initial Securities issued to certain Holders be issued in global form will still apply with respect to Holders of such Initial Securities that do not
exchange their Initial Securities, and Exchange Securities in certificated or global form, in each case without the restricted securities legend set forth in Exhibit 1 hereto will be available to Holders that exchange such Initial Securities in such
Registered Exchange Offer. 
  
 (v) Upon the
consummation of a Private Exchange with respect to the Initial Securities, all requirements pertaining to such Initial Securities that Initial Securities issued to certain Holders be issued in global form will still apply with respect to Holders of
such Initial Securities that do not exchange their Initial Securities, and Private Exchange Securities in global form with the global securities legend and the applicable restricted securities legend set forth in Exhibit 1 hereto will be available
to Holders that exchange such Initial Securities in such Private Exchange. 
  
 (f) Cancellation or Adjustment of Global Security. At such time as all beneficial interests in a Global Security have either been exchanged for Definitive Securities, redeemed, purchased or canceled, such
Global Security shall be returned to the Depository for cancellation or retained and canceled by the Trustee. At any time prior to such cancellation, if any beneficial interest in a Global Security is exchanged for certificated Securities, redeemed,
purchased or canceled, the principal amount of Securities represented by such Global Security shall be reduced and an adjustment shall be made on the books and records of the Trustee (if it is then the Securities Custodian for such Global Security)
with respect to such Global Security, by the Trustee or the Securities Custodian, to reflect such reduction. 
  
 (g) No Obligation of the Trustee. 
  
 (i) The Trustee shall have no responsibility or obligation to any beneficial owner of a Global Security, a member of, or a participant in
the Depository or 

  

 11 

 
other Person with respect to the accuracy of the records of the Depository or its nominee or of any participant or member thereof, with respect to any
ownership interest in the Securities or with respect to the delivery to any participant, member, beneficial owner or other Person (other than the Depository) of any notice (including any notice of redemption) or the payment of any amount, under or
with respect to such Securities. All notices and communications to be given to the Holders and all payments to be made to Holders under the Securities shall be given or made only to or upon the order of the registered Holders (which shall be the
Depository or its nominee in the case of a Global Security). The rights of beneficial owners in any Global Security shall be exercised only through the Depository subject to the applicable rules and procedures of the Depository. The Trustee may rely
and shall be fully protected in relying upon information furnished by the Depository with respect to its members, participants and any beneficial owners. 
  
 (ii) The Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer
imposed under this Indenture or under applicable law with respect to any transfer of any interest in any Security (including any transfers between or among Depository participants, members or beneficial owners in any Global Security) other than to
require delivery of such certificates and other documentation or evidence as are expressly required by, and to do so if and when expressly required by, the terms of this Indenture, and to examine the same to determine substantial compliance as to
form with the express requirements hereof. 
  
 2.4 Definitive
Securities. 
  
 (a) A Global Security deposited with the
Depository or with the Trustee as Securities Custodian for the Depository pursuant to Section 2.1 shall be transferred to the beneficial owners thereof in the form of Definitive Securities in an aggregate principal amount equal to the principal
amount of such Global Security, in exchange for such Global Security, only if such transfer complies with Section 2.3 hereof and (i) the Depository notifies the Company that it is unwilling or unable to continue as Depository for such Global
Security and the Depository fails to appoint a successor depository or if at any time such Depository ceases to be a “clearing agency” registered under the Exchange Act, in either case, and a successor depository is not appointed by the
Company within 90 days of such notice, or (ii) the Company, in its sole discretion, notifies the Trustee in writing that it elects to cause the issuance of Definitive Securities under this Indenture. 
  
 (b) Any Global Security that is transferable to the beneficial owners thereof
pursuant to this Section 2.4 shall be surrendered by the Depository to the Trustee located at its principal corporate trust office in the Borough of Manhattan, The City of New York, to be so transferred, in whole or from time to time in part,
without charge, and the Trustee shall authenticate and deliver, upon such transfer of each portion of such Global Security, an equal aggregate principal amount of Definitive Securities of authorized denominations. Any portion of a Global Security
transferred pursuant to this 

  

 12 

 
Section 2.4 shall be executed, authenticated and delivered only in minimum denominations of $2,000 principal amount and any integral multiple of $1,000 in
excess of $2,000 and registered in such names as the Depository shall direct. Any Definitive Security delivered in exchange for an interest in the Transfer Restricted Security shall, except as otherwise provided by Section 2.3(e) hereof, bear the
applicable restricted securities legend and definitive securities legend set forth in Exhibit 1 hereto. 
  
 (c) Subject to the provisions of Section 2.4(b) hereof, the registered Holder of a Global Security shall be entitled to grant proxies and otherwise
authorize any Person, including Agent Members and Persons that may hold interests through Agent Members, to take any action which a Holder is entitled to take under this Indenture or the Securities. 
  
 (d) In the event of the occurrence of one of the events specified in Section
2.4(a) hereof, the Company shall promptly make available to the Trustee a reasonable supply of Definitive Securities in definitive, fully registered form without interest coupons. In the event that such Definitive Securities are not issued, the
Company expressly acknowledges, with respect to the right of any Holder to pursue a remedy pursuant to Section 6.06 of this Indenture, the right of any beneficial owner of Securities to pursue such remedy with respect to the portion of the Global
Security that represents such beneficial owner’s Securities as if such Definitive Securities had been issued. 
  

 13 

  
 EXHIBIT 1 
 to 
 RULE 144A/ REGULATION S/IAI APPENDIX

  
 [FORM OF FACE OF INITIAL SECURITY] 
  
 [Global Securities Legend] 
  
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE
DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), NEW YORK, NEW YORK, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR SUCH
OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO., OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC) ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR
OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
  
 TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, TO NOMINEES OF DTC OR TO A SUCCESSOR THEREOF OR SUCH
SUCCESSOR’S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN THE INDENTURE REFERRED TO ON THE REVERSE HEREOF. 
  
 [[FOR REGULATION S GLOBAL SECURITY ONLY] UNTIL 40 DAYS AFTER THE LATER OF
COMMENCEMENT OR COMPLETION OF THE OFFERING, AN OFFER OR SALE OF SECURITIES WITHIN THE UNITED STATES BY A DEALER (AS DEFINED IN THE SECURITIES ACT) MAY VIOLATE THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IF SUCH OFFER OR SALE IS MADE
OTHERWISE THAN IN ACCORDANCE WITH RULE 144A THEREUNDER.] 
  
 [Restricted Securities Legend for Securities offered otherwise than in Reliance on Regulation S) 
  
 THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”), AND THIS SECURITY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THIS SECURITY IS HEREBY NOTIFIED THAT THE
SELLER OF THIS SECURITY MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. 
  

 THE HOLDER OF THIS SECURITY AGREES FOR THE BENEFIT OF THE COMPANY THAT (A) THIS SECURITY MAY BE OFFERED,
RESOLD, PLEDGED OR OTHERWISE TRANSFERRED, ONLY (I) TO THE COMPANY, (II) WITHIN THE UNITED STATES TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) IN A TRANSACTION
MEETING THE REQUIREMENTS OF RULE 144A, (III) TO AN INSTITUTIONAL “ACCREDITED INVESTOR” WITHIN THE MEANING OF RULE 501(A)(1),(2),(3) OR (7) UNDER THE SECURITIES ACT THAT IS NOT A QUALIFIED INSTITUTIONAL BUYER THAT IS PURCHASING FOR ITS OWN
ACCOUNT OR FOR THE ACCOUNT OF ANOTHER INSTITUTIONAL ACCREDITED INVESTOR, IN EACH CASE IN A MINIMUM PRINCIPAL AMOUNT OF $250,000, (IV) OUTSIDE THE UNITED STATES IN AN OFFSHORE TRANSACTION IN ACCORDANCE WITH RULE 904 UNDER THE SECURITIES ACT, (V)
PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF AVAILABLE) OR (VI) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH OF CASES (I) THROUGH (VI) IN ACCORDANCE WITH
ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND (B) THE HOLDER WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER OF THIS SECURITY FROM IT OF THE RESALE RESTRICTIONS REFERRED TO IN (A) ABOVE. 
  
 [Restricted Securities Legend for Securities Offered in Reliance on Regulation
S.] 
  
 THIS SECURITY (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED
IN A TRANSACTION ORIGINALLY EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND MAY NOT BE TRANSFERRED IN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, ANY U.S.
PERSON EXCEPT PURSUANT TO AN AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND ALL APPLICABLE STATE SECURITIES LAWS. TERMS USED ABOVE HAVE THE MEANINGS GIVEN TO THEM IN REGULATION S UNDER THE SECURITIES ACT.

  
 [Temporary Regulation S Global Security Legend] 
  
 EXCEPT AS SET FORTH BELOW, BENEFICIAL OWNERSHIP INTERESTS IN THIS TEMPORARY
REGULATION S GLOBAL SECURITY WILL NOT BE EXCHANGEABLE FOR INTERESTS IN THE PERMANENT REGULATION S GLOBAL SECURITY OR ANY OTHER SECURITY REPRESENTING AN INTEREST IN THE SECURITIES REPRESENTED HEREBY UNTIL THE EXPIRATION OF THE “40-DAY
DISTRIBUTION COMPLIANCE PERIOD” (WITHIN THE MEANING OF RULE 903(b)(2) OF REGULATION S UNDER THE SECURITIES ACT) AND THEN ONLY UPON CERTIFICATION IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE TRUSTEE 

  

 2 

 
THAT SUCH BENEFICIAL INTERESTS ARE OWNED EITHER BY NON-U.S. PERSONS OR U.S. PERSONS WHO PURCHASED SUCH INTERESTS IN A TRANSACTION THAT DID NOT REQUIRE
REGISTRATION UNDER THE SECURITIES ACT. DURING SUCH 40-DAY DISTRIBUTION COMPLIANCE PERIOD, BENEFICIAL OWNERSHIP INTERESTS IN THIS TEMPORARY REGULATION S GLOBAL SECURITY MAY ONLY BE SOLD, PLEDGED OR TRANSFERRED (I) TO THE COMPANY, (II) OUTSIDE THE
UNITED STATES IN A TRANSACTION IN ACCORDANCE WITH RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, OR (III) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH OF CASES (I) THROUGH (III) IN ACCORDANCE WITH ANY
APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES. HOLDERS OF INTERESTS IN THIS TEMPORARY REGULATION S GLOBAL SECURITY WILL NOTIFY ANY PURCHASER OF THIS SECURITY OF THE RESALE RESTRICTIONS REFERRED TO ABOVE, IF THEN APPLICABLE. BY ITS
ACQUISITION HEREOF, THE HOLDER HEREOF REPRESENTS AND AGREES THAT IT IS NOT A U.S. PERSON AND IS PURCHASING THE SECURITIES REPRESENTED HEREBY IN AN OFFSHORE TRANSACTION (AS SUCH TERMS ARE DEFINED IN REGULATION S) PURSUANT TO REGULATION S. 

 
 AFTER THE EXPIRATION OF THE DISTRIBUTION COMPLIANCE PERIOD BENEFICIAL
INTERESTS IN THIS TEMPORARY REGULATION S GLOBAL SECURITY MAY BE EXCHANGED FOR INTERESTS IN A RULE 144A GLOBAL SECURITY ONLY IF (1) SUCH EXCHANGE OCCURS IN CONNECTION WITH A TRANSFER OF THE SECURITIES IN COMPLIANCE WITH RULE 144A AND (2) THE
TRANSFEROR OF THE REGULATION S GLOBAL SECURITY FIRST DELIVERS TO THE TRUSTEE A WRITTEN CERTIFICATE (IN THE FORM ATTACHED TO THIS CERTIFICATE) TO THE EFFECT THAT THE REGULATION S GLOBAL SECURITY IS BEING TRANSFERRED (A) TO A PERSON WHO THE TRANSFEROR
REASONABLY BELIEVES TO BE A QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (B) TO A PERSON WHO IS PURCHASING FOR ITS OWN ACCOUNT OR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE
REQUIREMENTS OF RULE 144A, AND (C) IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED STATES AND OTHER JURISDICTIONS. 
  
 AFTER THE EXPIRATION OF THE DISTRIBUTION COMPLIANCE PERIOD, BENEFICIAL INTERESTS IN THIS TEMPORARY REGULATION S GLOBAL SECURITY MAY BE EXCHANGED FOR
INTERESTS IN AN IAI GLOBAL SECURITY ONLY IF (1) SUCH EXCHANGE OCCURS IN CONNECTION WITH A TRANSFER OF THE SECURITIES IN COMPLIANCE WITH AN EXEMPTION UNDER THE SECURITIES ACT AND (2) THE TRANSFEROR OF THE REGULATION S GLOBAL SECURITY FIRST DELIVERS
TO THE TRUSTEE A WRITTEN CERTIFICATE (IN THE FORM ATTACHED TO THIS CERTIFICATE) TO THE EFFECT THAT THE REGULATION S GLOBAL SECURITY IS BEING TRANSFERRED (A) TO AN “ACCREDITED INVESTOR” WITHIN THE MEANING 

  

 3 

 
OF RULE 501(A)(1),(2),(3) OR (7) UNDER THE SECURITIES ACT THAT, PRIOR TO SUCH TRANSFER, FURNISHES THE TRUSTEE A SIGNED LETTER CONTAINING CERTAIN
REPRESENTATIONS AND AGREEMENTS RELATING TO THE TRANSFER OF THIS SECURITY (THE FORM OF WHICH CAN BE OBTAINED FROM THE TRUSTEE) AND, IF SUCH TRANSFER IS IN RESPECT OF AN AGGREGATE PRINCIPAL AMOUNT OF SECURITIES LESS THAN $250,000, AN OPINION OF
COUNSEL ACCEPTABLE TO THE COMPANY THAT SUCH TRANSFER IS IN COMPLIANCE WITH THE SECURITIES ACT AND (B) IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED STATES AND OTHER JURISDICTIONS. 
  
 BENEFICIAL INTERESTS IN A RULE 144A GLOBAL SECURITY OR AN IAI GLOBAL SECURITY
MAY BE TRANSFERRED TO A PERSON WHO TAKES DELIVERY IN THE FORM OF AN INTEREST IN THE REGULATION S GLOBAL SECURITY, WHETHER BEFORE OR AFTER THE EXPIRATION OF THE 40-DAY DISTRIBUTION COMPLIANCE PERIOD, ONLY IF THE TRANSFEROR FIRST DELIVERS TO THE
TRUSTEE A WRITTEN CERTIFICATE (IN THE FORM ATTACHED TO THIS CERTIFICATE) TO THE EFFECT THAT SUCH TRANSFER IS BEING MADE IN ACCORDANCE WITH RULE 903 OR 904 OF REGULATION S OR RULE 144 (IF AVAILABLE). 
  
 [Definitive Securities Legend] 
  
 IN CONNECTION WITH ANY TRANSFER, THE HOLDER WILL DELIVER TO THE REGISTRAR AND
TRANSFER AGENT SUCH CERTIFICATES AND OTHER INFORMATION AS SUCH TRANSFER AGENT MAY REASONABLY REQUIRE TO CONFIRM THAT THE TRANSFER COMPLIES WITH THE FOREGOING RESTRICTIONS. 
  

 4 

 YELLOW ROADWAY CORPORATION 
 Senior Floating Rate Notes Due 2008 
  
 CUSIP No.             
 ISIN
No.             
  

					
	 No.                
	 	 	 	$                

  
 Yellow Roadway
Corporation, a Delaware corporation, promises to pay to [                ] or registered assigns, the principal sum of
[                ] Dollars on May 15, 2008. 
  
 Interest Payment Dates: February 15, May 15, August 15 and November 15. 
  
 Record Dates: February 1, May 1, August 1 and November 1. 
  
 Additional provisions of this Security are set forth on the other side of this Security. 
  
 Dated: 
  

			
	YELLOW ROADWAY CORPORATION,
		
	By	 	 
	 	 	 Name:

	 	 	 Title:

		
	By	 	 
	 	 	 Name:

	 	 	 Title:

  

			
	 TRUSTEE’S CERTIFICATE OF
         AUTHENTICATION

	
	 SUNTRUST BANK
 As Trustee, certifies
that this is one of the Securities referred to in the Indenture.

		
	By	 	 
	 	 	Authorized Signatory

  

 5 

 [FORM OF REVERSE SIDE OF INITIAL SECURITY] 
  
 YELLOW ROADWAY CORPORATION 
 Senior Floating Rate Note Due 2008 
  

	1.	Interest 

  
 Yellow Roadway Corporation, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to, being
herein called the “Company”), promises to pay interest on the principal amount of this Security at a rate per annum, reset quarterly, equal to LIBOR plus 1.375%, as determined by the Calculation Agent, which shall initially be the Trustee;
provided, however, that for the first 90-day period immediately following the occurrence and during the continuance of a Registration Default (as defined in the Registration Rights Agreement), additional interest will accrue on this
Security at a rate of 0.25% per annum (increasing by an additional 0.25% per annum with respect to each subsequent consecutive 90-day period during which such Registration Default continues up to a maximum additional interest rate of 0.50% per
annum) from and including the date on which any such Registration Default shall occur to but excluding the date on which any such Registration Default is no longer in effect, payable in each case on the interest payment dates described in Section 2
below. The Company will pay interest quarterly on February 15, May 15, August 15 and November 15 of each year, commencing August 15, 2005. Interest on the Securities will accrue from the most recent date to which interest has been paid or, if no
interest has been paid, from May 24, 2005. The amount of interest for each day that such Securities are outstanding (the “Daily Interest Amount”) will be calculated by dividing the interest rate in effect for such day by 360 and
multiplying the result by the principal amount of the Securities. The amount of interest to be paid on the Securities for each Interest Period will be calculated by adding the Daily Interest Amounts for each day in the Interest Period. All
percentages resulting from any of the above calculations will be rounded, if necessary, to the nearest one hundred thousandth of a percentage point, with five one-millionths of a percentage point being rounded upwards (e.g., 9.876545% (or
..09876545) being rounded to 9.87655% (or .0987655)) and all dollar amounts used in or resulting from such calculations will be rounded to the nearest cent (with one-half cent being rounded upwards). The Company will pay interest on overdue principal
at the rate borne by this Security, and it will pay interest on overdue installments of interest at the same rate, in each case, to the extent lawful. 
  
 The interest rate on the Securities will in no event be higher than the maximum rate permitted by New York law as the same may be modified by United
States law of general application. 
  
 The Calculation Agent will,
upon the request of any Holder of Securities, provide the interest rate then in effect with respect to the Securities. All calculations made by the Calculation Agent in the absence of manifest error will be conclusive for all purposes and binding on
the Company, the Subsidiary Guarantors and the holders of the Securities. 
  

 6 

	2.	Method of Payment 

  
 The Company will pay interest on the Securities (except defaulted interest) to the Persons who are registered holders of Securities at the close of
business on the February 1, May 1, August 1 or November 1 next preceding the interest payment date even if Securities are canceled after the record date and on or before the interest payment date. Holders must surrender Securities to a Paying Agent
to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts. Payments in respect of the Securities
represented by a Global Security (including principal, premium, if any, and interest) will be made by wire transfer of immediately available funds to the accounts specified by the Depository. The Company will make all payments in respect of a
certificated Security (including principal, premium, if any, and interest) by mailing a check to the registered address of each Holder thereof; provided, however, that payments on a certificated Security will be made by wire transfer
to a U.S. dollar account maintained by the payee with a bank in the United States if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such effect designating such account no later than 30
days immediately preceding the relevant due date for payment (or such other date as the Trustee may accept in its discretion). 
  

	3.	Paying Agent and Registrar 

  
 Initially, SunTrust Bank, a national banking corporation associated under the laws of the state of Georgia (the “Trustee”), will act as Paying
Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or co-registrar without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act as Paying Agent, Registrar or co-registrar.

  

	4.	Indenture 

  
 The Company issued the Securities under an Indenture dated as of May 24, 2005 (“Indenture”), among the Company, the Subsidiary Guarantors and
the Trustee. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) (the “Act”). Terms defined in
the Indenture and not defined herein have the meanings ascribed thereto in the Indenture. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and the Act for a statement of those terms. 
  
 The Securities are general unsecured obligations of the Company. The
Company shall be entitled to issue Additional Securities pursuant to Section 2.13 of the Indenture. The Initial Securities issued on the Issue Date, any Additional Securities and all Exchange Securities or Private Exchange Securities issued in
exchange therefor will be treated as a single class for all purposes under the Indenture. The Indenture contains covenants that limit the ability of the Company and its subsidiaries to create liens on assets; that require certain additional
guarantees to be entered into in certain 

  

 7 

 
circumstances; and that limit the ability of the Company to consolidate, merge or transfer all or substantially all of its assets and the assets of its
subsidiaries. These covenants are subject to important exceptions and qualifications. 
  

	5.	Optional Redemption 

  
 Except as set forth below and in paragraph 6, the Company shall not be entitled to redeem the Securities at its option prior to November 15, 2006.

  
 On and after November 15, 2006, the Company shall be entitled
at its option, at any time and from time to time prior to maturity, to redeem all or a portion of the Securities upon not less than 30 nor more than 60 days’ notice, at 100% of the principal amount thereof, plus accrued interest to the
redemption date (subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date). 
  

	6.	Special Mandatory Redemption 

  
 The Securities shall be subject to a special mandatory redemption by the Company in the event the Merger is not consummated on or prior to December 31,
2005 or the Merger Agreement is terminated in accordance with its terms at any time prior thereto, at a redemption price equal to 101% of the principal amount thereof plus accrued and unpaid interest to the redemption date (subject to the right of
Holders of record on the relevant record date to receive interest due on the relevant interest payment date). 
  

	7.	Notice of Redemption 

  
 Notice of optional redemption pursuant to paragraph 5 hereof will be mailed at least 30 days but not more than 60 days before the redemption date to each
Holder of Securities to be redeemed at his registered address. Notice of special mandatory redemption pursuant to paragraph 6 hereof will be mailed no later than the second Business Day following December 31, 2005 or following the date the Merger
Agreement is terminated, as applicable, and the Securities will be redeemed seven Business Days following the date of notice of redemption. Securities in denominations of $2,000 or less will be redeemed in whole but not in part. Securities in
denominations larger than $2,000 principal amount may be redeemed in part but only in whole multiples of $1,000 in excess of $2,000. If money sufficient to pay the redemption price of and accrued interest on all Securities (or portions thereof) to
be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Securities (or such portions thereof) called
for redemption. 
  

	8.	Guaranty 

  
 The payment by the Company of the principal of, and premium and interest on, the Securities is fully and unconditionally guaranteed on a joint and several
senior basis by each of the Subsidiary Guarantors to the extent set forth in the Indenture. 
  

 8 

	9.	Denominations; Transfer; Exchange 

  
 The Securities are in registered form without coupons in denominations of $2,000 principal amount and whole multiples of $1,000 in excess of $2,000. A
Holder may transfer or exchange Securities in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or permitted
by the Indenture. The Registrar need not register the transfer of or exchange any Securities selected for redemption (except, in the case of a Security to be redeemed in part, the portion of the Security not to be redeemed) or any Securities for a
period of 15 days before a selection of Securities to be redeemed or 15 days before an interest payment date. 
  

	10.	Persons Deemed Owners 

  
 The registered Holder of this Security may be treated as the owner of it for all purposes. 
  

	11.	Unclaimed Money 

  
 If money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at
its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee for payment. 
  

	12.	Discharge and Defeasance 

  
 Subject to certain conditions, the Company at any time shall be entitled to terminate some or all of its obligations under the Securities and the
Indenture if the Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Securities to redemption or maturity, as the case may be. 
  

	13.	Amendment, Waiver 

  
 Subject to certain exceptions set forth in the Indenture, (a) the Indenture and the Securities may be amended with the written consent of the Holders of
at least a majority in principal amount outstanding of the Securities and (b) any default or noncompliance with any provision may be waived with the written consent of the Holders of a majority in principal amount outstanding of the Securities.
Subject to certain exceptions set forth in the Indenture, without the consent of any Securityholder, the Company, the Subsidiary Guarantors and the Trustee shall be entitled to amend the Indenture, or the Securities to cure any ambiguity, omission,
defect or inconsistency, or to comply with Article 5 of the Indenture, or to provide for uncertificated Securities in addition to or in place of certificated Securities, or to add guarantees with respect to the Securities, including Subsidiary
Guaranties, or to secure the Securities, or to add additional covenants or surrender rights and powers conferred on the Company or the Subsidiary Guarantors, or to comply with any requirement of the SEC in connection with 

  

 9 

 
qualifying the Indenture under the Act, or to make any change that does not adversely affect the rights of any Securityholder, or to make amendments to
provisions of the Indenture relating to the transfer and legending of the Securities. 
  

	14.	Defaults and Remedies 

  
 Under the Indenture, Events of Default include (a) default for 30 days in payment of interest on the Securities; (b) default in payment of principal on
the Securities at maturity, upon redemption pursuant to paragraph 5 or 6 of the Securities, upon acceleration or otherwise, or failure by the Company to redeem Securities when required; (c) failure by the Company or any Subsidiary Guarantor to
comply with other agreements in the Indenture or the Securities, subject to notice and lapse of time; (d) certain accelerations or failures to pay (after the expiration of applicable grace periods) of certain other Indebtedness of the Company or
certain of its Subsidiaries; (e) certain events of bankruptcy or insolvency with respect to the Company and the Significant Subsidiaries; and (f) certain defaults with respect to Subsidiary Guaranties. If an Event of Default occurs and is
continuing, the Trustee or the Holders of at least 25% in principal amount of the Securities may declare all the Securities to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the
Securities being due and payable immediately upon the occurrence of such Events of Default. 
  
 Securityholders may not enforce the Indenture or the Securities except as provided in the Indenture. The Trustee may refuse to enforce the Indenture or the Securities unless it receives indemnity or security
satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Securities may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Securityholders notice of any continuing
Default (except a Default in payment of principal or interest) if it determines that withholding notice is in the interest of the Holders. 
  

	15.	Trustee Dealings with the Company 

  
 Subject to certain limitations imposed by the Act, the Trustee under the Indenture, in its individual or any other capacity, may become the owner or
pledgee of Securities and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. 
  

	16.	No Recourse Against Others 

  
 No past or future director, officer, employee, incorporator or owner of any Capital Stock, as such, of the Company or the Trustee shall not have any
liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Security, each Securityholder waives and releases all such
liability. The waiver and release are part of the consideration for the issue of the Securities. 
  

 10 

	17.	Authentication 

  
 This Security shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the other side of this Security. 
  

	18.	Abbreviations 

  
 Customary abbreviations may be used in the name of a Securityholder or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by the
entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). 
  

	19.	CUSIP Numbers 

  
 Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures the Company has caused CUSIP numbers to be printed
on the Securities and has directed the Trustee to use CUSIP numbers in notices of redemption as a convenience to Securityholders. No representation is made as to the accuracy of such numbers either as printed on the Securities or as contained in any
notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 
  

	20.	Holders’ Compliance with Registration Rights Agreement. 

  
 Each Holder of a Security, by acceptance hereof, acknowledges and agrees to the provisions of the Registration Rights Agreement, including the obligations
of the Holders with respect to a registration and the indemnification of the Company to the extent provided therein. 
  

	21.	Governing Law. 

  
 THIS SECURITY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
  
 The Company will furnish to any Securityholder upon written request and
without charge to the Security holder a copy of the Indenture which has in it the text of this Security in larger type. Requests may be made to: 
  
 Yellow Roadway Corporation 
 10990 Roe Avenue

 Overland Park, Kansas 66211 
  
 Attention: Daniel J. Churay, Esq. 
  

 11 

 ASSIGNMENT FORM 
  

To assign this Security, fill in the form below: 
  
 I or we assign and transfer this Security to 
  
 (Print or type assignee’s name, address and zip code) 
  
 (Insert assignee’s soc. sec. or tax I.D. No.) 
  
 and irrevocably appoint
                             agent to transfer this Security on the books of the Company. The agent may
substitute another to act for him. 
  
                                       
                                        
                                        
                                        
                                        
                                        
                    
  
 Date:                                     Your
Signature
                                        
                                        
                                 
  
                                       
                                        
                                        
                                        
                                        
                                        
                    
  
 Sign exactly as your name appears on the other side of this Security. 
  
 In connection with any transfer of any of the Securities evidenced by this certificate occurring prior to the expiration of the period referred to in Rule 144(k) under
the Securities Act after the later of the date of original issuance of such Securities and the last date, if any, on which such Securities were owned by the Company or any Affiliate of the Company, the undersigned confirms that such Securities are
being transferred in accordance with its terms: 
  
 CHECK ONE BOX BELOW

  

	 ̈	to the Company; or 

  

						
	 (1)
	  	 ̈	 	  	pursuant to an effective registration statement under the Securities Act of 1933; or
			
	 (2)
	  	 ̈	 	  	inside the United States to a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act of 1933) that purchases for its own account or for the account of a
qualified institutional buyer to whom notice is given that such transfer is being made in reliance on Rule 144A, in each case pursuant to and in compliance with Rule 144A under the Securities Act of 1933; or

  

 12 

						
	 (3)
	  	 ̈	 	  	outside the United States in an offshore transaction within the meaning of Regulation S under the Securities Act in compliance with Rule 904 under the Securities Act of 1933;
or
			
	 (4)
	  	 ̈	 	  	pursuant to the exemption from registration provided by Rule 144 under the Securities Act of 1933; or
			
	 (5)
	  	 ̈	 	  	to an institutional “accredited investor” (as defined in Rule 501(a)(1),(2),(3) or (7) under the Securities Act of 1933) that has furnished to the Trustee a signed letter containing
certain representations and agreements.

  
 Unless one of the
boxes is checked, the Trustee will refuse to register any of the Securities evidenced by this certificate in the name of any person other than the registered holder thereof; provided, however, that if box (3), (4) or (5) is checked,
the Company may require, prior to registering any such transfer of the Securities, in its sole discretion, such legal opinions, certifications and other information as the Company may reasonably request to confirm that such transfer is being made
pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act of 1933, such as the exemption provided by Rule 144 under such Act. 
  

									
			
	 	 	 	 	 
	 	 	 	 	Signature

  
 Signature Guarantee: 
  

									
			
	 	 	 	 	 
	Signature must be guaranteed	 	 	 	Signature

  
 Signatures must be
guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other
“signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 
  
                                       
                                        
                                        
                                        
                                        
                                        
                    
  

 13 

 TO BE COMPLETED BY PURCHASER IF (2) ABOVE IS CHECKED. 
  
 The undersigned represents and warrants that it is purchasing this Security
for its own account or an account with respect to which it exercises sole investment discretion and that it and any such account is a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act of 1933, and is
aware that the sale to it is being made in reliance on Rule 144A and acknowledges that it has received such information regarding the Company as the undersigned has requested pursuant to Rule 144A or has determined not to request such information
and that it is aware that the transferor is relying upon the undersigned’s foregoing representations in order to claim the exemption from registration provided by Rule 144A. 
  

									
					
	Dated:	 	 _____________________
	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	Notice: To be executed by an executive officer

  

 14 

 [TO BE ATTACHED TO GLOBAL SECURITIES] 
  
 SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY 
  
 The following increases or decreases in this Global Security have been made: 
  

									
	 Date of
Exchange

	 	 Amount of decrease in
Principal amount of this
Global Security

	 	 Amount of increase in
Principal amount of this
Global Security

	 	 Principal amount of this
Global Security following
such decrease or increase)

	 	 Signature of authorized
officer of Trustee or
Securities Custodian

  

 15 

  
 EXHIBIT A 
  
 [FORM OF FACE OF EXCHANGE SECURITY 
 OR PRIVATE EXCHANGE SECURITY] 
  
 */**/ 

	*	If the Security is to be issued in global form add the Global Securities Legend from Exhibit 1 to Appendix A and the attachment from such Exhibit 1 captioned “[TO BE ATTACHED
TO GLOBAL SECURITIES] - SCHEDULE OF INCREASES OR DECREASES IN GLOBAL SECURITY”. 

  

	**	If the Security is a Private Exchange Security issued in a Private Exchange to an Initial Purchaser holding an unsold portion of its initial allotment, add the Restricted Securities
Legend from Exhibit 1 to Appendix A and replace the Assignment Form included in this Exhibit A with the Assignment Form included in such Exhibit 1. 

  

 Yellow Roadway Corporation 
 Senior Floating Rate Notes Due 2008 
  
 CUSIP No.              
 ISIN
No.             
  

			
	 No.            
	 	$                

  
 Yellow Roadway
Corporation, a Delaware corporation, promises to pay to             , or registered assigns, the principal sum of
                     Dollars on May 15, 2008. 
  

Interest Payment Dates: February 15, May 15, August 15 and November 15. 
  
 Record Dates: February 1, May 1, August 1 and November 1. 
  
 Additional provisions of this Security are set forth on the other side of this Security. 
  
 Dated: 
  

					
	YELLOW ROADWAY CORPORATION,
		
	 By
	 	 
	 	 	 Name:
	 	 
	 	 	 Title:
	 	 
		
	 By
	 	 
	 	 	 Name:
	 	 
	 	 	 Title:
	 	 

  

			
	 TRUSTEE’S CERTIFICATE OF
         AUTHENTICATION

	
	SUNTRUST BANK
	As Trustee, certifies that this is one of the Securities referred to in the Indenture.
		
	By	 	 
	 	 	 Authorized Signatory

  

 2 

 [FORM OF REVERSE SIDE OF EXCHANGE SECURITY 
 OR PRIVATE EXCHANGE SECURITY] 
  
 Senior Floating Rate Note Due 2008 
  

	1.	Interest 

  
 Yellow Roadway Corporation, a Delaware corporation (such corporation, and its successors and assigns under the Indenture hereinafter referred to, being
herein called the “Company”), promises to pay interest on the principal amount of this Security at a rate per annum, reset quarterly, equal to LIBOR plus 1.375%, as determined by the Calculation Agent, which shall initially be the Trustee;
provided, however, that for the first 90-day period immediately following the occurrence and during the continuance of a Registration Default (as defined in the Registration Rights Agreement), additional interest will accrue on this
Security at a rate of 0.25% per annum (increasing by an additional 0.25% per annum with respect to each subsequent consecutive 90-day period during which such Registration Default continues up to a maximum additional interest rate of 0.50% per
annum) from and including the date on which any such Registration Default shall occur to but excluding the date on which any such Registration Default is no longer in effect, payable in each case on the interest payment dates described in Section 2
below.]1 The Company will pay interest quarterly on February 15, May 15, August 15 and November 15 of each year,
commencing August 15, 2005. Interest on the Securities will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from May 24, 2005. The amount of interest for each day that such Securities are
outstanding (the “Daily Interest Amount”) will be calculated by dividing the interest rate in effect for such day by 360 and multiplying the result by the principal amount of the Securities. The amount of interest to be paid on the
Securities for each Interest Period will be calculated by adding the Daily Interest Amounts for each day in the Interest Period. All percentages resulting from any of the above calculations will be rounded, if necessary, to the nearest one hundred
thousandth of a percentage point, with five one-millionths of a percentage point being rounded upwards (e.g., 9.876545% (or .09876545) being rounded to 9.87655% (or .0987655)) and all dollar amounts used in or resulting from such calculations
will be rounded to the nearest cent (with one-half cent being rounded upwards). The Company will pay interest on overdue principal at the rate borne by this Security, and it will pay interest on overdue installments of interest at the same rate, in
each case, to the extent lawful. 
  
 The interest rate on the
Securities will in no event be higher than the maximum rate permitted by New York law as the same may be modified by United States law of general application. 
  

The Calculation Agent will, upon the request of any Holder of Securities, provide the interest rate then in effect with respect to the Securities. All
calculations made by the 

	1	Insert if at the date of issuance of the Exchange Security or Private Exchange Security (as the case may be) any Registration Default has occurred with respect to
the related Initial Securities during the interest period in which such date of issuance occurs. 

  

 3 

 Calculation Agent in the absence of manifest error will be conclusive for all purposes and binding on the Company, the
Subsidiary Guarantors and the holders of the Securities. 
  

	2.	Method of Payment 

  
 The Company will pay interest on the Securities (except defaulted interest) to the Persons who are registered holders of Securities at the close of
business on the February 1, May 1, August 1 or November 1 next preceding the interest payment date even if Securities are canceled after the record date and on or before the interest payment date. Holders must surrender Securities to a Paying Agent
to collect principal payments. The Company will pay principal, premium, if any, and interest in money of the United States that at the time of payment is legal tender for payment of public and private debts. Payments in respect of the Securities
represented by a Global Security (including principal, premium, if any, and interest) will be made by wire transfer of immediately available funds to the accounts specified by The Depository Trust Company. The Company will make all payments in
respect of a certificated Security (including principal, premium, if any, and interest) by mailing a check to the registered address of each Holder thereof; provided, however, that payments on a certificated Security will be made by
wire transfer to a U.S. dollar account maintained by the payee with a bank in the United States if such Holder elects payment by wire transfer by giving written notice to the Trustee or the Paying Agent to such effect designating such account no
later than 30 days immediately preceding the relevant due date for payment (or such other date as the Trustee may accept in its discretion). 
  

	3.	Paying Agent and Registrar 

  
 Initially, SunTrust Bank, a national banking corporation associated under the laws of the state of Georgia (the “Trustee”), will act as Paying
Agent and Registrar. The Company may appoint and change any Paying Agent, Registrar or co-registrar without notice. The Company or any of its domestically incorporated Wholly Owned Subsidiaries may act as Paying Agent, Registrar or co-registrar.

  

	4.	Indenture 

  
 The Company issued the Securities under an Indenture dated as of May 24, 2005 (“Indenture”), among the Company, the Subsidiary Guarantors and
the Trustee. The terms of the Securities include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939 (15 U.S.C. §§ 77aaa-77bbbb) as in effect on the date of the
Indenture (the “Act”). Terms defined in the Indenture and not defined herein have the meanings ascribed thereto in the Indenture. The Securities are subject to all such terms, and Securityholders are referred to the Indenture and the Act
for a statement of those terms. 
  
 The Securities are general
unsecured obligations of the Company. The Company shall be entitled to issue Additional Securities pursuant to Section 2.13 of the Indenture. The Initial Securities issued on the Issue Date, any Additional Securities and all Exchange
Securities or Private Exchange Securities issued in exchange therefor will be 

  

 4 

 
treated as a single class for all purposes under the Indenture. The Indenture contains covenants that limit the ability of the Company and its subsidiaries
to create liens on assets; that require certain additional guarantees to be entered into in certain circumstances; and that limit the ability of the Company to consolidate, merge or transfer all or substantially all of its assets and the assets of
its subsidiaries. These covenants are subject to important exceptions and qualifications. 
  

	5.	Optional Redemption 

  
 Except as set forth below and in paragraph 6, the Company shall not be entitled to redeem the Securities at its option prior to November 15, 2006.

  
 On and after November 15, 2006, the Company shall be entitled
at its option, at any time and from time to time prior to maturity, to redeem all or a portion of the Securities upon not less than 30 nor more than 60 days’ notice, at 100% of the principal amount thereof plus accrued interest to the
redemption date (subject to the right of Holders of record on the relevant record date to receive interest due on the relevant interest payment date). 
  

	6.	Special Mandatory Redemption 

  
 The Securities shall be subject to a special mandatory redemption by the Company in the event the Merger is not consummated on or prior to December 31,
2005 or the Merger Agreement is terminated in accordance with its terms at any time prior thereto, at a redemption price equal to 101% of the principal amount thereof plus accrued and unpaid interest to the redemption date (subject to the right of
Holders of record on the relevant record date to receive interest due on the relevant interest payment date). 
  

	7.	Notice of Redemption 

  
 Notice of optional redemption pursuant to paragraph 5 hereof will be mailed at least 30 days but not more than 60 days before the redemption date to each
Holder of Securities to be redeemed at his registered address. Notice of special mandatory redemption pursuant to paragraph 6 hereof will be mailed no later than the second Business Day following December 31, 2005 or following the date the Merger
Agreement is terminated, as applicable, and the Securities will be redeemed seven Business Days following the date of notice of redemption. Securities in denominations of $2,000 or less will be redeemed in whole but not in part. Securities in
denominations larger than $2,000 principal amount may be redeemed in part but only in whole multiples of $1,000 in excess of $2,000. If money sufficient to pay the redemption price of and accrued interest on all Securities (or portions thereof) to
be redeemed on the redemption date is deposited with the Paying Agent on or before the redemption date and certain other conditions are satisfied, on and after such date interest ceases to accrue on such Securities (or such portions thereof) called
for redemption. 
  

 5 

	8.	Guaranty 

  
 The payment by the Company of the principal of, and premium and interest on, the Securities is fully and unconditionally guaranteed on a joint and several
senior basis by each of the Subsidiary Guarantors to the extent set forth in the Indenture. 
  

	9.	Denominations; Transfer; Exchange 

  
 The Securities are in registered form without coupons in denominations of $2,000 principal amount and whole multiples of $1,000 in excess of $2,000. A
Holder may transfer or exchange Securities in accordance with the Indenture. The Registrar may require a Holder, among other things, to furnish appropriate endorsements or transfer documents and to pay any taxes and fees required by law or permitted
by the Indenture. The Registrar need not register the transfer of or exchange any Securities selected for redemption (except, in the case of a Security to be redeemed in part, the portion of the Security not to be redeemed) or any Securities for a
period of 15 days before a selection of Securities to be redeemed or 15 days before an interest payment date. 
  

	10.	Persons Deemed Owners 

  
 The registered Holder of this Security may be treated as the owner of it for all purposes. 
  

	11.	Unclaimed Money 

  
 If money for the payment of principal or interest remains unclaimed for two years, the Trustee or Paying Agent shall pay the money back to the Company at
its request unless an abandoned property law designates another Person. After any such payment, Holders entitled to the money must look only to the Company and not to the Trustee for payment. 
  

	12.	Discharge and Defeasance 

  
 Subject to certain conditions, the Company at any time shall be entitled to terminate some or all of its obligations under the Securities and the
Indenture if the Company deposits with the Trustee money or U.S. Government Obligations for the payment of principal and interest on the Securities to redemption or maturity, as the case may be. 
  

	13.	Amendment; Waiver 

  
 Subject to certain exceptions set forth in the Indenture, (1) the Indenture and the Securities may be amended with the written consent of the Holders of
at least a majority in principal amount outstanding of the Securities and (2) any default or noncompliance with any provision may be waived with the written consent of the Holders of a majority in principal amount outstanding of the Securities.
Subject to certain exceptions set forth in the Indenture, without the consent of any Securityholder, the Company, the Subsidiary Guarantors and the Trustee shall be entitled to amend the Indenture or the Securities to cure any ambiguity, omission,
defect or inconsistency, or to comply with Article 5 of the 

  

 6 

 
Indenture, or to provide for uncertificated Securities in addition to or in place of certificated Securities, or to add guarantees with respect to the
Securities, including Subsidiary Guaranties, or to secure the Securities, or to add additional covenants or surrender rights and powers conferred on the Company or the Subsidiary Guarantors, or to comply with any requirement of the SEC in connection
with qualifying the Indenture under the Act, or to make any change that does not adversely affect the rights of any Securityholder, or to make amendments to provisions of the Indenture relating to the transfer and legending of the Securities.

  

	14.	Defaults and Remedies 

  
 Under the Indenture, Events of Default include (a) default for 30 days in payment of interest on the Securities; (b) default in payment of principal on
the Securities at maturity, upon redemption pursuant to paragraph 5 or 6 of the Securities, upon acceleration or otherwise, or failure by the Company to redeem Securities when required; (c) failure by the Company or any Subsidiary Guarantor to
comply with other agreements in the Indenture or the Securities, subject to notice and lapse of time; (d) certain accelerations or failures to pay (after the expiration of any applicable grace periods) of certain other Indebtedness of the Company or
certain of its Subsidiaries; (e) certain events of bankruptcy or insolvency with respect to the Company and the Significant Subsidiaries; and (f) certain defaults with respect to Subsidiary Guaranties. If an Event of Default occurs and is
continuing, the Trustee or the Holders of at least 25% in principal amount of the Securities may declare all the Securities to be due and payable immediately. Certain events of bankruptcy or insolvency are Events of Default which will result in the
Securities being due and payable immediately upon the occurrence of such Events of Default. 
  
 Securityholders may not enforce the Indenture or the Securities except as provided in the Indenture. The Trustee may refuse to enforce the Indenture or the Securities unless it receives indemnity or security
satisfactory to it. Subject to certain limitations, Holders of a majority in principal amount of the Securities may direct the Trustee in its exercise of any trust or power. The Trustee may withhold from Securityholders notice of any continuing
Default (except a Default in payment of principal or interest) if it determines that withholding notice is in the interest of the Holders. 
  

	15.	Trustee Dealings with the Company 

  
 Subject to certain limitations imposed by the Act, the Trustee under the Indenture, in its individual or any other capacity, may become the owner or
pledgee of Securities and may otherwise deal with and collect obligations owed to it by the Company or its Affiliates and may otherwise deal with the Company or its Affiliates with the same rights it would have if it were not Trustee. 
  

 7 

	16.	No Recourse Against Others 

  
 No past or future director, officer, employee, incorporator or owner of any Capital Stock, as such, of the Company or the Trustee shall not have any
liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. By accepting a Security, each Securityholder waives and releases all such
liability. The waiver and release are part of the consideration for the issue of the Securities. 
  

	17.	Authentication 

  
 This Security shall not be valid until an authorized signatory of the Trustee (or an authenticating agent) manually signs the certificate of
authentication on the other side of this Security. 
  

	18.	Abbreviations 

  
 Customary abbreviations may be used in the name of a Securityholder or an assignee, such as TEN COM (=tenants in common), TEN ENT (=tenants by the
entireties), JT TEN (=joint tenants with rights of survivorship and not as tenants in common), CUST (=custodian), and U/G/M/A (=Uniform Gift to Minors Act). 
  

	19.	CUSIP Numbers 

  
 Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures the Company has caused CUSIP numbers to be printed
on the Securities and has directed the Trustee to use CUSIP numbers in notices of redemption as a convenience to Securityholders. No representation is made as to the accuracy of such numbers either as printed on the Securities or as contained in any
notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 
  

	20.	Holders’ Compliance with Registration Rights Agreement 

  
 Each Holder of a Security, by acceptance hereof, acknowledges and agrees to the provisions of the Registration Rights Agreement, including the obligations
of the Holders with respect to a registration and the indemnification of the Company to the extent provided therein.]2 
  

	21.	Governing Law 

  
 THIS SECURITY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 

	2	Delete if this Security is not being issued in exchange for an Initial Security. 

  
 [Note: Leave footnote in form of Security unless Rule 144A Appendix is deleted from Indenture.] 
  

 8 

 The Company will furnish to any Securityholder upon written request and without charge to the Security
holder a copy of the Indenture which has in it the text of this Security in larger type. Requests may be made to: 
  
 Yellow Roadway Corporation 
 10990 Roe Avenue

 Overland Park, Kansas 66211 
  
 Attention: Daniel J. Churay, Esq. 
  

 9 

 ASSIGNMENT FORM 
  

To assign this Security, fill in the form below: 
  
 I or we assign and transfer this Security to 
  
 (Print or type assignee’s name, address and zip code) 
  
 (Insert assignee’s soc. sec. or tax I.D. No.) 
  
 and irrevocably appoint                     agent to transfer this
Security on the books of the Company. The agent may substitute another to act for him. 
  
                                       
                                        
                                        
                                        
                                        
                                        
                    
  
 Date:                                    
    Your
Signature:                                      
                                        
                               
  
                                       
                                        
                                        
                                        
                                        
                                        
                    
  
 Sign exactly as your name appears on the other side of this Security. 
  

 10 

 EXHIBIT 2 to Rule 144A/REGULATION S/IAI APPENDIX 
  
 Form of 
 Transferee Letter of Representation 
  
 Yellow Roadway Corporation 
  
 In care of

 [            ] 
 [            ] 
 [            ] 
  
 Ladies and Gentlemen: 
  
 This certificate is delivered
to request a transfer of $[        ] principal amount of the Floating Rate Notes due 2008 (the “Securities”) of Yellow Roadway Corporation (the “Company”). 
  
 Upon transfer, the Securities would be registered in the name of the new
beneficial owner as follows: 
  
 Name:                                     
                        
  
 Address:                                     
                    
  
 Taxpayer ID
Number:                                     
  
 The undersigned represents and warrants to you that: 
  
 1. We are an institutional “accredited investor” (as defined in
Rule 501(a)(1), (2), (3) or (7) under the Securities Act of 1933, as amended (the “Securities Act”)), purchasing for our own account or for the account of such an institutional “accredited investor” at least $250,000 principal
amount of the Securities, and we are acquiring the Securities not with a view to, or for offer or sale in connection with, any distribution in violation of the Securities Act. We have such knowledge and experience in financial and business matters
as to be capable of evaluating the merits and risks of our investment in the Securities, and we invest in or purchase securities similar to the Securities in the normal course of our business. We, and any accounts for which we are acting, are each
able to bear the economic risk of our or its investment. 
  
 2. We
understand that the Securities have not been registered under the Securities Act and, unless so registered, may not be sold except as permitted in the following sentence. We agree on our own behalf and on behalf of any investor account for which we
are purchasing Securities to offer, sell or otherwise transfer such Securities prior to the date that is two years after the later of the date of original issue and the last date on which the Company or any affiliate of the Company was the owner of
such Securities (or 

  

 
any predecessor thereto) (the “Resale Restriction Termination Date”) only (i) to the Company, (ii) in the United States to a person whom the seller
reasonably believes is a qualified institutional buyer in a transaction meeting the requirements of Rule 144A, (iii) to an institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act
that is an institutional accredited investor purchasing for its own account or for the account of an institutional accredited investor, in each case in a minimum principal amount of the Securities of $250,000, (iv) outside the United States in a
transaction complying with the provisions of Rule 904 under the Securities Act, (v) pursuant to an exemption from registration under the Securities Act provided by Rule 144 (if available) or (vi) pursuant to an effective registration statement under
the Securities Act, in each of cases (i) through (vi) subject to any requirement of law that the disposition of our property or the property of such investor account or accounts be at all times within our or their control and in compliance with any
applicable state securities laws. The foregoing restrictions on resale will not apply subsequent to the Resale Restriction Termination Date. If any resale or other transfer of the Securities is proposed to be made pursuant to clause (iii) above
prior to the Resale Restriction Termination Date, the transferor shall deliver a letter from the transferee substantially in the form of this letter to the Company and the Trustee, which shall provide, among other things, that the transferee is an
institutional “accredited investor” within the meaning of Rule 501(a)(1), (2), (3) or (7) under the Securities Act and that it is acquiring such Securities for investment purposes and not for distribution in violation of the Securities
Act. Each purchaser acknowledges that the Company and the Trustee reserve the right prior to the offer, sale or other transfer prior to the Resale Restriction Termination Date of the Securities pursuant to clause (iii), (iv) or (v) above to require
the delivery of an opinion of counsel, certifications or other information satisfactory to the Company and the Trustee. 
  

					
			
	TRANSFEREE:	 	 	 	,

					
			
	by:	 	 	 	 

  

 2 

  
 APPENDIX B 
  
 [FORM OF SUPPLEMENTAL INDENTURE TO BE 
 DELIVERED BY FUTURE GUARANTORS] 
  
 SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of [        ] among,
[        ], a [        ] corporation and a [direct][indirect] subsidiary of Yellow Roadway Corporation (the “Company”) (the “New Subsidiary
Guarantor”), the existing Subsidiary Guarantors (the “Existing Subsidiary Guarantors”), the Company and SunTrust Bank, a national banking corporation associated under the laws of the state of Georgia, as Trustee under the Indenture
referred to below (the “Trustee”). 
  
 WITNESSETH:

  
 WHEREAS, the Company and the Existing Subsidiary Guarantors
have heretofore executed and delivered to the Trustee an Indenture (as supplemented and in effect, the “Indenture”), dated as of May 24, 2005, providing for the issuance of Senior Floating Rate Notes (the “Securities”);

  
 WHEREAS, Section 4.04 and Section 10.08 of the Indenture
provide that under certain circumstances the Company is required to cause the New Subsidiary Guarantors to execute and deliver to the Trustee a Guaranty Agreement pursuant to which the New Subsidiary Guarantors shall jointly and severally and
unconditionally and irrevocably guarantee the Guaranteed Obligations on the same terms and conditions as those set forth in Article 10 of the Indenture; and 
  
 WHEREAS, pursuant to Section 9.01(4) of the Indenture, the Trustee, the Existing Subsidiary Guarantors and the Company are authorized to execute and
deliver this Supplemental Indenture. 
  
 NOW THEREFORE, in
consideration of the foregoing and for good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Existing Subsidiary Guarantors, the New Subsidiary Guarantor and the Trustee mutually covenant and agree for the
equal and ratable benefit of the Holders of the Securities as follows: 
  
 SECTION 1. Capitalized Terms. Capitalized terms used herein but not defined shall have the meanings assigned to them in the Indenture. 
  
 SECTION 2. Guaranties. The New Subsidiary Guarantor hereby agrees, jointly and severally and unconditionally and irrevocably, with all other
Existing Subsidiary Guarantors, to guarantee the Guaranteed Obligations under the Securities on the terms and subject to the conditions set forth in Article 10 of the Indenture and to be bound by all other provisions of the Indenture applicable to a
Subsidiary Guarantor to the same extent the Existing Subsidiary Guarantors are so bound. From and after the date hereof, the New Subsidiary Guarantor shall be a Subsidiary Guarantor for all purposes under the Indenture and the Securities.

  
 SECTION 3. Ratification of Indenture; Supplemental
Indentures Part of Indenture. Except as expressly amended hereby, the Indenture is in all respects ratified 

  

 
and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of
the Indenture for all purposes, and every Holder of Securities heretofore or hereafter authenticated and delivered shall be bound hereby. 
  
 SECTION 4. Governing Law. THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW
YORK. 
  
 SECTION 5. Trustee Makes No Representation.
The Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture. 
  
 SECTION 6. Counterparts. The parties may sign any number of copies of this Supplemental Indenture, and copies of this Supplemental Indenture may be
separately executed by the different parties hereto in separate counterparts. Each signed copy shall be an original, but all of them together represent the same agreement. 
  
 SECTION 7. Effect of Headings. The Section headings herein are for convenience only and shall not effect the
construction of this Supplemental Indenture. 
  

 2 

 IN WITNESS WHEREOF, the parties have caused this Supplemental Indenture to be duly executed and delivered
as of the date first written above. 
  

					
	YELLOW ROADWAY CORPORATION,
		
	By	 	 
	 	 	 Name:
	 	 
	 	 	 Title:
	 	 
	
	EXISTING SUBSIDIARY GUARANTORS,
	
	Roadway LLC
	Roadway Express, Inc.
	Roadway Next Day Corporation
	Yellow Transportation, Inc.
	Yellow Relocation Services, Inc.
	Yellow Roadway Technologies, Inc.
	MIQ LLC
	Meridian IQ, Inc.
	Globe.com Lines, Inc.
	Mission Supply Company
		
	By	 	 
	 	 	 Name:
	 	 
	 	 	 Title:
	 	 

  

 3 

					
	[NEW SUBSIDIARY GUARANTOR],
		
	By	 	 
	 	 	 Name:
	 	 
	 	 	 Title:
	 	 

  

 4 

					
	SUNTRUST BANK, AS TRUSTEE,
		
	By	 	 
	 	 	 Name:
	 	 
	 	 	 Title:
	 	 

  

 5 

  
 APPENDIX B 
  
 SCHEDULE I 
  
 List of Guarantors 
  
 Roadway LLC 
 Roadway Express, Inc. 
 Roadway Next Day Corporation 
 Yellow Transportation, Inc. 
 Yellow Relocation Services, Inc. 
 Yellow Roadway Technologies, Inc.

 Meridian IQ, Inc. 
 MIQ LLC 
 Globe.com Lines, Inc. 
 Mission Supply Company

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]